
<html lang="en"     class="pb-page"  data-request-id="3e86bd20-2293-43a2-9957-ff15b8bb632d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00570;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes" /></meta><meta name="dc.Creator" content="Andrew S.  Bell" /></meta><meta name="dc.Creator" content="Zhiyong  Yu" /></meta><meta name="dc.Creator" content="Jennie A.  Hutton" /></meta><meta name="dc.Creator" content="Megan H.  Wright" /></meta><meta name="dc.Creator" content="James A.  Brannigan" /></meta><meta name="dc.Creator" content="Daniel  Paape" /></meta><meta name="dc.Creator" content="Shirley M.  Roberts" /></meta><meta name="dc.Creator" content="Charlotte L.  Sutherell" /></meta><meta name="dc.Creator" content="Markus  Ritzefeld" /></meta><meta name="dc.Creator" content="Anthony J.  Wilkinson" /></meta><meta name="dc.Creator" content="Deborah F.  Smith" /></meta><meta name="dc.Creator" content="Robin J.  Leatherbarrow" /></meta><meta name="dc.Creator" content="Edward W.  Tate" /></meta><meta name="dc.Description" content="The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, res..." /></meta><meta name="Description" content="The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, res..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00570" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00570" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00570" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00570" /></link>
        
    
    

<title>Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00570" /></meta><meta property="og:title" content="Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0013.jpeg" /></meta><meta property="og:description" content="The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, resistance, and cost. N-Myristoyltransferase (NMT), an enzyme ubiquitous and essential in all eukaryotes, has been validated via genetic and pharmacological methods as a promising anti-leishmanial target. Here we describe a comprehensive structure–activity relationship (SAR) study of a thienopyrimidine series previously identified in a high-throughput screen against Leishmania NMT, across 68 compounds in enzyme- and cell-based assay formats. Using a chemical tagging target engagement biomarker assay, we identify the first inhibitor in this series with on-target NMT activity in leishmania parasites. Furthermore, crystal structure analyses of 12 derivatives in complex with Leishmania major NMT revealed key factors important for future structure-guided optimization delivering IMP-105 (43), a compound with modest activity against Leishmania donovani intracellular amastigotes and excellent selectivity (&gt;660-fold) for Leishmania NMT over human NMTs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00570"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00570">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00570&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00570&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00570&amp;href=/doi/10.1021/acs.jmedchem.0c00570" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7740-7765</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00564" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00587" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Thienopyrimidine Inhibitors of <i>Leishmania N</i>-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Andrew S. Bell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew S. Bell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+S.++Bell">Andrew S. Bell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0581-9387" title="Orcid link">http://orcid.org/0000-0002-0581-9387</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiyong Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiyong Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiyong++Yu">Zhiyong Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennie A. Hutton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennie A. Hutton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennie+A.++Hutton">Jennie A. Hutton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Megan H. Wright</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Megan H. Wright</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Leeds, Leeds, U.K. LS2 9JT</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Megan+H.++Wright">Megan H. Wright</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2731-4707" title="Orcid link">http://orcid.org/0000-0003-2731-4707</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James A. Brannigan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James A. Brannigan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology Laboratory, York Biomedical Research Institute, Department of Chemistry, University of York, York, U.K. YO10 5DD</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+A.++Brannigan">James A. Brannigan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6597-8972" title="Orcid link">http://orcid.org/0000-0001-6597-8972</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Paape</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Paape</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Immunology and Infection, York Biomedical Research Institute, Department of Biology, University of York, York, U.K. YO10 5NG</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Paape">Daniel Paape</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shirley M. Roberts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shirley M. Roberts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology Laboratory, York Biomedical Research Institute, Department of Chemistry, University of York, York, U.K. YO10 5DD</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shirley+M.++Roberts">Shirley M. Roberts</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charlotte L. Sutherell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charlotte L. Sutherell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charlotte+L.++Sutherell">Charlotte L. Sutherell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5987-4149" title="Orcid link">http://orcid.org/0000-0001-5987-4149</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markus Ritzefeld</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Ritzefeld</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Ritzefeld">Markus Ritzefeld</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9898-4110" title="Orcid link">http://orcid.org/0000-0002-9898-4110</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony J. Wilkinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony J. Wilkinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology Laboratory, York Biomedical Research Institute, Department of Chemistry, University of York, York, U.K. YO10 5DD</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+J.++Wilkinson">Anthony J. Wilkinson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah F. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah F. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Immunology and Infection, York Biomedical Research Institute, Department of Biology, University of York, York, U.K. YO10 5NG</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+F.++Smith">Deborah F. Smith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robin J. Leatherbarrow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robin J. Leatherbarrow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robin+J.++Leatherbarrow">Robin J. Leatherbarrow</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Edward W. Tate</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward W. Tate</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, U.K. W12 0BZ</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#21440f5540554461484c51445348404d0f40420f544a"><span class="__cf_email__" data-cfemail="c0a5eeb4a1b4a580a9adb0a5b2a9a1aceea1a3eeb5ab">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward+W.++Tate">Edward W. Tate</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2213-5814" title="Orcid link">http://orcid.org/0000-0003-2213-5814</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00570&amp;href=/doi/10.1021%2Facs.jmedchem.0c00570" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7740–7765</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 April 2020</li><li><span class="item_label"><b>Published</b> online</span>24 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00570" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00570</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00570"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1878</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00570" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;S. Bell&quot;},{&quot;first_name&quot;:&quot;Zhiyong&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Jennie&quot;,&quot;last_name&quot;:&quot;A. Hutton&quot;},{&quot;first_name&quot;:&quot;Megan&quot;,&quot;last_name&quot;:&quot;H. Wright&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;A. Brannigan&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Paape&quot;},{&quot;first_name&quot;:&quot;Shirley&quot;,&quot;last_name&quot;:&quot;M. Roberts&quot;},{&quot;first_name&quot;:&quot;Charlotte&quot;,&quot;last_name&quot;:&quot;L. Sutherell&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Ritzefeld&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;J. Wilkinson&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;F. Smith&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;J. Leatherbarrow&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;W. Tate&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7740-7765&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00570&quot;},&quot;abstract&quot;:&quot;The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, resistance, and cost. N-Myristoyltransferase (NMT), an enzyme ubiquitous and essential in all eukaryotes, has been validated via genetic and pharmacological methods as a promising anti-leishmanial target. Here we describe a comprehensive structure–activity relationship (SAR) study of a thienopyrimidine series previously identified in a high-throughput screen against Leishmania NMT, across 68 compounds in enzyme- and cell-based assay formats. Using a chemical tagging target engagement biomarker assay, we identify the first inhibitor in this series with on-target NMT activity in leishmania parasites. Furthermore, crystal structure analyses of 12 derivatives in complex with Leishmania major NMT revealed key factors important for future structure-guided optimization delivering IMP-105 (43), a compound with modest activity &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00570&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00570" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00570&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00570" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00570&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00570" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00570&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00570&amp;href=/doi/10.1021/acs.jmedchem.0c00570" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00570" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00570" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00570%26sid%3Dliteratum%253Aachs%26pmid%3D32575985%26genre%3Darticle%26aulast%3DBell%26date%3D2020%26atitle%3DNovel%2BThienopyrimidine%2BInhibitors%2Bof%2BLeishmania%2BN-Myristoyltransferase%2Bwith%2BOn-Target%2BActivity%2Bin%2BIntracellular%2BAmastigotes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7740%26epage%3D7765%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The leishmaniases, caused by <i>Leishmania</i> species of protozoan parasites, are neglected tropical diseases with millions of cases worldwide. Current therapeutic approaches are limited by toxicity, resistance, and cost. <i>N</i>-Myristoyltransferase (NMT), an enzyme ubiquitous and essential in all eukaryotes, has been validated via genetic and pharmacological methods as a promising anti-leishmanial target. Here we describe a comprehensive structure–activity relationship (SAR) study of a thienopyrimidine series previously identified in a high-throughput screen against <i>Leishmania</i> NMT, across 68 compounds in enzyme- and cell-based assay formats. Using a chemical tagging target engagement biomarker assay, we identify the first inhibitor in this series with on-target NMT activity in leishmania parasites. Furthermore, crystal structure analyses of 12 derivatives in complex with <i>Leishmania major</i> NMT revealed key factors important for future structure-guided optimization delivering IMP-105 (<b>43</b>), a compound with modest activity against <i>Leishmania donovani</i> intracellular amastigotes and excellent selectivity (>660-fold) for <i>Leishmania</i> NMT over human NMTs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Leishmaniases are diseases caused by protozoan parasites of the genus <i>Leishmania</i>, which are transmitted to humans by female sandflies of the genera <i>Phlebotomus</i> and <i>Lutzomyia</i>. The clinical symptoms depend on the <i>Leishmania</i> species involved and range from skin ulcers with permanent scars (cutaneous leishmaniasis, CL) to swelling of the spleen and liver (visceral leishmaniasis, VL). Leishmaniasis is distributed worldwide: in 2015, 87 countries were considered endemic for CL and 75 for VL, with 12–15 million people infected and up to 30 000 deaths per year. Three hundred and fifty million people are at risk of infection, and 1 million new cases occur each year.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Therapeutic approaches currently rely on four main drugs: pentavalent antimonials (sodium stibogluconate, SSG), miltefosine, amphotericin B, and paromomycin. However, these drugs are limited by toxicity, cost, and problematic treatment regimens, while drug resistance to SSG has emerged in India.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is therefore important to develop new drugs and therapeutic strategies for leishmaniases.</div><div class="NLM_p"><i>N</i>-Myristoyltransferase (NMT) catalyzes the co-translational N-terminal myristoylation of a wide variety of proteins in all eukaryotes. Recent studies identified NMT as a potential target in drug discovery against diseases caused by fungi<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> and several protozoan parasites, including <i>Plasmodium falciparum</i>,<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a><i>Plasmodium vivax</i>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and <i>Trypanosoma brucei</i>.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Human (host) NMT has also been explored in viral infections, including the common cold, poliovirus, foot-and-mouth disease virus,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> enterovirus,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and HIV,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as well as in cancer.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> In <i>Leishmania</i>, more than 30 high-confidence NMT substrates have been identified, including a number of proteins known to be critical for parasite function, suggesting that NMT inhibition will have pleiotropic effects on the parasite.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24">(19−24)</a> The recent discovery and characterization of DDD100097 have provided pharmacological validation of NMT as a drug target in <i>Leishmania;</i><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> however, significant challenges remain in translating its potent enzymatic activity into <i>in vivo</i> activity while retaining selectivity over human (<i>Hs</i>) NMTs. Despite DDD100097’s potency against the <i>Leishmania major</i> (<i>Lm</i>) NMT and modest activity in intracellular amastigotes (EC<sub>50</sub> 2.4 μM), it only has a 10-fold selectivity over <i>Hs</i>NMTs.</div><div class="NLM_p">We have previously reported peptidomimetic inhibitors of <i>Lm</i>NMT with sub-micromolar potency but minimal selectivity over the two human NMTs 1 and 2,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and a series of small-molecule inhibitors targeting <i>Leishmania donovani</i> (<i>Ld</i>) NMT from an initial benzo[<i>b</i>]thiophene scaffold, with optimized analogues showing minimal host cell toxicity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, neither series inhibited intramacrophage <i>L. donovani</i> amastigotes, the clinically relevant life stage of the parasite, implying problems with stability or poor cellular uptake. In a previous publication, we reported a high-throughput screen (HTS) of <i>Plasmodium falciparum</i> (<i>Pf</i>) NMT and <i>Ld</i>NMT against a 150 000 compound diversity set<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> using a scintillation proximity assay,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> identifying four series with good to excellent selectivity against <i>Ld</i>NMT over other NMTs, based on aminoacylpyrrolidines, piperidinylindoles, thienopyrimidines, and biphenyl derivatives. Subsequently, we reported the binding mode of all four series, elucidated by cocrystallization with <i>Lm</i>NMT,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and these findings were used to improve the potency of the aminoacylpyrrolidines and piperidinylindoles in a structure-guided approach, leading to a 40-fold increased potency and good selectivity over <i>Hs</i>NMTs.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, due to poor cellular uptake, these inhibitors also lacked cell-based activity.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">Here we report a comprehensive structure–activity relationship (SAR) study of the thienopyrimidine series of potent <i>Leishmania</i> NMT inhibitors, improving their selectivity over human NMTs and identifying the first cell-active on-target <i>Ld</i>NMT inhibitors within this series.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A more synthetically accessible analogue of the initial thienopyrimidine HTS-hit, PF-00349412, resulted in a recently published high-resolution crystal structure of derivative <b>1</b> (also known as IMP-083) in complex with <i>Lm</i>NMT<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Interestingly, the structure indicates that two molecules occupy the peptide-binding groove. The ligand proximal to myristoyl-CoA is proposed to be of higher affinity due to its better fit to the electron density maps and its lower mean atomic temperature (<i>B</i>) factor, while the distal ligand is sometimes absent (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">S2A</a>). The basic center in the <i>N</i>-methylpiperidine ring in <b>1</b> is predicted to be 92% protonated at pH 7.4, and in the crystal structure, this group in the proximal ligand is protonated. It forms a hydrogen bond with a water molecule, which in turn may interact with <i>Lm</i>NMT Tyr80, Tyr92, and Asn167, and ion-pairing with the carboxylate of Leu421 is also observed. Aromatic stacking interactions between <i>Lm</i>NMT Tyr217 and the thienopyrimidine system also contribute to the overall recognition (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). The N<sub>4</sub> atom of the pyrimidine ring additionally forms a direct hydrogen bond with Tyr345. The third structural feature of the inhibitor, the nitrile group, is surrounded by <i>Lm</i>NMT Val81, Ala204, and Gly205. The corresponding moiety in the distal ligand may form a hydrogen bond with Asn376. Although the major interactions between <i>Lm</i>NMT and compound <b>1</b> are known, explaining the 17-fold selectivity (IC<sub>50</sub> (<i>Hs</i>NMT1)/IC<sub>50</sub> (<i>Ld</i>NMT)) of the inhibitor (<b>1</b>) for <i>Leishmania</i> NMTs over the human enzyme is not straightforward since all amino acid side chains involved in significant interactions are conserved in human NMT. We hypothesized that conformational preferences in <i>Ld</i>NMT and <i>Lm</i>NMT Tyr217 compared with that of the equivalent <i>Hs</i>NMT1 residue might cause the observed potency differences.<a onclick="showRef(event, 'ref9 ref30'); return false;" href="javascript:void(0);" class="ref ref9 ref30">(9,30)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding pocket of compound <b>1</b> in <i>Lm</i>NMT. (A) Ribbon rendering of <i>Lm</i>NMT color ramped from amino (blue) to carboxy (red) terminus. The atoms of the myristoyl-CoA and <b>1</b> ligands are shown in space-filling representations and colored by atom types C (gray), O (red), N (blue), P (magenta), and S (yellow). (B) Structure of <b>1</b> (also known as IMP-083). (C) Cylinder rendering of the ligands emphasizing the proximal and distal binding sites for a pair of molecules of <b>1</b>, which pack against one another. (D) Binding pocket for <b>1</b> showing the Cα and side chains of <b>1</b>-interacting residues together with the C-terminal residue Leu421 whose α-carboxylate makes an ion-pairing interaction with the tertiary amino group of the proximal ligand. Water molecules in the neighborhood of <b>1</b> are shown as red spheres, and polar protein–ligand interactions are denoted by dashed lines. PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this SAR study, variation in the ligand core and substitutions at the C<sub>2</sub>, C<sub>4</sub>, C<sub>6</sub>, and C<sub>7</sub> positions were all of interest (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The syntheses of lead ligand <b>1</b> and analogues were designed to allow variation at each of these positions, exploiting the ability to selectively displace the 4-chloro substituent of 2,4-dichloropyrimidines to thieno[3,2-<i>d</i>]pyrimidines and other fused heterocyclic cores of interest.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> After synthesis of the heterocyclic core according to literature methods, the C<sub>4</sub> substituent was selectively incorporated by 4-chloro displacement using stoichiometric quantities of the appropriate amine and controlled temperatures. Displacement at the 2-chloro position to generate C<sub>2</sub> analogues, such as <b>2</b>, was then achieved using an excess of a second amine and higher reaction temperatures, often under microwave irradiation (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Correlation of <i>Lm</i>NMT-based and <i>Ld</i>NMT-based pIC<sub>50</sub> values obtained with the CPM assay. The Pearson coefficient (ρ) and P-value are shown. (B) Schematic representation of the SAR results. The four structural segments of the inhibitor are highlighted. All symbols are annotated in the lowest box.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Scheme for the Synthesis of 1 and Related Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine (1.0 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 1.2 equiv), EtOAc, room temperature (rt), 18 h; (ii) amine (4–10 equiv), EtOAc, microwave, 120–200 °C, 30–90 min; (iii) 1-chloroethyl chloroformate (1.0 equiv), DCE, reflux, 1 h; (iv) MeOH, reflux, 1 h; and (v) aldehyde (1.0 equiv), NaBH(OAc)<sub>3</sub>, DCE, rt 3–18 h.</p></p></figure><div class="NLM_p last">However, it was not possible to use a one-step 2-chloro displacement to access compound <b>1</b> or later analogues such as <b>3</b>, <b>10–13</b>, or <b>15–16</b>, either due to the presence of two possible nucleophilic centers in the amine reagent, e.g., <i>N</i>-methylpiperidin-4-amine for analogue <b>10</b>, or limited commercial availability. Attempts to synthesize <i>des</i>-methyl derivatives, for example, using 4-amino-<i>N</i>-methylpiperidine, failed due to a competing demethylation/displacement reaction that led to an inseparable mix of products.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Instead, the additional basic center was protected using a more sterically hindering <i>N</i>-benzyl group during the displacement reaction and then deprotected in a two-step process, generally using 1-chloroethyl chloroformate and methanol.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The resulting secondary amine could be derivatized using reductive amination to give the desired products. This methodology was successfully applied to generate compound <b>1</b> and also analogues with quinazoline cores (<b>3</b>) or molecules containing linear- (<b>11</b>, <b>15</b>), pyrrolidine- (<b>26</b>, <b>52</b>, <b>53</b>), or piperidine-based amines at the C<sub>2</sub> position (<b>12</b>, <b>13</b>). Detailed procedures for the different cores and scaffolds are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Activity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A fluorogenic assay was used to analyze the potency of all inhibitors against <i>Ld</i>, <i>Lm</i> NMTs, and <i>Hs</i>NMT1.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The assay quantifies the amount of coenzyme A liberated during the acyl transfer reaction using the fluorogenic thiol-reactive dye 7-diethylamino-3-(4-maleimido-phenyl)-4-methylcoumarin (CPM). Initial analysis of a selection of 11 compounds against both <i>Leishmania</i> NMTs revealed a strong correlation in activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), as expected from the sequence alignment of the enzymes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S1</a>), with an identity of 98%. Due to the varied availability of the <i>Ld</i>NMT and <i>Lm</i>NMT enzymes, enzymatic activity data for ligands against both <i>Ld</i>NMT and <i>Lm</i>NMT enzymes was considered during the SAR analysis. Cocrystal structures were generated solely with <i>Lm</i>NMT thanks to the capacity to solve structures rapidly by soaking ligands into crystals of this protein. The SAR findings are summarized schematically in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B.</div><div class="NLM_p">In our previous structural analysis,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> it was proposed that conformational variations between human and <i>Leishmania</i> NMTs in <i>Lm</i>NMT Tyr217 might be responsible for selectivity differences.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> To assess the impact of the π interaction, we initially investigated the importance of the inhibitor core by exchanging the thienopyrimidine (<b>1</b>, <b>2</b>) with a quinazoline (<b>3</b>, <b>4</b>), a pyridopyrimidine (<b>5</b>), a purine (<b>6</b>), or a monocyclic pyrimidine (<b>7</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Thienopyrimidines (<b>1</b>, <b>2</b>), quinazolines (<b>3</b>, <b>4</b>), and pyridopyrimidine (<b>5</b>) exhibit comparable potency and selectivity profiles in this series, supported by an overlay of the crystal structures of compounds <b>1</b> and <b>3</b> in complex with <i>Lm</i>NMT (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A), which reveals an identical binding mode for both compounds. In contrast, inhibitory potency is entirely lost in the case of purine (<b>6</b>) and pyrimidine (<b>7</b>) derivatives, which may be due to reduced lipophilicity compared with those of <b>2</b> and <b>4</b>. We therefore focused our subsequent SAR study on C<sub>2</sub>, C<sub>4</sub>, and C<sub>6</sub>/C<sub>7</sub> substituents on thienopyrimidine and quinazoline cores to obtain small-molecule inhibitors with enhanced potency.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the modes of binding of selected inhibitors with varied cores or C<sub>2</sub> substitution. MyrCoA is not shown in the binding site, for clarity. Stereo renderings can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S3</a>. (A) <b>1</b> and <b>3</b> emphasizing the highly similar binding modes of the proximal ligand pair, which differ only in the core substitution of the thienopyrimidine for a quinazoline. Protein carbons: light green or green; ligand carbons: gray, dark gray; and waters: crimson or red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, 6qda. (B) <b>1</b>, <b>10</b>, and <b>12</b> exploring <i>N</i>-substitutions on the piperidine ring. As before, the proximal ligands are closely superimposable. The same is true of the distal ligands, with the exception of the piperidine ring, which is significantly displaced in the ethyl-substituted <b>12</b>. Protein carbons: light green, green, lawn green; ligand carbons: gray, dark gray, light gray; and waters: crimson, red, violet red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb">6qdb</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc">6qdc</a>. (C) <b>1</b> and <b>2</b> probing the significance of linear versus cyclic amine extensions from C<sub>2</sub> of the core. The proximal ligand’s binding mode is altered in <b>2</b>, with tilting of the thienopyrimidine core, dual conformations of the C<sub>2</sub> amine extension, and repositioning of the C<sub>4</sub> aminopropionitrile. No distal ligand was observed in the <i>Lm</i>NMT complex with <b>2</b>. Protein carbons: light green or green; ligand carbons: gray, dark gray; and waters: crimson or red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9">6qd9</a>. (D) Chemical structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Changing Core Structures on Enzyme- and Cell-Based Activities<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0009.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Selectivity = IC<sub>50</sub> (<i>Hs</i>NMT1)/IC<sub>50</sub> (<i>Ld</i>NMT<i>)</i>. LipE = pIC<sub>50</sub> – clog <i>P</i>; where values for <i>Ld</i>NMT and <i>Lm</i>NMT were obtained, the average LipE is reported. EC<sub>50</sub> for intracellular <i>L. donovani</i> amastigotes.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Toxicity against bone-marrow-derived macrophages; nAUC, normalized area under the curve. The dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S6–S10</a>.</p></div></div><div></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effect of C<sub>2</sub> Substitution on <i>Ld</i>NMT and <i>Lm</i>NMT Enzyme Activities</h3><div class="NLM_p">We first looked at the effect of variation in the C<sub>2</sub> unit (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Exchanging the piperidine for a tetrahydropyran (<b>8</b>) or hydroxypropyl substituent (<b>9</b>) resulted in complete loss of activity. Considering the striking differences in basicity and hydrogen-bond interaction energies,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> these findings support the importance of the basic center, consistent with the binding mode of compound <b>1</b> and trends in previously reported ligand series.<a onclick="showRef(event, 'ref11 ref25 ref30'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref30">(11,25,30)</a> The potency deviation between a tertiary (<b>1</b>–<b>4</b>) or secondary amine as the basic center (<b>10</b>–<b>11</b>, <b>23</b>) is negligible, presumably due to calculated p<i>K</i> differences of less than one unit (compound <b>2</b> p<i>K</i><sub>b</sub> = 4.6; compound <b>11</b> p<i>K</i><sub>b</sub> = 3.8). However, further extending the <i>N</i>-methyl substituent or inserting an aromatic system (<b>12</b>–<b>16</b>, <b>20</b>) gradually decreases the inhibitory potency, presumably because the steric demand of the moiety is limited by the size of the pocket formed by <i>Lm</i>NMT Tyr80, Tyr92, Asn167, Thr203, and Leu421, and myristoyl-CoA (MyrCoA). While the crystal structures of <b>1</b>, <b>10</b>, and <b>12</b> in complex with <i>Lm</i>NMT (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) show that these compounds are well accommodated and show similar binding modes, the basic centers in the C<sub>2</sub> substituents of the distal ligands deviate from <b>10</b> to <b>1</b> by 0.8 Å and from <b>1</b> to <b>12</b> by 1.5 Å due to steric interactions with Asp396. However, these small differences are likely unimportant since the proximal ligand appears to drive inhibition. Between the overlaid proximal ligands, there is even greater similarity; for example, the basic centers deviate by only 0.2 Å. Enhancing the flexibility of the basic center by applying acyclic amine-based C<sub>2</sub> substituents (<b>2</b>, <b>4</b>) has no effect on the inhibitory activity against <i>Ld</i>NMT. Considering sequence alignment (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S1</a>), the same result was expected for <i>Lm</i>NMT; however, <b>2</b> and <b>4</b> exhibited a 10-fold decreased activity against the <i>L. major</i> enzyme. The corresponding crystal structure of <b>2</b> with <i>Lm</i>NMT shows a small displacement of the core and dual conformations of the C2 derivatives in the linear amine side chain compared with <b>1</b>, while no electron density was observed for the distal ligand, suggesting it is absent (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). There is also a significant difference observed in the position of the aminopropionitrile group: instead of occupying a groove composed of <i>Lm</i>NMT Val81 and Gly205 as in <b>1</b>, the moiety is vertically aligned in compound <b>2</b>. It is possible therefore that the orientation of the C<sub>2</sub> substituent in <b>2</b> and <b>4</b> varies between the two <i>Leishmania</i> enzymes.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Changing C<sub>2</sub> Substitution Using Thienopyrimidine and Quinazoline Cores (Compounds <b>8</b>–<b>30</b>)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">95% CI = 95% confidence interval. Selectivity = IC<sub>50</sub> (<i>Hs</i>NMT)/IC<sub>50</sub> (<i>Ld</i>NMT<i>)</i>. LipE = pIC<sub>50</sub> – clog <i>P</i>; where values for <i>Ld</i>NMT and <i>Lm</i>NMT were obtained, the average LipE is reported. EC<sub>50</sub> for intracellular <i>L. donovani</i> amastigotes.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Toxicity against bone-marrow-derived macrophages; nAUC, normalized area under the curve. The dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S6–S10</a>.</p></div></div><div></div></div><div class="NLM_p">Significantly changing the geometry of the C<sub>2</sub> substituent and thereby decreasing the distance between the basic center and the core resulted in decisively reduced inhibitory potency and selectivity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). This occurs if piperazine- (<b>17</b>–<b>18</b>), pyrrolidine-amine- (<b>19</b>, <b>25</b>–<b>26</b>, <b>53</b>–<b>55</b>), or inverted piperidine-amine (<b>20–22</b>)-based moieties are substituted on either thienopyrimidine or quinazoline cores, suggesting that the basic center and the bicyclic core must adopt a specific conformation to permit optimal interactions in the peptide-binding pocket of <i>Lm</i>NMT. The crystal structure of compound <b>52</b>, which is discussed further below, supports this rationalization (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The geometry of the basic center and bicyclic core seems to be optimal in compound <b>1</b>. Further increasing degrees of freedom (<b>2</b>, <b>4</b>) appears to be counterproductive and results in a decreased activity in <i>Lm</i>NMT as discussed above. Increasing the rigidity and bulkiness of the piperidine ring using a bicyclic system (<b>27</b>) diminishes the inhibitory activity against both <i>Ld</i> and <i>Lm</i>NMT.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the modes of binding of selected inhibitors with varied C<sub>4</sub> or C<sub>6</sub> substitution. For clarity, MyrCoA is not shown in the binding site. Stereo renderings can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S4</a>. (A) <b>1</b> and <b>43</b> demonstrate similar binding interactions despite the rigidification of the aminopropionitrile. The distal ligand does not appear, and <b>43</b> demonstrates dual conformations of the C<sub>2</sub> substituent. Protein carbons: light green, green; ligand carbons: gray, dark gray; and waters: crimson, red, violet red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd">6qdd</a>. (B) Chemical structures of relevant ligands. (C, D) <i>tert-</i>Butyl C<sub>6</sub> substitution is accommodated in the proximal ligands for <b>51</b> and <b>52</b>. However, the distal ligand conformation is inverted in <b>51</b> and dual C<sub>2</sub> conformations are observed in <b>52</b>, which is present at partial occupancy PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde">6qde</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf">6qdf</a>. (E) <b>2</b> and <b>56</b> have analogous binding modes with an additional hydrogen bond in <b>56</b> mediated by the bromine substituent. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg">6qdg</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, we explored whether variation at the first amine in the C<sub>2</sub> substituent was tolerated. Extending the alkyl chain with a hydroxyethyl (<b>28</b>) or hydroxypropyl (<b>29</b>–<b>30</b>) group decreases inhibitory potency, presumably due to the increased steric demand.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effect of C<sub>4</sub> Substitution on <i>Ld</i>NMT and <i>Lm</i>NMT Enzyme Activities</h3><div class="NLM_p">Substitution at C<sub>4</sub> was shown to be crucial as compound <b>31</b>, a derivative of <b>2</b> lacking the aminopropionitrile in position C<sub>4</sub>, was no longer active. We explored the effect of differing substituents at this position using linear moieties of similar size that, like the aminopropionitrile, were also potential hydrogen-bond acceptors. The results indicate that alkyl ethers (<b>32</b>–<b>33</b>), amino alcohols (<b>34</b>–<b>35</b>, <b>39</b>), and amino amides (<b>36</b>–<b>38</b>) are not tolerated but increasing the rigidity of the alkyl ethers with a pyrrolidine motif (<b>40</b>–<b>42</b>) restores the inhibitory activity. However, applying the same strategy to the aminopropionitriles (<b>43</b>–<b>45</b>) failed to improve their potency.</div><div class="NLM_p">It had been noted that the aminopropionitrile side chains had different geometries in the proximal and distal ligands (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S5</a>). Therefore, only one enantiomer was made for compounds <b>40–45</b>, in which the geometry was proposed to match the pro-stereochemistry observed in the proximal ligand in previous structures such as <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A. Theoretically, the proximal ligands should still be able to bind, but the C<sub>4</sub> side chain would clash in the distal ligand and be unable to bind (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Changing C<sub>4</sub> and C<sub>2</sub> Substitutions on Enzyme- and Cell-Based Activities (Compounds <b>31</b>–<b>49</b>)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0011.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">95% CI = 95% confidence interval. Selectivity = IC<sub>50</sub> (<i>Hs</i>NMT)/IC<sub>50</sub> (<i>Ld</i>NMT). LipE = pIC<sub>50</sub> – clog <i>P</i>; where values for <i>Ld</i>NMT and <i>Lm</i>NMT were obtained, the average LipE is reported. nAUC, normalized area under the curve. The dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S6–S10</a>.</p></div></div><div></div></div><div class="NLM_p">This was supported by the crystal structures of <b>1</b> and <b>43</b> in complex with <i>Lm</i>NMT, which indicated a similar binding mode for both proximal ligands, with little deviation between the cores and C<sub>4</sub> substituents, and no distal ligand present. However, the structure of <b>43</b> does show two possible conformations of the C<sub>2</sub> substituent (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). This result also helps confirm that the proximal ligand is of primary importance for activity.</div><div class="NLM_p last">To test the impact of the nitrile group, analogues with a simple amino ethyl moiety at C<sub>4</sub> were synthesized (<b>46</b>–<b>49</b>). Interestingly, this simple group is sufficient to deliver small-molecule inhibitors with moderate activity, although at the cost of a slight drop in selectivity over <i>Hs</i>NMT1 (<b>46</b> compared with <b>1</b> or <b>43</b>). This finding supports the hypothesis that the main role of the substituent in position C<sub>4</sub> is to facilitate ideal positioning of the major interaction sites—the aromatic core and the basic center in the C<sub>2</sub> moiety—mainly via hydrophobic interactions.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of Substitution at C<sub>6</sub> on <i>Ld</i>NMT and <i>Lm</i>NMT Enzyme Activities</h3><div class="NLM_p">Finally, we probed the effect of substitution at C<sub>6</sub> in combination with a range of C<sub>2</sub> substituents. Modifications here are generally tolerated and do not prevent binding to <i>Leishmania</i> NMTs. Introducing a bulky <i>tert</i>-butyl group (<b>50</b>–<b>54</b>) results in a 10-fold increased inhibitory potency (<b>50</b>) and a similar selectivity profile when compared with derivatives without a C<sub>6</sub> substituent. Compound <b>50</b> is the most potent inhibitor in this SAR study, with a 7-fold improved IC<sub>50</sub> value against <i>Ld</i>NMT of 46 nM (95% CI: 35–60 nM) and a similar selectivity (IC<sub>50</sub>(<i>Hs</i>NMT1)/IC<sub>50</sub>(<i>Ld</i>NMT) = 12-fold) to that of compound <b>1</b>. The crystal structures of <b>51</b> and <b>52</b> in complex with <i>Lm</i>NMT reveal that the <i>tert</i>-butyl group has only a modest impact on the binding mode of the proximal ligand (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C,D). However, the distal ligand exhibits a flipped orientation in <b>51</b>, most likely due to the steric demand of the C<sub>6</sub> moiety that alters the conformation of <i>Lm</i>NMT His219 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). In the structure with <b>52</b>, there is only partial ligand occupancy; moreover, the pyrrolidine moiety at the C<sub>2</sub> position in the proximal ligand displays two alternate conformations. As a result, key interactions of the basic center with the Leu421 carboxylate and the water molecule bound to <i>Lm</i>NMT Tyr80, Tyr92, and Asn167 are weakened and make a smaller contribution to binding (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Considering the potency difference between <b>51</b> and <b>52</b>, this observation corroborates our hypothesis that decreased activities of <b>18–22</b>, <b>25</b>–<b>26</b>, and <b>52–54</b> are caused by conformational deviations in the C<sub>2</sub> moiety.</div><div class="NLM_p">Substitution at C<sub>6</sub>/C<sub>7</sub> on the quinazoline core was also explored. Inhibitors with bromo (<b>55</b>–<b>57</b>), methoxy (<b>58</b>–<b>59</b>), or aromatic substituents (<b>60</b>–<b>62</b>) in position C<sub>6</sub> exhibit comparable activity and selectivity in comparison to compounds lacking a C<sub>6</sub> moiety. The crystal structure of compound <b>56</b> in complex with <i>Lm</i>NMT indicates similar binding modes of the bromo (<b>56</b>) and the corresponding thienopyrimidine derivative (<b>2</b>). An additional interaction is potentially formed between the bromide and a water molecule bound to His219 and the backbone amide of Asp396 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). In contrast to substitution at C<sub>6</sub>, moving the methoxy group from C<sub>6</sub> (<b>59</b>) to C<sub>7</sub> (<b>63</b>) significantly decreases the inhibitory potency.</div><div class="NLM_p">Although the SAR discussed so far (compounds <b>1</b>–<b>63</b>) revealed some derivatives with significantly improved nanomolar potency with respect to initial compound <b>1</b> (e.g., <b>43</b> and <b>50</b>), none of them exhibit lipophilic efficiency (LipE; LipE = pIC<sub>50</sub> – clog <i>P</i>) values above 4 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Previous work on inhibitors for NMT in <i>Trypanosoma brucei</i><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and <i>P. vivax</i><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> established that interactions around <i>Pv</i>NMT Ser319 (<i>Lm</i>NMT Ser330) are important for higher affinity compounds. In this thienopyrimidine series, the proximal ligand does not extend into this pocket, which is occupied by the distal ligand. To try and grow into this pocket, and to further improve the molecules’ drug-like properties, a fragment merging approach with DDD85646<a onclick="showRef(event, 'ref11 ref39'); return false;" href="javascript:void(0);" class="ref ref11 ref39">(11,39)</a> a <i>T. brucei</i> NMT inhibitor was trialed. Crystallography performed on DDD85646 in <i>Lm</i>NMT had shown that the sulfonamide group projected the pyrazole into the desired pocket, forming a hydrogen bond to <i>Lm</i>NMT Ser330 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Plot of pIC<sub>50</sub> against clog <i>P</i>. Diagonal lines represent areas of corresponding lipophilic efficiency (LipE) values. (B) Plot of LipE against selectivity (selectivity = IC<sub>50</sub> (<i>Hs</i>NMT)/IC<sub>50</sub> (<i>Ld</i>NMT)). (C) Schematic representation of fragment merging strategy between <b>3</b> and <b>DDD85646</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> to generate <b>64</b> and related analogues. (D) Crystal structure of <b>1</b> and <b>64</b> in complex with <i>Lm</i>NMT. <b>64</b> principally occupies the site of the proximal ligand in <b>1</b> extending through the sulfonamide group, which forms hydrogen bonds with the <i>Lm</i>NMT backbone amide. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh">6qdh</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of Changing C<sub>2</sub> and C<sub>6/7</sub>  Substitutions and Fragment Merging on Enzyme- and Cell-Based Activities (Compounds <b>50</b>–<b>67</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">95% CI = 95% confidence interval. Selectivity = IC<sub>50</sub> (<i>Hs</i>NMT)/IC<sub>50</sub> (<i>Ld</i>NMT). LipE = pIC<sub>50</sub> – log <i>P</i>; where values for <i>Ld</i>NMT and <i>Lm</i>NMT were obtained, the average LipE is reported. nAUC, normalized area under the curve. The dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S6–S10</a>.</p></div></div><div></div></div><div class="NLM_p">Merged ligands were therefore proposed, in which a sulfonamide and pyrazole group would grow off the C<sub>6</sub> position (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C), The strongly acidic reaction conditions required for chlorosulfonylation of the quinazoline core were not compatible with the aminopropionitrile side chain; hence, this modification was attempted on the more accessible N-ethyl derivative, given that analogues <b>46</b>–<b>49</b> still retained some activity. These efforts resulted in the pyrazole-based sulfonamide derivatives <b>64</b>–<b>67</b>.</div><div class="NLM_p">These compounds have lower clog <i>P</i> values and combine the major interactions of the distal and the proximal ligands. The crystal structure of <b>64</b> in complex with <i>Lm</i>NMT (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) demonstrates the success of this approach. The quinazoline core and C<sub>2</sub> substituent of <b>64</b> exhibit the same conformation in the peptide-binding pocket as the proximal ligand of <b>1</b>, while the pyrazole moiety of <b>64</b> coincides with the aromatic system of the distal ligand of <b>1</b>. Additionally, the sulfonamide group of <b>64</b> mediates a hydrogen bond with the backbone amides of Gly395 and Asn396. Analysis of the potency of all sulfonamide derivatives (<b>64</b>–<b>67</b>) revealed decisively improved IC<sub>50</sub> values in comparison to the corresponding thienopyrimidine derivatives, resulting in LipE values above 5 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A).</div><div class="NLM_p last">However, a significant drawback of this new subseries is their lower selectivity in relation to <i>Hs</i>NMT1. For instance, inhibitors <b>65</b> and <b>66</b>, respectively, exhibit a decreased and marginal selectivity of only 5.2- and 4.6-folds (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). It is proposed that exchanging the amino ethyl C<sub>4</sub> substituent with aminopropionitrile could result in sulfonamides with improved selectivity over <i>Hs</i>NMT1 and better early lead-compound properties. However, these molecules have proven synthetically challenging, and the corresponding derivatives will be part of future studies.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Cell-Based Assays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24665" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24665" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A selection of 22 compounds was further studied in an Alamar blue-based cellular assay, which had been previously validated against known anti-leishmanial drugs amphotericin B and miltefosine,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to quantify their cytotoxicity against macrophages and their activity against intracellular amastigotes of <i>L. donovani</i>. Due to the steep slope of the toxicity profile and the correspondingly low accuracy of the CC<sub>50</sub> values, the normalized area under the curve (nAUC) was used as the toxicity parameter (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Strikingly, all compounds with an EC<sub>50</sub> below 50 μM that show a toxic effect against macrophages (nAUC ≪ 1) share the <i>tert</i>-butyl group as C<sub>6</sub> substituent (<b>50</b>–<b>53</b>). This increased effect on macrophages may be due to the larger clog <i>P</i> and clog <i>D</i> values of compounds <b>50</b>–<b>53</b>, potentially improving membrane permeability or increasing compound promiscuity. Comparing pIC<sub>50</sub> values against <i>Leishmania</i> NMT with intracellular amastigote pEC<sub>50</sub> values indicates a good correlation for all compounds apart from <b>26</b>, <b>52</b>, and <b>53</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), which show greater potency in cells than anticipated. Interestingly, these three inhibitors are the only derivatives tested that share a pyrrolidine-based C<sub>2</sub> moiety (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Plot of anti-<i>L. donovani</i> amastigote activity (pEC<sub>50</sub>) against macrophage toxicity (normalized area under the curve, nAUC). Thienopyrimidine <b>1</b> is highlighted in blue. (B) Plot of <i>Leishmania</i> NMT pIC<sub>50</sub> (either <i>Ld</i> or <i>Lm</i>) against cell-based pEC<sub>50</sub>. A significant correlation (ρ = 0.75, <i>P</i> = 0.0006) is evident if <b>26</b>, <b>52</b>, and <b>53</b> (highlighted in red) are excluded. Compound <b>1</b> is highlighted in blue. (C–E) In-gel fluorescence and anti-<i>Ld</i>NMT Western blot results for the cell-based tagging assay. (F) Fluorescence intensities of several individual bands between 25 and 15 kDa were quantified in (C–E) and normalized to the corresponding intensities of the control samples (without inhibitor) and the anti-<i>Ld</i>NMT blot results. Tagging IC<sub>50</sub> values (TC<sub>50</sub>) were extracted by nonlinear regression with a sigmoidal dose–response model (constraints: bottom = 0; top = 1.0) to the mean normalized intensity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furthermore, <b>26</b> and <b>52</b> exhibit a 3- to 6-fold improved EC<sub>50</sub> value with respect to compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). To test the hypothesis that this improved potency is due to an on-target effect, a cell-based tagging assay<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was performed with <b>1</b>, <b>26</b>, and <b>52</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C–F). Briefly, <i>L. donovani</i> amastigotes were treated with varying concentrations of the corresponding compound and YnMyr, an alkyne analogue of myristic acid.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Following cell lysis, labeling with a trifunctional capture reagent<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> via copper-catalyzed azide–alkyne cycloaddition facilitated the visualization of myristoylated proteins by in-gel fluorescence. Western blot analysis using an antibody against <i>Ld</i>NMT revealed no variations of the total protein amount or the NMT expression level over the investigated inhibitor concentration range (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C–E), and all three compounds (<b>1</b>, <b>26</b>, and <b>52</b>) significantly decreased myristoylation in a dose-dependent manner. To obtain the tagging IC<sub>50</sub> value (TC<sub>50</sub>), a quantitative measure of target engagement, the fluorescence intensities of several individual bands between 25 and 15 kDa were quantified and normalized to the corresponding intensities of the control sample (no inhibitor) and the anti-<i>Ld</i>NMT blot results (loading control). The TC<sub>50</sub> and EC<sub>50</sub> values of compound <b>1</b> are in good agreement, indicating that the anti-<i>L. donovani</i> activity is due to on-target NMT inhibition (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>F). However, the TC<sub>50</sub> values of compounds <b>26</b> and <b>52</b> are both 5- to 6-fold above the EC<sub>50</sub> values obtained with the Alamar blue assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Although compounds <b>26</b> and <b>52</b> do not show toxic off-target effects against macrophages, these findings suggest that nonspecific effects may also contribute to the anti-<i>L. donovani</i> activity for these compounds.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NMT inhibitors with a fused pyrimidine core exhibit three sites involved in interactions with the enzyme: the aromatic system of the core, an amine-based C<sub>4</sub> moiety, and the basic center in the C<sub>2</sub> substituent. The central scaffold forms stacking interactions with Tyr217, with scaffold lipophilicity particularly being important. The reason for C<sub>4</sub> preference is less evident; although it does not appear to form any important interactions with the protein, its contribution to affinity may be through the quality of its packing with the C<sub>2</sub> substituent. In the case of the C<sub>2</sub> substituent, our data show that a specific geometry is essential for the appropriate positioning of the basic center. Although linear C<sub>2</sub> moieties are well tolerated, exchanging the piperidine with a pyrrolidine system results in decreased activity against NMT due to a flipped orientation in the binding pocket, leading to a different set of hydrogen bonds. Remarkably, the corresponding derivatives exhibit a significantly improved anti-Leishmanial activity. In fact, compounds <b>26</b> and <b>52</b> are the most potent derivatives in the cellular assay that additionally show no toxic effect against macrophages. However, results from the tagging assay suggest that although <b>26</b> and <b>52</b> cause a dose-dependent decrease in protein-myristoylation, off-target effects may also contribute to anti-leishmanial activity. This explanation is supported by the fact that the pyrrolidine-based derivatives (<b>26</b>, <b>52</b>, and <b>53</b>) are the only inhibitors that deviate from the correlation between enzyme- and cell-based potencies. A particularly promising new inhibitor, IMP-105 (<b>43</b>), exhibits enhanced selectivity for <i>Leishmania</i> NMT over human NMT1 of >660-fold, while both enzyme- and cell-based activities are maintained (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Considering the importance of selectivity, IMP-105 (<b>43</b>) is a useful tool molecule to investigate the impact of NMT inhibition in <i>Leishmania</i>. However, as yet, these compounds do not have the optimal potency or pharmacokinetic properties to enable <i>in vivo</i> experiments to be undertaken to confirm whether these compounds can reduce parasite burden <i>in vivo</i>. Future studies to further improve the potency and properties of these compounds will focus on the combination of the improved selectivity features shown in compound <b>43</b> with the improved inhibitory activities and LipE values of the pyrazole-based sulfonamides displayed by compounds <b>64</b>–<b>67</b>.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison between ligands <b>1</b> and <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry General Methods</h3><div class="NLM_p">With the exception of those described in the following sections, all chemicals were purchased from Sigma-Aldrich Ltd. (Gillingham, U.K.), Apollo Scientific (Stockport, U.K.), Acros Organics (Geel, Belgium), Alfa Aesar (Heysham, U.K.), or TCI-UK (Oxford, U.K.) and were used without further purification.</div><div class="NLM_p">Microwave-assisted experiments were undertaken on a Biotage Initiator using Biotage microwave vials (2–5 mL), which were sealed and heated to the targeted temperature using variable power to maintain the set temperature.</div><div class="NLM_p">Flash column chromatography of compounds was undertaken either using an Isolera One (Biotage) or manually on silica gel (silicagel 60 [40–63 μm]) using glass columns and an appropriate solvent mixture.</div><div class="NLM_p">High-performance liquid chromatography (HPLC) of compounds was undertaken using a Gilson semipreparative reverse-phase HPLC system equipped with a HICHROM C18 Column (250 mm × 21.2 mm), #306 pumps, and a Gilson UV/vis detector, detecting at 220 nm. For the latter, the mobile phase consisted of water + 0.1% formic acid (solvent A) and methanol + 0.1% formic acid (solvent B), with an elution method of 0–2 min 5% B, 2–30 min 5–98% B, 30–32 min 98% B, and 32–32.5 min 2% B at a flow rate of 12 mL/min.</div><div class="NLM_p">For liquid chromatography-mass spectrometry (LC-MS), the compounds were purified and analyzed on an LC-MS system equipped with both an XBridge prep C18 5 μm, 19 mm × 100 mm OBD column, and an XBridge C18 5 μm, 4.6 mm × 100 mm column. Unless specified otherwise, all compounds were analyzed over a gradient of methanol in water (5–98% over 12 min and then 98% methanol for 3 min at a flow rate of 1.2 mL/min), both containing 0.1% formic acid. Alternative gradient elutions started from 20 or 50% methanol for the same time periods. Retention times (<i>R</i><sub>t</sub>) and mass peaks (MH<sup>+</sup>) were recorded, and purity was determined as >95% by integration of the diode array trace, unless otherwise stated.</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 101 MHz, respectively, on Bruker AV instruments at room temperature and referenced to residual solvent signals. Data are presented as follows: chemical shift in ppm, multiplicity (br = broad, app = apparent, s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet), coupling constants in Hz, and integration.</div><div class="NLM_p last">High-resolution mass spectra were obtained from the Mass Spectrometry Service of the Department of Chemistry, Imperial College London.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Synthetic Methods</h3><div id="sec7_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Method for C<sub>4</sub> Displacements (<b>Method A</b>)</h4><div class="NLM_p last">To a solution of the appropriate 2,4-dichloro-fused pyrimidine intermediate (1.0 equiv) in EtOAc (10 mL) was added DIPEA (1.2 equiv) followed by the appropriate amine (1.0 equiv), and the reaction was stirred at room temperature overnight. The reaction mixture was washed with sodium hydroxide solution (1 M, 10 mL), and the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and then concentrated under reduced pressure. Where necessary, the crude product was purified by flash column chromatography.</div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Method for Displacement at C<sub>2</sub> (<b>Method B</b>)</h4><div class="NLM_p last">The appropriate 4-amino-2-chloro-fused pyrimidine (1.0 equiv) was suspended in EtOAc (1 mL) in a 2 mL Biotage microwave vial. An excess of the appropriate amine (4–10 equiv) was added, and the vial was sealed. The closed vial was heated in a Biotage Initiator microwave oven for 30–90 min to a fixed target temperature of between 120 and 180 °C depending on the molecule. The reaction mixture was partitioned between EtOAc (20 mL) and sodium hydroxide solution (1 M, 10 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash column chromatography or by reverse-phase HPLC. Fractions containing the desired product were combined and evaporated under reduced pressure or partially evaporated and lyophilized after HPLC purification.</div></div><div id="sec7_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Method for Debenzylation (<b>Method C</b>)</h4><div class="NLM_p last">A solution of the appropriate <i>N</i>-benzyl derivative in 1,2-dichloroethane (DCE, 5.0 mL) was cooled to 0 °C before the addition of 1-chloroethyl chloroformate (ACE-Cl, 1.0 equiv). The reaction mixture was heated under reflux for 1 h, cooled to room temperature, and then evaporated to dryness. The intermediate was redissolved in methanol (5.0 mL) and returned to reflux for a further 1 h. The reaction mixture was evaporated once again and partitioned between EtOAc (10 mL) and sodium hydroxide solution (1 M, 10 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash column chromatography or by reverse-phase HPLC. Fractions containing the desired product were combined and evaporated under reduced pressure or partially evaporated and lyophilized after HPLC purification.</div></div><div id="sec7_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Method for Reductive Amination (<b>Method D</b>)</h4><div class="NLM_p last">A solution of the appropriate amine in DCE was treated with a solution of the appropriate aldehyde (1–10 equiv) in DCE. The solution was stirred at room temperature for 15 min before being treated with solid sodium triacetoxyborohydride (4–10 mol equiv). The mixture was stirred for 3–18 h at room temperature until complete by thin-layer chromatography (TLC) and then partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and saturated NaHCO<sub>3</sub> solution (10 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and the crude product was purified by reverse-phase HPLC. Fractions containing the desired product were partially evaporated and lyophilized after HPLC purification.</div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of Final Compounds</h3><div id="sec7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(Methyl(2-(methyl(1-methylpiperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>1</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, 3-(methyl(2-(methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>11</b>, 0.033 g, 0.1 mmol) was dissolved in DCE (3 mL) and treated with paraformaldehyde (6.0 mg, 0.2 mmol). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (85 mg, 0.4 mmol) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>1</b>) as a formate salt (24.9 mg, 0.064 mmol, 64%). LC-MS <i>R</i><sub>t</sub> = 5.9 min; MH<sup>+</sup> 345; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.38 (s, 2H), 7.94 (d, <i>J</i> = 5.5 Hz, 1H), 7.20 (d, <i>J</i> = 5.5 Hz, 1H), 4.99–4.95 (m, 1H), 4.08 (t, <i>J</i> = 6.6 Hz, 2H), 3.64–3.59 (m, 2H), 3.56 (s, 3H), 3.20 (dt, <i>J</i> = 12.8, 3.0 Hz, 2H), 3.07 (s, 3H), 2.93 (t, <i>J</i> = 6.6 Hz, 2H), 2.88 (s, 3H), 2.19 (dq, <i>J</i> = 12.9, 3.6 Hz, 2H), 2.01–1.95 (m, 2H). ESI HRMS, found 345.1875 (C<sub>17</sub>H<sub>25</sub>N<sub>6</sub>S, [M + H]<sup>+</sup>, requires 345.1861).</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>2</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (50.0 mg, 0.20 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (0.5 mL, 2 mmol). After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>2</b>) as the formate salt (12 mg, 0.032 mmol, 16%). LC-MS <i>R</i><sub>t</sub> = 3.8 min; MH<sup>+</sup> 333; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 7.61 (d, <i>J</i> = 5.5 Hz, 1H), 7.14 (d, <i>J</i> = 5.5 Hz, 1H), 4.00 (t, <i>J</i> = 7.0 Hz, 2H), 3.70 (t, <i>J</i> = 7.0 Hz, 2H), 3.55 (s, 3H), 3.15 (s, 3H), 2.81 (t, <i>J</i> = 7.0 Hz, 2H), 2.65 (t, <i>J</i> = 7.0 Hz, 2H), 2.48 (s, 6H), 2.03–1.88 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>), δ 186.3, 167.8, 163.9, 160.3, 157.9, 132.1, 124.2, 118.6, 56.6, 47.7, 47.3, 44.4, 38.5, 35.6, 24.8, 16.3; ESI HRMS, found 333.1861 (C<sub>16</sub>H<sub>25</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 333.1869).</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-(Methyl(2-(methyl(1-methylpiperidin-4-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>3</b>)</h4><div class="NLM_p last">3-(Methyl(2-(methyl(piperidin-4-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>23</b>, 0.022 g, 0.068 mmol) was dissolved in DCE (1 mL) and treated with paraformaldehyde (15.0 mg, 0.5 mmol). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (44 mg, 0.21 mmol) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>3</b>) as a di-formate salt (2.9 mg, 0.007 mmol, 10%). LC-MS <i>R</i><sub>t</sub> = 5.98 min; MH<sup>+</sup> 339; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.39 (s, 3H), 8.20 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.78–7.74 (m, 1H), 7.69 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.39 (dt, <i>J</i> = 8.3, 1.2 Hz, 1H), 5.06–4.98 (m, 1H), 4.19 (t, <i>J</i> = 6.8 Hz, 2H), 3.65 (s, 3H), 3.65–3.58 (m, 2H), 3.24–3.18 (m, 4H), 3.18 (s, 3H), 3.03 (t, <i>J</i> = 6.8 Hz, 2H), 2.85 (s, 3H), 2.31–2.19 (m, 2H), 2.05–2.00 (m, 2H). ESI HRMS, found 339.2299 (C<sub>19</sub>H<sub>27</sub>N<sub>6</sub> [M + H]<sup>+</sup> requires 339.2297).</div></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>4</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM2</b> (0.04 g, 0.16 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (200 μL, 1.6 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound, <b>4</b>, as a colorless di-formate salt (9.2 mg, 0.022 mmol, 14%). LC-MS <i>R</i><sub>t</sub> = 6.8 min; MH<sup>+</sup> 327; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.52 (s, 2H), 8.14 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.5, 7.0, 1.4 Hz, 1H), 7.60 (d, <i>J</i> = 8.5 Hz, 1H), 7.31 (ddd, <i>J</i> = 8.5, 7.0, 1.4 Hz, 1H), 4.15 (t, <i>J</i> = 6.7 Hz, 2H), 3.84 (t, <i>J</i> = 7.0 Hz, 2H), 3.61 (s, 3H), 3.30 (s, 3H), 3.16 (t, <i>J</i> = 7.0 Hz, 2H), 3.05 (t, <i>J</i> = 6.7 Hz, 2H), 2.88 (s, 6H), 2.18 (p, <i>J</i> = 7.0 Hz, 2H); ESI HRMS, found 327.2302 (C<sub>18</sub>H<sub>27</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 327.2297).</div></div><div id="sec7_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)pyrido[2,3-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>5</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM3</b> (0.022 g, 0.09 mmol) was suspended in EtOAc (1 mL) in a 2 mL microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (50 μL, 0.40 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid), partially evaporated and then lyophilized to give the title compound, <b>5</b>, as a pale yellow formate salt (21.1 mg, 0.056 mmol, 64%). LC-MS <i>R</i><sub>t</sub> = 1.7 min; MH<sup>+</sup> 328; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.67 (dd, <i>J</i> = 4.5, 1.7 Hz, 1H), 8.53 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 8.45 (s, 1H), 7.18 (dd, <i>J</i> = 8.4, 4.5 Hz, 1H), 4.11 (t, <i>J</i> = 6.7 Hz, 2H), 3.79 (m, 2H), 3.58 (s, 3H), 3.26 (s, 3H), 3.13–3.07 (m, 2H), 3.01 (t, <i>J</i> = 6.7 Hz, 2H), 2.88 (s, 6H), 2.19–2.11 (m, 2H); ESI HRMS, found 328.2263 (C<sub>17</sub>H<sub>26</sub>N<sub>7</sub> [M + H]<sup>+</sup> requires 328.225).</div></div><div id="sec7_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-7-methyl-7<i>H</i>-purin-6-yl)(methyl)amino)propanenitrile (<b>6</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM4</b> (0.021g, 0.08 mmol) was suspended in EtOAc (1 mL) in a 2 mL microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (200 μL, 0.8 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound as a colorless formate salt (13 mg, 0.035 mmol, 44%). LC-MS <i>R</i><sub>t</sub> = 1.6 min; MH<sup>+</sup> 331; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.55 (s, 1H), 8.04 (s, 1H), 4.00 (s, 3H), 3.84 (t, <i>J</i> = 6.6 Hz, 2H), 3.69 (t, <i>J</i> = 6.6 Hz, 2H), 3.25 (s, 3H), 3.17 (s, 3H), 2.92 (t, <i>J</i> = 6.6 Hz, 2H), 2.84 (t, <i>J</i> = 6.6 Hz, 2H), 2.67 (s, 6H), 2.02 (p, <i>J</i> = 6.6 Hz, 2H). ESI HRMS, found 331.2365 (C<sub>16</sub>H<sub>27</sub>N<sub>8</sub> [M + H]<sup>+</sup>, requires 331.2359).</div></div><div id="sec7_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>7</b>)</h4><div class="NLM_p last">3-((2-Chloropyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM22</b>, 50 mg, 0.25 mmol) and <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (149 μL, 1.02 mmol) were dissolved in n-BuOH (1.0 mL) and heated at 120 °C for 4 h. After cooling, the solution was diluted with EtOAc, washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>7</b> (67 mg, 0.20 mmol, 82%). LC-MS <i>R</i><sub>t</sub> = 1.04 min; MH<sup>+</sup> 277.4; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 7.95 (d, <i>J</i> = 5.9 Hz, 1H), 5.81 (d, <i>J</i> = 6.0 Hz, 1H), 3.86 (t, <i>J</i> = 6.6 Hz, 2H), 3.66 (t, <i>J</i> = 6.9 Hz, 2H), 3.09 (s, 6H), 2.93–2.85 (m, 2H), 2.71 (t, <i>J</i> = 6.5 Hz, 2H), 2.65 (s, 6H), 2.07–1.99 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.8, 161.7, 161.1, 156.4, 92.4, 55.4, 46.5, 45.8, 42.8, 36.6, 35.2, 23.2, 16.2; ESI HRMS, found 277.2142 (C<sub>14</sub>H<sub>25</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 277.2141).</div></div><div id="sec7_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(Methyl(2-(methyl(tetrahydro-2<i>H</i>-pyran-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>8</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1 mL) in a 2 mL Biotage microwave vial and treated with excess <i>N-</i>methyltetrahydro-2<i>H</i>-pyran-4-amine (92 mg, 0.8 mmol). After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound (<b>8</b>), as a formate salt (5.0 mg, 0.013 mmol, 13%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.31 (s, 2H), 7.98 (d, <i>J</i> = 5.6 Hz, 1H), 7.22 (d, <i>J</i> = 5.6 Hz, 1H), 4.13–4.04 (m, 6H), 3.59 (s, 3H), 3.07 (s, 3H), 2.94–2.91 (m, 1H), 2.92 (t, <i>J</i> = 6.7 Hz, 2H), 1.98–1.60 (m, 4H), ESI HRMS, found 332.1549 (C<sub>16</sub>H<sub>22</sub>N<sub>5</sub>OS [M + H]<sup>+</sup>, requires 332.1545).</div></div><div id="sec7_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-((2-((3-Hydroxypropyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>9</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess 3-(methylamino)propan-1-ol (80 mg, 0.8 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound (<b>9</b>) as a formate salt (5.0 mg, 0.014 mmol, 14%). LC-MS <i>R</i><sub>t</sub> = 9.3 min; MH<sup>+</sup> 306; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.58 (s, 1H), 7.83 (d, <i>J</i> = 5.5 Hz, 1H), 7.12 (d, <i>J</i> = 5.5 Hz, 1H), 4.05 (t, <i>J</i> = 6.5 Hz, 2H), 3.74 (t, <i>J</i> = 6.5 Hz, 2H), 3.61 (t, <i>J</i> = 6.5 Hz, 2H), 3.54 (s, 3H), 3.17 (s, 3H), 3.15–3.04 (m, 1H), 2.90 (t, <i>J</i> = 6.5 Hz, 2H), 1.94–1.78 (m, 2H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.7, 161.9, 160.1, 157.9, 132.5, 122.5, 118.4, 59.1, 58.7, 46.0, 37.1, 34.6, 30.2 15.1; ESI HRMS, found 306.1402 (C<sub>14</sub>H<sub>20</sub>N<sub>5</sub>OS [M + H]<sup>+</sup>, requires 306.1389).</div></div><div id="sec7_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(Methyl(2-(methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>10</b>)</h4><div class="NLM_p last">According to general method C for debenzylation, a solution of 3-((2-((1-benzylpiperidin-4-yl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>14</b>, 380 mg, 0.9 mmol) in DCE (7 mL) was reacted with 1-chloroethyl chloroformate (107 μL, 0.9 mmol). After workup, the crude product was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub>; 95:5:0.5–90:10:1–80:20:1) to give the title compound (<b>10</b>) as an orange foam (150 mg, 0.45 mmol, 50%). LC-MS <i>R</i><sub>t</sub> = 6.0 min; MH<sup>+</sup> 331; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 5.4 Hz, 1H), 7.11 (d, <i>J</i> = 5.4 Hz, 1H), 4.70 (m, 1H), 3.94 (t, <i>J</i> = 6.8 Hz, 2H), 3.49 (s, 3H), 3.20 (m, 2H), 3.05 (br, 1H), 3.01 (s, 3H), 2.80–2.73 (m, 4H), 1.80–1.68 (m, 4H); ESI HRMS, found 331.1718 (C<sub>16</sub>H<sub>23</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 331.1705).</div></div><div id="sec7_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(Methyl-(2-(methyl-(3-(methylamino)propyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>11</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>′-dimethylpropane-1,3-diamine (80 mg, 0.8 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude residue was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid) to give the title compound (<b>11</b>) as a formate salt (1.6 mg, 0.044 mmol, 4%). LC-MS <i>R</i><sub>t</sub> = 6.1 min; MH<sup>+</sup> 319; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.44 (s, 2H), 7.91 (d, <i>J</i> = 5.5 Hz, 1H), 7.20 (d, <i>J</i> = 5.5 Hz, 1H), 4.09 (t, <i>J</i> = 6.5 Hz, 2H), 3.74 (t, <i>J</i> = 6.5 Hz, 2H), 3.57 (s, 3H), 3.18 (s, 3H), 2.97 (t, <i>J</i> = 6.5 Hz, 2H), 2.91 (t, <i>J</i> = 6.5 Hz, 2H), 2.64 (s, 3H), 2.10–1.98 (m, 2H); ESI HRMS, found 319.1714 (C<sub>15</sub>H<sub>23</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 319.1705).</div></div><div id="sec7_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(Methyl(2-(methyl(1-ethylpiperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>12</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, 3-(methyl(2-(methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>10</b>, 0.030 g, 0.1 mmol) was dissolved in DCE (3 mL), treated with acetaldehyde (10 mL, 0.2 mmol) and solid sodium triacetoxyborohydride (85 mg, 0.4 mmol), and then stirred at room temperature overnight. After workup, the crude residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized. The product was impure and so was repurified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>12</b>) as a di-formate salt (13.8 mg, 0.031 mmol, 31%). LC-MS <i>R</i><sub>t</sub> = 6.6 min; MH<sup>+</sup> 359; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2H), 7.89 (d, <i>J</i> = 5.5 Hz, 1H), 7.17 (d, <i>J</i> = 5.5 Hz, 1H), 5.01–4.93 (m, 1H), 4.08 (t, <i>J</i> = 7.0 Hz, 2H), 3.71–3.65 (m, 2H), 3.55 (s, 3H), 3.20 (q, <i>J</i> = 7.0 Hz, 2H), 3.14 (dt, <i>J</i> = 13.1, 2.6 Hz, 2H), 3.07 (s, 3H), 2.90 (t, <i>J</i> = 7.0 Hz, 2H), 2.21–2.10 (m, 2H), 2.04–1.97 (m, 2H), 1.37 (t, <i>J</i> = 7.0 Hz, 3H); ESI HRMS, found 359.2001 (C<sub>18</sub>H<sub>27</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 359.2018).</div></div><div id="sec7_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-((2-((1-Isobutylpiperidin-4-yl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>13</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, 3-(methyl(2-(methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>10</b>, 0.030 g, 0.1 mmol) was dissolved in DCE (3 mL) and treated with isobutyraldehyde (7.2 mg, 0.1 mmol) and then sodium triacetoxyborohydride (85 mg, 0.4 mmol) before stirring at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>13</b>) as a formate salt (22.0 mg, 0.051 mmol, 51%). LC-MS <i>R</i><sub>t</sub> = 7.8 min; MH<sup>+</sup> 387; <sup>1</sup>H NMR (CD<sub>3</sub>OD, δ, ppm) 8.41 (s, 2H), 7.91 (d, <i>J</i> = 5.5 Hz, 1H), 7.18 (d, <i>J</i> = 5.5 Hz, 1H), 4.96 (m, 1H), 4.08 (t, <i>J</i> = 7.0 Hz, 2H), 3.72–3.66 (m, 2H), 3.56 (s, 3H), 3.15 (dt, <i>J</i> = 13.0, 2.9 Hz, 2H), 3.07 (s, 3H), 2.98 (d, <i>J</i> = 7.0 Hz, 2H), 2.90 (t, <i>J</i> = 7.0 Hz, 2H), 2.29–2.13 (m, 3H), 2.00–1.95 (m, 2H), 1.10 (d, <i>J</i> = 7.0 Hz, 6H); ESI HRMS, found 387.2323 (C<sub>20</sub>H<sub>31</sub>N<sub>6</sub>S, [M + H]<sup>+</sup>, requires 387.2331).</div></div><div id="sec7_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-((2-((1-Benzylpiperidin-4-yl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>14</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.25 g, 1.0 mmol) was suspended in EtOAc (3 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpiperidin-4-amine (830 mg, 4 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by column chromatography on silica by elution with CH<sub>2</sub>Cl<sub>2</sub> and then CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub> solution (97:3:0.5). A second column (EtOAc, 100%) gave the title compound (<b>14</b>) as a colorless oil (380 mg, 0.090 mmol, 90%). LC-MS <i>R</i><sub>t</sub> = 8.8 min; MH<sup>+</sup> 421; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59 (d, <i>J</i> = 5.5 Hz, 1H), 7.37–7.27 (m, 5H), 7.14 (d, <i>J</i> = 5.5 Hz, 1H), 4.62 (t, <i>J</i> = 11.5 Hz, 1H), 3.98 (t, <i>J</i> = 6.8 Hz, 2H), 3.55 (m, 5H), 3.03 (m, 5H), 2.79 (t, <i>J</i> = 6.8 Hz, 2H), 2.20–2.10 (m, 2H), 1.94–1.84 (m, 2H), 1.671 (d, <i>J</i> = 11.5 Hz, 2H); ESI HRMS, found 421.2187 (C<sub>23</sub>H<sub>29</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 421.2174).</div></div><div id="sec7_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-((2-((3-(Isobutyl(methyl)amino)propyl)(methyl)-amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)-amino)propanenitrile (<b>15</b>)</h4><div class="NLM_p last">According to general method D, 3-(methyl(2-(methyl(3-(methylamino)propyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>11</b>, 0.032 g, 0.1 mmol) was dissolved in DCE (3 mL) and treated with isobutyraldehyde (7.2 mg, 0.1 mmol). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (85 mg, 0.4 mmol) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound <b>15</b> as a formate salt (5.0 mg; 0.012 mol, 12%). LC-MS <i>R</i><sub>t</sub> = 7.9 min; MH<sup>+</sup> 375; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 1H), 7.61 (d, <i>J</i> = 5.4 Hz, 1H), 7.13 (d, <i>J</i> = 5.4 Hz, 1H), 3.99 (t, <i>J</i> = 6.6 Hz, 2H), 3.68 (t, <i>J</i> = 6.6 Hz, 2H), 3.54 (s, 3H), 3.14 (s, 3H), 2.82–2.75 (m, 4H), 2.52–2.47 (m, 5H), 2.00–1.99 (m, 3H), 0.97 (d, <i>J</i> = 6.6 Hz, 6H); ESI HRMS, found 375.2345 (C<sub>19</sub>H<sub>31</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 375.2331).</div></div><div id="sec7_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-((2-((3-(Benzyl(methyl)amino)propyl)(methyl)amino)thieno-[3,2-d]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>16</b>)</h4><div class="NLM_p last">According to general method D, 3-(methyl(2-(methyl(3-(methylamino)propyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>11</b>, 0.032 g, 0.1 mmol) was dissolved in DCE (3 mL) and treated with benzaldehyde (10 mg, 0.1 mmol) and then sodium triacetoxyborohydride (85 mg, 0.4 mmol). The resulting suspension was stirred at room temperature overnight, and after workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>16</b>) as a formate salt (7.0 mg, 0.015 mmol, 15%). LC-MS <i>R</i><sub>t</sub> = 8.4 min; MH<sup>+</sup> 409; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.46 (s, 1H), 7.62 (d, <i>J</i> = 5.5 Hz, 1H), 7.36–7.31 (m, 5H), 7.09 (d, <i>J</i> = 5.5 Hz, 1H), 4.00 (s, 2H), 3.96 (t, <i>J</i> = 6.6 Hz, 2H), 3.68 (t, <i>J</i> = 6.6 Hz, 2H), 3.55 (s, 3H), 3.11 (s, 3H), 2.90–2.85 (m, 2H), 2.76 (t, <i>J</i> = 6.6 Hz, 2H), 2.53 (s, 3H), 2.11–2.02 (m, 2H); ESI HRMS found 409.2165, (C<sub>22</sub>H<sub>29</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 409.2174).</div></div><div id="sec7_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(Methyl(2-(piperazin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>17</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess piperazine (70 mg, 0.8 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound (<b>17</b>) as a formate salt (1.5 mg, 0.004 mmol, 4%). LC-MS <i>R</i><sub>t</sub> = 8.1 min; MH<sup>+</sup> 303; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 1H), 7.91 (d, <i>J</i> = 5.5 Hz, 1H), 7.15 (d, <i>J</i> = 5.5 Hz, 1H), 4.08 (t, <i>J</i> = 6.5 Hz, 2H), 4.06–4.02 (m, 4H), 3.79–3.70 (m, 2H), 3.57 (s, 3H), 3.29–3.25 (m, 4H), 2.88 (t, <i>J</i> = 6.5 Hz, 2H); ESI HRMS, found 303.1394 (C<sub>14</sub>H<sub>19</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 303.1392).</div></div><div id="sec7_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-(Methyl(2-(4-methylpiperazin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)amino)propanenitrile (<b>18</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.05 g, 0.2 mmol) was suspended in ethyl acetate (1 mL) in a microwave vial and treated with excess <i>N</i>-methylpiperazine (0.3 mL, 2 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by flash column chromatography using CH<sub>2</sub>Cl<sub>2</sub> and then CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub> solution (95:5:0.5) to give the title compound (<b>18</b>) as a colorless solid (45 mg, 0.14 mmol, 72%). LC-MS <i>R</i><sub>t</sub> = 5.2 min; MH<sup>+</sup> 317; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.65 (d, <i>J</i> = 5.7 Hz, 1H), 7.18 (d, <i>J</i> = 5.7 Hz, 1H), 4.01 (t, <i>J</i> = 6.6 Hz, 2H), 3.84 (dd, <i>J</i> = 6.1, 4.1 Hz, 4H), 3.57 (s, 3H), 2.81 (t, <i>J</i> = 6.6 Hz, 2H), 2.60–2.47 (m, 4H), 2.37 (s, 3H); ESI HRMS, found 317.1542 (C<sub>15</sub>H<sub>21</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 317.1548).</div></div><div id="sec7_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-((2-((1-Benzylpyrrolidin-3-yl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>19</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.10 g, 0.4 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpyrrolidin-3-amine (385 μL, 2.0 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by flash column chromatography using EtOAc (100%) and then CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub> (97:3:0.5) to give the title compound (<b>19</b>) as a colorless oil (95 mg, 0.23 mmol, 58%). LC-MS <i>R</i><sub>t</sub> = 8.5 min; MH<sup>+</sup> 407; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61 (d, <i>J</i> = 5.4 Hz, 1H), 7.43–7.25 (m, 5H), 7.17 (d, <i>J</i> = 5.4 Hz, 1H), 5.57–5.50 (m, 1H), 3.99 (t, <i>J</i> = 6.6 Hz, 2H), 3.73 (d, <i>J</i> = 12.8 Hz, 1H), 3.61 (d, <i>J</i> = 12.8 Hz, 1H), 3.56 (s, 3H,), 3.15 (s, 3H), 2.93–2.87 (m,1H), 2.79 (t, <i>J</i> = 6.6 Hz, 2H), 2.74–2.65 (m, 2H), 2.54–2.46 (m, 1H), 2.28–2.19 (m, 1H), 1.95–1.86 (m, 1H); ESI HRMS, found 407.2010 (C<sub>22</sub>H<sub>27</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 407.2018).</div></div><div id="sec7_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-((2-(4-(Ethylamino)piperidin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>20</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess <i>N-</i>ethyl-1-methylpiperidin-4-amine (0.4 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water) to give the title compound (<b>20</b>) as a di-formate salt (3.5 mg, 0.008 mmol, 8%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (br s, 2H), 7.89 (d, <i>J</i> = 5.5 Hz, 1H), 7.14 (d, <i>J</i> = 5.5 Hz), 4.88–4.84 (m, 2H), 4.07 (t, <i>J</i> = 6.7 Hz, 2H), 3.56 (s, 3H), 3.43–3.35 (m, 1H), 3.42–3.35 (m, 1H), 3.15–3.10 (q, <i>J</i> = 7.3 Hz, 2H), 3.02–2.94 (m, 2H), 2.88 (t, <i>J</i> = 6.4 Hz), 2.18–2.10 (m, 2H), 1.62–1.53 (m, 2H), 1.32 (t, <i>J</i> = 7.3 Hz, 3H). ESI HRMS, found 345.1886 (C<sub>17</sub>H<sub>25</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 345.1861).</div></div><div id="sec7_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-((2-((3<i>S</i>,4<i>S</i>)-3-Fluoro-4-(methylamino)piperidin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>21</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess (3<i>S</i>,4<i>S</i>)-3-fluoro-<i>N</i>,1-dimethylpiperidin-4-amine (0.088 g, 0.4 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water) to give the title compound (<b>21</b>) as a formate salt (7.0 mg, 0.018 mmol, 18%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.55 (br s, 1H), 7.91 (d, <i>J</i> = 5.5 Hz, 1H), 7.18 (d, <i>J</i> = 5.6 Hz, 1H), 5.08 (dtd, <i>J</i> = 12.4, 5.1, 2.0 Hz, 1H), 4.79 (ddd, <i>J</i> = 13.7, 4.7, 2.4 Hz, 1H), 4.59 (dtd, <i>J</i> = 50.0, 9.8, 5.3 Hz, 1H), 4.09 (t, <i>J</i> = 6.6 Hz, 2H), 3.58 (s, 3H), 3.11–2.95 (m, 2H), 2.91 (t, <i>J</i> = 6.6 Hz, 3H), 2.70 (s, 3H), 2.23 (ddt, <i>J</i> = 12.9, 5.0, 2.5 Hz, 1H), 1.58 (qd, <i>J</i> = 12.4, 4.5 Hz, 1H); ESI HRMS, found 349.1623 (C<sub>16</sub>H<sub>22</sub>N<sub>6</sub>SF [M + H]<sup>+</sup>, requires 349.1611).</div></div><div id="sec7_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-((2-((3<i>R</i>,4<i>S</i>)-3-Fluoro-4-(methylamino)piperidin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>22</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM1</b> (0.025 g, 0.1 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess (3<i>R</i>,4<i>S</i>)-3-fluoro-<i>N</i>,1-dimethylpiperidin-4-amine (0.088 g, 0.4 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water) to give the title compound (<b>22</b>) as a formate salt (6.4 mg, 0.016 mmol, 16%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.40 (s, 1H), 7.88 (d, <i>J</i> = 5.5 Hz, 1H), 7.14 (d, <i>J</i> = 5.6 Hz, 1H), 5.26 (ddt, <i>J</i> = 14.9, 12.0, 2.9 Hz, 1H), 5.14 (d, <i>J</i> = 49.7 Hz, 1H), 4.99–4.92* (m, 1H), 4.14–4.00 (m, 2H), 3.59–3.46 (m, 4H), 3.28–3.12 (m, 1H), 3.04–2.96 (m, 1H), 2.89 (td, <i>J</i> = 6.7, 1.8 Hz, 2H), 2.11–2.05 (m, 1H), 1.98–1.87 (m, 1H); ESI HRMS, found 349.1594 (C<sub>16</sub>H<sub>22</sub>N<sub>6</sub>SF [M + H]<sup>+</sup>, requires 349.1611). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-(Methyl(2-(methyl(piperidin-4-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>23</b>)</h4><div class="NLM_p last">3-((2-Chloroquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM2</b>) (50 mg, 0.20 mmol, 1.0 equiv) was dissolved in n-BuOH (1.0 mL), and 1-benzyl-<i>N</i>-methylpiperidin-4-amine (163 mg, 0.80 mmol, 4.0 equiv) was added. The reaction was heated at 200 °C for 2 h. After cooling to room temperature, the reaction mixture was partitioned between EtOAc (20 mL) and sodium hydroxide solution (1 M, 10 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash column chromatography with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) to give 3-((2-((1-benzylpyrrolidin-3-yl)(methyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (88 mg). This intermediate was then debenzylated using 10% Pd/C (22 mg) and ammonium formate (126 mg) in EtOH (2.0 mL). After filtration through celite and concentration <i>in vacuo</i>, the residue was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>23</b>) as a formate salt (33 mg, 0.089 mmol, 44% over two steps). LC-MS <i>R</i><sub>t</sub> = 8.8 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (s, 2H), 8.17 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.78–7.61 (m, 2H), 7.35 (ddd, <i>J</i> = 8.4, 6.8, 1.5 Hz), 5.02*, 4.17 (t, <i>J</i> = 7.1 Hz, 2H), 3.57 (m, 1H), 3.55 (m, 1H), 3.26–3.18 (m, 2H), 3.18 (s, 3H), 2.16 (m, 2H), 2.04 (m, 1H), 2.01 (m, 1H). ESI HRMS, found 325.2166 (C<sub>18</sub>H<sub>25</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 325.2141). *Partially obscured by the H<sub>2</sub>O signal and identified by analogy with compound <b>3</b>.</div></div><div id="sec7_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-((2-((1-Ethylpiperidin-4-yl)(methyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>24</b>)</h4><div class="NLM_p last">In a variation on general method D for reductive amination, 3-(methyl(2-(methyl(piperidin-4-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>23</b>, 0.009 g, 0.028 mmol) was dissolved in DCM (1 mL) and treated with isobutyraldehyde (5.0 μL, 0.14 mmol). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (30 mg, 0.14 mmol) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>24</b>) as a 2.5 × formate salt (2.0 mg, 0.004 mmol, 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (br s, 2H), 8.14 (d, <i>J</i> = 8.4 Hz, 1H), 7.71 (ddd, <i>J</i> = 8.3, 7.0, 1.0 Hz, 1H), 7.63 (dd, <i>J</i> = 8.4, 0.9 Hz, 1H), 7.31 (ddd, <i>J</i> = 8.3, 7.1, 1.3 Hz, 1H), 5.50 (tt, <i>J</i> = 12.1, 4.0 Hz, 1H), 4.14 (t, <i>J</i> = 6.9 Hz, 2H), 3.67 (m, 2H), 3.60 (s, 3H), 3.21–3.10 (m, 7H), 3.02 (t, <i>J</i> = 6.9 Hz, 2H), 2.19 (m, 2H), 2.04 (m, 2H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H); ESI HRMS, found 353.2449 (C<sub>20</sub>H<sub>29</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 353.2454).</div></div><div id="sec7_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(Methyl(2-(methyl(pyrrolidin-3-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>25</b>)</h4><div class="NLM_p last">3-((2-Chloroquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM2</b>) (50 mg, 0.20 mmol, 1.0 equiv) was dissolved in n-BuOH (1.0 mL), and 1-benzyl-<i>N</i>-methylpyrrolidin-3-amine (154 μL, 0.80 mmol, 4.0 equiv) was added. The reaction was heated at 120 °C for 2 h. After cooling to room temperature, the reaction mixture was partitioned between EtOAc (20 mL) and sodium hydroxide solution (1 M, 10 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash column chromatography with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) to give 3-((2-((1-benzylpyrrolidin-3-yl)(methyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (41 mg, 0.10 mmol). This intermediate (24 mg, 0.06 mmol) was then debenzylated using 10% Pd/C (7 mg) and ammonium formate (38 mg, 0.6 mmol) in EtOH (2.0 mL). After filtration through celite and concentration <i>in vacuo</i>, the residue was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>25</b>) as a formate salt (1.5 mg, 0.004 mmol, 67%). LC-MS <i>R</i><sub>t</sub> = 9.6 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (s br, 1H), 8.04 (dd, <i>J</i> = 8.4, 0.9 Hz, 1H), 7.61 (m, 1H), 7.53 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.19 (ddd, <i>J</i> = 8.3, 6.8, 1.4 Hz, 1H), 5.22 (m, 1H), 4.03 (t, <i>J</i> = 6.7 Hz, 2H), 3.71 (ddd, <i>J</i> = 11.8, 8.6, 3.3 Hz, 1H), 3.52–3.42 (m, 5H), 3.31–3.26 (m, 1H), 3.25 (s, 3H), 2.99 (t, <i>J</i> = 6.6 Hz, 2H), 2.45–2.34 (m, 1H), 2.31–2.20 (m, 1H); ESI HRMS, found 311.1985 (C<sub>17</sub>H<sub>23</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 311.1984).</div></div><div id="sec7_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-(Methyl(2-(methyl(1-methylpyrrolidin-3-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>26</b>)</h4><div class="NLM_p last">In a variation on general method D for reductive amination, 3-(methyl(2-(methyl(pyrrolidin-3-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>25</b>, 3.1 mg, 0.01 mmol, 1.0 equiv) was dissolved in DCM (1 mL) and treated with formaldehyde (10 equiv). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (11 mg, 0.05 mmol, 5.0 equiv) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>26</b>) as a yellow oil (2.4 mg, 0.007 mmol, 74%). LC-MS <i>R</i><sub>t</sub> = 2.7 min; MH<sup>+</sup> 325; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.53 (ddd, <i>J</i> = 8.4, 6.9, 1.5 Hz, 1H), 7.46 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.10 (ddd, <i>J</i> = 8.3, 6.6, 1.2 Hz, 1H), 5.68–5.60 (m, 1H), 3.46 (s, 3H), 3.14 (s, 3H), 2.97 (t, <i>J</i> = 6.8 Hz, 2H), 2.85–2.77 (m, 2H), 2.70–2.61 (m, 2H), 2.42 (s, 3H), 2.28–2.18 (m, 1H), 2.00–1.91 (m, 1H); ESI HRMS, found 325.2132 (C<sub>18</sub>H<sub>25</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 325.2141).</div></div><div id="sec7_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-(Methyl(2-(methyl((1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino)quinazolin-4-yl)amino)propanenitrile (<b>27</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM2</b> (0.03 g, 0.12 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess (1<i>R</i>,3<i>R</i>,5<i>S</i>)-<i>N</i>,8-dimethyl-8-azabicyclo[3.2.1]octan-3-amine (0.115 g, 0.75 mmol). The vial was sealed and irradiated for 90 min at 150 °C. After workup, the crude residue was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized. The product was repurified using gradient elution (10–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>27</b>) as a colorless di-formate salt (2.9 mg, 0.006 mmol, 5%). LC-MS <i>R</i><sub>t</sub> = 7.1 min; MH<sup>+</sup> 365; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.47 (s, 2H), 8.08 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.65 (ddd, <i>J</i> = 8.5, 6.8, 1.4 Hz, 1H), 7.57 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.24 (ddd, <i>J</i> = 8.5, 6.8, 1.4 Hz, 1H), 5.44 (m, 1H), 4.12 (t, <i>J</i> = 7.0 Hz, 2H), 4.07–4.00 (m, 2H), 3.56 (s, 3H), 3.14 (s, 3H), 3.04 (t, <i>J</i> = 7.0 Hz, 2H), 2.87 (s, 3H), 2.48 (m, 2H), 2.39–2.22 (m, 4H), 1.98 (m, 2H). ESI HRMS, found 365.246 (C<sub>21</sub>H<sub>29</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 365.2454).</div></div><div id="sec7_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-((2-((2-Hydroxyethyl)(piperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>28</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM2</b> (50 mg, 0.20 mmol) was suspended in <i>n</i>-BuOH (1 mL) in a microwave vial and treated with excess 2-((1-benzylpiperidin-4-yl)amino)ethanol (188 mg, 0.80 mmol). The vial was sealed and irradiated at 200 °C for 2 h. After workup, the crude residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH; 95:5) to give the intermediate 3-((2-((1-benzylpiperidin-4-yl)(2-hydroxyethyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (32 mg, 0.072 mmol, 36%). The intermediate was debenzylated with 10% Pd/C (10 mg) and ammonium formate (50 mg, 0.79 mmol) in EtOH (2.0 mL). After filtration through celite, the filtrate was concentrated <i>in vacuo</i> and then purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound, <b>28</b>, as a di-formate salt (2.0 mg, 0.004 mmol, 5%). LC-MS <i>R</i><sub>t</sub> = 6.2 min; MH<sup>+</sup> 355; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.39 (s, 2H), 8.08 (dd, <i>J</i> = 8.3, 1.0 Hz, 1H), 7.64 (ddd, <i>J</i> = 8.5, 7.2, 1.3 Hz, 1H), 7.48 (dd, <i>J</i> = 8.3, 0.8 Hz, 1H), 7.24 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 5.02–4.96* (m, 1H), 4.10 (t, <i>J</i> = 7.0 Hz, 2H), 3.82 (d, <i>J</i> = 5.6 Hz, 2H), 3.71 (d, <i>J</i> = 5.6 Hz, 2H), 3.59–3.52 (m, 5H), 3.25–3.18 (m, 2H), 3.00 (t, <i>J</i> = 7.0 Hz, 2H), 2.10–2.04 (m, 4H); ESI HRMS, found 355.2242 (C<sub>19</sub>H<sub>27</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 355.2246). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-((2-((3-Hydroxypropyl)(piperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>29</b>)</h4><div class="NLM_p last">In a variation on general method B for C<sub>2</sub> displacements, intermediate <b>IM2</b> (50 mg, 0.20 mmol) was suspended in <i>n</i>-BuOH (1 mL) in a microwave vial and treated with excess 3-((1-benzylpiperidin-4-yl)amino)propan-1-ol (198 mg, 0.80 mmol). The vial was sealed and irradiated at 200 °C for 2 h. After workup, the crude residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH; 95/5) to give the intermediate 3-((2-((1-benzylpiperidin-4-yl)(3-hydroxypropyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (45 mg, 0.098 mmol, 49%). The intermediate was debenzylated with 10% Pd/C (11 mg) and ammonium formate (63 mg, 1.0 mmol) in EtOH (2.0 mL). After filtration through celite, the filtrate was concentrated <i>in vacuo</i> and then purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound, <b>29</b>, as a di-formate salt (12.0 mg, 0.026 mmol, 13%). LC-MS <i>R</i><sub>t</sub> = 7.0 min; MH<sup>+</sup> 369; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 2H), 8.14 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.3, 7.0, 1.2 Hz, 1H), 7.51 (d, <i>J</i> = 8.2 Hz, 1H), 7.30 (ddd, <i>J</i> = 8.2, 7.2, 1.1 Hz, 1H), 4.99–4.92* (m, 1H), 4.14 (t, <i>J</i> = 7.0 Hz, 2H), 3.73–3.69 (m, 4H), 3.60 (s, 3H), 3.60–3.53 (m, 2H), 3.25–3.17 (m, 2H), 3.00 (t, <i>J</i> = 6.8 Hz, 2H), 2.19–2.07 (m, 4H), 1.92 (qt, <i>J</i> = 6.2 Hz, 2H); ESI HRMS, found 369.2399 (C<sub>20</sub>H<sub>29</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 369.2403). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-((2-((3-Hydroxypropyl)(1-methylpiperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>30</b>)</h4><div class="NLM_p last">In a variation of general method D for reductive amination, 3-((2-((3-hydroxypropyl)(piperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>29</b>, 9.0 mg, 0.024 mmol, 1.0 equiv) was dissolved in DCM (2.0 mL) and treated with formaldehyde (10 equiv). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (16 mg, 0.072 mmol, 3.0 equiv) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound, <b>30</b>, as a formate salt (2.0 mg, 0.005 mmol, 19%). LC-MS <i>R</i><sub>t</sub> = 6.9 min; MH<sup>+</sup> 383.5; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.49 (s, 1H), 8.05 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.61 (ddd, <i>J</i> = 8.4, 6.9, 1.5 Hz, 1H), 7.44 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 7.20 (ddd, <i>J</i> = 8.4, 6.8, 1.3 Hz, 1H), 4.97–4.90* (m, 1H), 4.07 (t, <i>J</i> = 7.0 Hz, 2H), 3.68 (dt, <i>J</i> = 11.7, 6.3 Hz, 2H), 5.54–5.49 (m, 5H), 3.07 (dt, <i>J =</i> 12.8, 2.8 Hz, 2H), 2.99 (t, <i>J</i> = 7.0 Hz, 2H), 2.80 (s, 3H), 2.21–2.20 (m, 4H), 1.88 (qt, <i>J</i> = 6.4 Hz, 2H); ESI HRMS, found 383.2578 (C<sub>21</sub>H<sub>31</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 383.2559). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-Trimethyl-<i>N</i><sup>3</sup>-(thieno[3,2-<i>d</i>]pyrimidin-2-yl)propane-1,3-diamine (<b>31</b>)</h4><div class="NLM_p last">2-Chlorothieno[3,2-<i>d</i>]pyrimidine (10 mg, 0.059 mmol) was dissolved in <i>N</i>,<i>N-</i>dimethylacetamide (DMA, 1.0 mL), and <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (52 μL) was added and then sealed and heated at 120 °C for 4 h. The reaction mixture was partitioned between EtOAc (10 mL) and 1 M NaOH solution (5 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash column chromatography to give the product (<b>31</b>) as a colorless oil (9.0 mg, 0.036 mmol, 61%) with a purity of 90%. LC-MS <i>R</i><sub>t</sub> = 8.3 min; MH<sup>+</sup> 251.3 <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81 (s, 1H), 7.76 (d, <i>J</i> = 5.4 Hz, 1H), 7.20 (d, <i>J</i> = 5.4 Hz, 1H), 3.75 (t, <i>J</i> = 7.2 Hz, 2H), 3.23 (s, 3H), 2.35 (t, <i>J</i> = 7.4 Hz, 2H), 2.26 (s, 6H), 1.84 (m, 2H). ESI HRMS, found 251.1331 (C<sub>12</sub>H<sub>19</sub>N<sub>4</sub>S [M + H]<sup>+</sup>, requires 251.1330).</div></div><div id="sec7_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i><sup>2</sup>-(3-(Dimethylamino)propyl)-<i>N</i><sup>4</sup>-(2-methoxyethyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylthieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>32</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM5</b> (50 mg, 0.19 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (0.5 mL, 2.0 mmol) and then sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>33</b>) (5.3 mg, 0.016 mmol, 8%). LC-MS <i>R</i><sub>t</sub> = 7.6 min; MH<sup>+</sup> 338; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.54 (d, <i>J</i> = 5.5 Hz, 1H), 7.14 (d, <i>J</i> = 5.5 Hz, 1H), 3.90 (t, <i>J</i> = 6.0 Hz, 2H), 3.75–3.58 (m, 4H), 3.44 (s, 3H), 3.36 (s, 3H), 3.15 (s, 3H), 2.56 (t, <i>J</i> = 6.0 Hz, 2H), 2.41 (s, 6H), 1.93 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 163.2, 160.3, 158.3, 131.3, 124.0, 104.8, 71.3, 59.2, 57.0, 50.8, 47.4, 44.8, 38.7, 35.6, 25.1; ESI HRMS, found 338.2014 (C<sub>16</sub>H<sub>28</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 338.2015).</div></div><div id="sec7_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2-Methoxyethyl)-<i>N</i>-methyl-2-(4-methylpiperazin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-4-amine (<b>33</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM5</b> (50 mg, 0.19 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>-methylpiperazine (0.3 mL, 2.0 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>33</b>) as a formate salt (21 mg, 0.057 mmol, 30%). LC-MS <i>R</i><sub>t</sub> = 7.0 min; MH<sup>+</sup> 322; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.49 (s, 1H), 7.57 (d, <i>J</i> = 5.5 Hz, 1H), 7.13 (d, <i>J</i> = 5.5 Hz, 1H), 3.90 (t, <i>J</i> = 5.8 Hz, 2H), 3.87–3.83 (m, 4H), 3.66 (t, <i>J</i> = 5.8 Hz, 2H), 3.45 (s, 3H), 3.36 (s, 3H), 2.57 (m, 4H), 2.39 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.9, 163.2, 160.2, 158.3, 131.4, 124.0, 71.1, 59.1, 54.8, 50.8, 45.8, 43.9, 38.7; ESI HRMS, found 322.1696 (C<sub>15</sub>H<sub>24</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 322.1688).</div></div><div id="sec7_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol (<b>34</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM6</b> (50 mg, 0.21 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (0.5 mL, 2 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>34</b>) as a formate salt (22 mg, 0.06 mmol, 28%). LC-MS <i>R</i><sub>t</sub> = 6.1 min; MH<sup>+</sup> 324; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (s, 1H), 7.64 (d, <i>J</i> = 5.5 Hz, 1H), 7.20 (d, <i>J</i> = 5.5 Hz, 1H), 4.47 (s, 1H), 3.98–3.84 (m, 4H), 3.78 (t, <i>J</i> = 6.9 Hz, 2H), 3.52 (s, 3H), 3.18 (s, 3H), 3.06–2.95 (m, 2H), 2.70 (s, 6H), 2.17–1.99 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.6, 162.5, 159.8, 159.0, 32.1, 123.7, 60.0, 55.4, 53.2, 47.0, 42.8, 38.1, 35.4, 23.3; ESI HRMS, found 324.1863 (C<sub>15</sub>H<sub>26</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 324.1858).</div></div><div id="sec7_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propan-1-ol (<b>35</b>)</h4><div class="NLM_p last">2-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol <b>IM7</b> (23 mg, 0.088 mmol, 1.0 equiv) was dissolved in n-BuOH, and <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (78 μL, 0.53 mmol, 6.0 equiv) was added. The reagents were heated at 150 °C under MW radiation for 1 h and then concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound (<b>35</b>) as a formate salt (5.7 mg, 0.015 mmol, 17%). LC-MS <i>R</i><sub>t</sub> = 7.16 min; MH<sup>+</sup> 338; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.57 (s, 1H), 7.89 (d, <i>J</i> = 5.5 Hz, 1H), 7.19 (d, <i>J</i> = 5.5 Hz, 1H), 3.90 (t, <i>J</i> = 7.3 Hz), 3.72 (t, <i>J</i> = 6.3 Hz, 2H), 3.67 (t, <i>J</i> = 6.1 Hz, 2H), 3.45 (s, 3H), 3.18 (s, 3H), 3.08 (t, <i>J</i> = 6.9 Hz, 2H), 2.85 (s, 6H), 2.09 (q, <i>J</i> = 6.6 Hz, 2H), 1.99–1.89 (m, 2H); ESI HRMS, found 338.2013 (C<sub>16</sub>H<sub>36</sub>N<sub>5</sub>OS, [M + H]<sup>+</sup>, requires 338.2015).</div></div><div id="sec7_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propenamide (<b>36</b>)</h4><div class="NLM_p last">3-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propenamide (<b>IM8</b>) (24 mg, 0.088 mmol, 1.0 equiv), was dissolved in EtOAc (1.0 mL) and <i>N</i>,<i>N</i>-dimethylformamide (DMF, 1.0 mL), and then <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (78 μL, 0.53 mmol, 6.0 equiv) was added. The reagents were heated at 150 °C under MW radiation for 1 hr and then concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound (<b>36</b>) as a formate salt (8.8 mg, 0.022 mmol, 25%). Purity 85%; LC-MS <i>R</i><sub>t</sub> = 5.4 min; MH<sup>+</sup> 351; <sup>1</sup>H NMR (CD<sub>3</sub>OD, δ, ppm) δ 8.07 (d, <i>J</i> = 5.5 Hz, 1H), 7.30 (d, <i>J</i> = 5.5 Hz, 1H), 4.16–4.09 (m, 2H), 3.77 (t, <i>J</i> = 6.8 Hz, 2H), 3.57 (s, 3H), 3.24 (s, 3H), 3.22–3.16 (m, 2H), 2.91 (s, 6H), 2.68 (s, 6H), 2.72–2.62 (m, 2H); ESI HRMS, found 351.1957 (C<sub>16</sub>H<sub>27</sub>N<sub>6</sub>OS, [M + H]<sup>+</sup>, requires 351.1967).</div></div><div id="sec7_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(2-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethyl)-<i>N</i>-methylacetamide (<b>37</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM9</b> (20 mg, 0.07 mmol) was suspended in EtOAc in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (100 μL, 0.8 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>37</b>) as a formate salt as a mixture of rotamers (7.1 mg, 0.017 mmol, 23%). LC-MS <i>R</i><sub>t</sub> = 6.9 min; MH<sup>+</sup> 379; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.58 (s, 1H), 7.87 (d, <i>J</i> = 5.4 Hz, 0.3H), 7.85 (d, <i>J</i> = 5.4 Hz, 0.7H), 7.22–7.13 (m, 1H), 4.04 (t, <i>J</i> = 6.0 Hz, 0.6H), 3.99 (t, <i>J</i> = 6.0 Hz, 1.4H), 3.78–3.65 (m, 4H), 3.50 (d, <i>J</i> = 2.0 Hz, 3H), 3.19 (s, 3H), 3.10 (s, 2H), 3.01 (m, 1H), 2.63 (m, 2H), 2.49 (s, 3H), 2.46 (s, 2H), 2.04 (s, 2H), 2.02 (s, 1H), 1.95 (m, 2H); ESI HRMS, found 379.2287 (C<sub>18</sub>H<sub>31</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> requires 379.228).</div></div><div id="sec7_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>38</b>)</h4><div class="NLM_p last">3-((6-(<i>tert</i>-Butyl)-2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile <b>IM10</b> (42 mg, 0.14 mmol) was suspended in DMA (1 mL) in a microwave vial, treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (80 μL, 0.55 mmol), and then heated for 24 h at 100 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>38</b>) as a formate salt (11.6 mg, 0.027 mmol, 19%). LC-MS <i>R</i><sub>t</sub> = 7.1 min; MH<sup>+</sup> 379; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.58 (s, 1H), 7.85 (d, <i>J</i> = 5.5 Hz, 1H), 7.17 (d, <i>J</i> = 5.5 Hz, 1H), 4.13–4.01 (m, 2H), 3.70 (t, <i>J</i> = 7.0 Hz, 2H), 3.48 (s, 3H), 3.18 (s, 3H), 3.06 (s, 3H), 2.97 (s, 3H), 2.89–2.79 (m, 2H), 2.70 (t, <i>J</i> = 7.0 Hz, 2H), 2.53 (s, 6H), 1.97 (p, 2H); ESI HRMS, found 379.2282 (C<sub>18</sub>H<sub>31</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> requires 379.228).</div></div><div id="sec7_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-(1-(2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)methanol (<b>39</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM11</b> (27 mg, 0.1 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (127 μL, 1.0 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid) to give the title compound (<b>39</b>) as a formate salt (12.1 mg, 0.031 mmol, 31%). LC-MS <i>R</i><sub>t</sub> = 7.0 min; MH<sup>+</sup> 350; <sup>1</sup>H NMR (CD<sub>3</sub>OD, δ, ppm) 8.45 (s, 2H), 7.93 (d, <i>J</i> = 5.4 Hz, 1H), 7.20 (d, <i>J</i> = 5.4 Hz, 1H), 4.63–4.56 (m, 1H), 4.09–4.01 (m, 1H), 3.97–3.89 (m, 1H), 3.89–3.84 (m, 1H), 3.74–3.64 (m, 2H), 3.69–3.84 (m, 1H), 3.19 (s, 3H), 3.10 (t, <i>J</i> = 7.1 Hz, 2H), 2.86 (s, 6H), 2.78–2.68 (m, 1H), 2.32–2.01 (m, 6H); ESI HRMS, found 350. 2017 (C<sub>17</sub>H<sub>28</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 350.2015).</div></div><div id="sec7_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-4-(2-(Methoxymethyl)pyrrolidin-1-yl)-<i>N</i>-methyl-<i>N</i>-(1-methylpiperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidin-2-amine (<b>40</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, (<i>S</i>)-4-(2-(methoxymethyl)pyrrolidin-1-yl)-<i>N</i>-methyl-<i>N</i>-(piperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidin-2-amine (<b>41</b>, 15 mg, 0.04 mmol) was dissolved in DCE (5 mL) and treated with paraformaldehyde (6.0 mg, 0.2 mmol). After stirring at room temperature for 10 min, solid sodium triacetoxyborohydride (85 mg, 0.4 mmol) was added, and the resulting suspension was stirred at room temperature overnight. After workup, the crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>40</b>) as a colorless formate salt (6.8 mg, 0.016 mmol, 40%). LC-MS <i>R</i><sub>t</sub> = 8.3 min; MH<sup>+</sup> 376; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.49 (s, 2H), 7.87 (d, <i>J</i> = 5.4 Hz, 1H), 7.15 (d, <i>J</i> = 5.4 Hz, 1H), 4.87–4.84* (m, 1H), 4.68–4.61 (m, 1H), 4.05–3.99 (m, 1H), 3.91–3.84 (m, 1H), 3.73 (dd, <i>J</i> = 9.0, 3.1 Hz, 1H), 3.59–3.51 (m, 2H), 3.43 (t, <i>J</i> = 8.4 Hz, 1H), 3.38 (s, 3H), 3.12–2.99 (m, 5H), 2.84 (s, 3H), 2.26–2.01 (m, 6H), 2.00–1.91 (m, 2H); ESI HRMS, found 376.2185 (C<sub>19</sub>H<sub>30</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 376.2171). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-4-(2-(Methoxymethyl)pyrrolidin-1-yl)-<i>N</i>-methyl-<i>N</i>-(piperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidin-2-amine (<b>41</b>)</h4><div class="NLM_p">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM12</b> (0.10 g, 0.35 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpiperidin-4-amine (430 μL, 2.1 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by flash column chromatography (EtOAc, 100%) to give the intermediate, <i>N</i>-(1-benzylpiperidin-4-yl)-4-(2-(methoxymethyl)pyrrolidin-1-yl)-<i>N</i>-methylthieno[3,2-<i>d</i>]pyrimidin-2-amine, a colorless oil (140 mg, 0.31 mmol, 89%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 5.4 Hz, 1H), 7.39–7.24 (m, 5H), 7.15 (d, <i>J</i> = 5.4 Hz, 1H), 4.71 (m, 1H), 4.67–4.62 (m, 1H), 4.00 (m, 1H), 3.84 (m, 1H), 3.77 (m, 1H), 3.56 (s, 2H), 3.38 (s, 3H), 3.35 (m, 1H), 3.08 (s, 3H), 3.02 (m, 2H), 2.25–2.08 (m, 5H), 1.89 (m, 3H), 1.71 (m, 2H).</div><div class="NLM_p last">The intermediate (140 mg, 0.31 mmol) was then debenzylated according to general method C. After workup, the crude product was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid), partially evaporated and then lyophilized to give the title compound (<b>41</b>) as a di-formate salt (18.9 mg, 0.042 mmol, 13%). LC-MS <i>R</i><sub>t</sub> = 8.3 min; MH<sup>+</sup> 362; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 1H), 7.96 (d, <i>J</i> = 5.5 Hz, 1H), 7.22 (d, <i>J</i> = 5.5 Hz, 1H), 4.91–4.87* (m, 1H), 4.69–4.64 (m, 1H), 4.05 (td, <i>J</i> = 9.1, 2.4 Hz, 1H), 3.90 (td, <i>J</i> = 9.4, 7.0 Hz, 1H), 3.73 (dd, <i>J</i> = 9.0, 3.1 Hz, 1H), 3.61–3.52 (m, 2H), 3.43 (dd, <i>J</i> = 9.0, 7.9 Hz, 1H), 3.38 (s, 3H), 3.22–3.11 (m, 2H), 3.09 (s, 3H), 2.29–2.13 (m, 1H), 2.16–1.95 (m, 7H) *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-<i>N</i><sup>1</sup>-(4-(2-(Methoxymethyl)pyrrolidin-1-yl)thieno[3,2-<i>d</i>]pyrimidin-2-yl)-<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (<b>42</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM12</b> (15 mg, 0.053 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (100 μL, 0.78 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid) to give the title compound (<b>42</b>) as a formate salt (3.3 mg, 0.008 mmol, 15%). LC-MS <i>R</i><sub>t</sub> = 8.4 min; MH<sup>+</sup> 364; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.55 (s, 1H), 7.83 (d, <i>J</i> = 5.5 Hz, 1H), 7.14 (d, <i>J</i> = 5.5 Hz, 1H), 4.68–4.61 (m, 1H), 4.04–3.94 (m, 1H), 3.91–3.84 (m, 1H), 3.73 (dd, <i>J</i> = 9.2, 3.1 Hz, 1H), 3.71–3.63 (m, 2H), 3.48 (dd, <i>J</i> = 9.0, 7.8 Hz, 1H), 3.37 (s, 3H), 3.16 (s, 3H), 2.72 (t, <i>J</i> = 7.3 Hz, 2H), 2.55 (s, 6H), 2.23–2.01 (m, 4H), 2.01–1.91 (m, 2H); ESI HRMS, found 364.2182 (C<sub>18</sub>H<sub>30</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> requires 364.2171).</div></div><div id="sec7_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-2-(1-(2-(Methyl(1-methylpiperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile (<b>43</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, (<i>S</i>)-2-(1-(2-(methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile (<b>44</b>, 15 mg, 0.042 mmol) was reacted with paraformaldehyde (6.0 mg, 0.2 mmol) and sodium triacetoxyborohydride (85 mg, 0.4 mmol). After workup, the crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>43</b>) as a formate salt (9.6 mg, 0.023 mmol, 55%). LC-MS <i>R</i><sub>t</sub> = 7.5 min; MH<sup>+</sup> 371; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.90 (d, <i>J</i> = 5.5 Hz, 1H), 7.17 (d, <i>J</i> = 5.5 Hz, 1H), 5.03–4.93 (m, 1H), 4.78–4.72 (m, 1H), 4.15–4.09 (m, 1H), 4.00–3.93 (m, 1H), 3.65–3.57 (m, 2H), 3.25–3.15 (m, 2H), 3.13–3.08 (m, 1H), 3.07 (s, 3H), 2.92–2.84 (m, 1H), 2.88 (s, 3H), 2.35–2.11 (m, 5H), 2.04–1.93 (m, 3H); ESI HRMS, found 371.2020 (C<sub>19</sub>H<sub>27</sub>N<sub>6</sub>S [M + H]<sup>+</sup> requires 371.2018).</div></div><div id="sec7_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-2-(1-(2-(Methyl(piperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile (<b>44</b>)</h4><div class="NLM_p">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM13</b> (0.10 g, 0.35 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpiperidin-4-amine (430 μL, 2.1 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by flash column chromatography (EtOAc; 100%) to give (<i>S</i>)-2-(1-(2-((1-benzylpiperidin-4-yl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile, as a colorless oil (126 mg, 0.28 mmol, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (d, <i>J</i> = 5.4 Hz, 1H), 7.42–7.23 (m, 5H), 7.16 (d, <i>J</i> = 5.4 Hz, 1H), 4.68 (m, 3H), 4.09 (m, 1H), 3.99–3.88 (m, 1H), 3.57 (s, 2H), 3.11 (m, 1H), 3.08 (s, 3H), 3.04 (m, 2H), 2.81–2.69 (m, 1H), 2.33–2.08 (m, 4H), 1.99–1.84 (m, 2H), 1.70 (m, 2H).</div><div class="NLM_p last">The intermediate (126 mg, 0.28 mmol, 0.28 mmol) was debenzylated using 1-chloroethyl chloroformate according to general method C. After workup, the crude product was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub>; 97:3:0.5–95:5:0.5–90:10:1) to give the title compound (<b>44</b>) as a colorless oil (25 mg, 0.070 mmol, 25%). LC-MS <i>R</i><sub>t</sub> = 7.6 min; MH<sup>+</sup> 357; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58 (d, <i>J</i> = 5.4 Hz, 1H), 7.14 (d, <i>J</i> = 5.4 Hz, 1H), 4.78–4.69 (m, 1H), 4.69–4.62 (m, 1H), 4.10–4.04 (m, 1H), 3.96–3.86 (m, 1H), 3.24–3.16 (m, 2H), 3.13–3.06 (m, 1H), 3.04 (s, 3H), 2.84–2.76 (m, 2H), 2.76–2.69 (m, 1H), 2.28–2.07 (m, 2H), 2.23–2.06 (m, 3H), 1.80–1.69 (m, 4H); ESI HRMS, found 357.1861 (C<sub>18</sub>H<sub>25</sub>N<sub>6</sub>S [M + H]<sup>+</sup> requires 357.1861).</div></div><div id="sec7_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>S</i>)-2-(1-(2-((3-(Dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile (<b>45</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM13</b> (15 mg, 0.042 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (100 μL, 0.78 mmol). The vial was sealed and irradiated for 30 min at 150 °C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>45</b>) as a formate salt (6.3 mg, 0.016 mmol, 37%). LC-MS <i>R</i><sub>t</sub> = 7.8 min; MH<sup>+</sup> 359; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.38 (s, 1H), 8.00 (d, <i>J</i> = 5.5 Hz, 1H), 7.31 (d, <i>J</i> = 5.5 Hz, 1H), 4.79–4.73* (m, 2H), 4.16–4.10 (m, 1H), 4.05–3.97 (m, 1H), 3.80–3.67 (m, 2H), 3.21 (s, 3H), 3.16–3.11 (m, 2H), 3.08–3.05 (m, 1H), 2.88 (s, 6H), 2.40–2.23 (m, 2H), 2.22–2.05 (m, 4H). ESI HRMS, found 359.2021, (C<sub>18</sub>H<sub>27</sub>N<sub>6</sub>S [M + H]<sup>+</sup> requires 359.2018). * Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i><sup>4</sup>-Ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethyl-<i>N</i><sup>2</sup>-(1-methylpiperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>46</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, <i>N</i><sup>4</sup>-ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethyl-<i>N</i><sup>2</sup>-(piperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>47</b>, 18 mg, 0.045 mmol) was dissolved in DCE (5 mL) and treated with paraformaldehyde (6.0 mg, 0.2 mmol) and sodium triacetoxyborohydride (85 mg, 0.4 mmol). After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>46</b>) as a di-formate salt (14.0 mg, 0.034 mmol, 58%). LC-MS <i>R</i><sub>t</sub> = 7.8 min; MH<sup>+</sup> 320; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.50 (br s, 2H), 7.88 (d, <i>J</i> = 5.5 Hz, 1H), 7.17 (d, <i>J</i> = 5.5 Hz, 1H), 4.93–4.90* (m, 1H), 3.85 (q, <i>J</i> = 7.0 Hz, 2H), 3.60–3.53 (m, 2H), 3.40 (s, 3H), 3.16–3.08 (m, 2H), 3.07 (s, 3H), 2.85 (s, 3H), 2.17 (dq, <i>J</i> = 13.3, 3.9 Hz, 2H), 2.00–1.93 (m, 2H), 1.29 (t, <i>J</i> = 7.0 Hz, 3H); ESI HRMS, found 320.1910, (C<sub>16</sub>H<sub>26</sub>N<sub>5</sub>S [M + H]<sup>+</sup> requires 320.1909). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i><sup>4</sup>-Ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethyl-<i>N</i><sup>2</sup>-(piperidin-4-yl)thieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>47</b>)</h4><div class="NLM_p last">A solution of <i>N</i><sup>2</sup>-(1-benzylpiperidin-4-yl)-<i>N</i><sup>4</sup>-ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylthieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>49</b>, 31 mg, 0.078 mmol) was debenzylated using 1-chloroethyl chloroformate (20 μL) according to general method C. After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid) to give the title compound (<b>47</b>) as a di-formate salt (22 mg, 0.055 mmol, 71%). LC-MS <i>R</i><sub>t</sub> = 7.9 min; MH<sup>+</sup> 331; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.26 (s, 1H), 8.12 (d, <i>J</i> = 5.5 Hz, 1H), 7.37 (d, <i>J</i> = 5.5 Hz, 1H), 4.95–4.90* (m, 1H), 3.93 (q, <i>J</i> = 7.0 Hz, 2H), 3.60–3.54 (m, 2H), 3.50 (s, 3H), 3.27–3.18 (m, 2H), 3.14 (s, 3H), 2.15 (dq, <i>J</i> = 13.1, 4.2 Hz, 2H), 2.10–2.00 (m, 2H), 1.35 (t, <i>J</i> = 7.0 Hz, 3H); ESI HRMS, found 306.1750 (C<sub>15</sub>H<sub>24</sub>N<sub>5</sub>S [M + H]<sup>+</sup> requires 306.1752). *Partially obscured by the H<sub>2</sub>O signal.</div></div><div id="sec7_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i><sup>2</sup>-(3-(Dimethylamino)propyl)-<i>N</i><sup>4</sup>-ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylthieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>48</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM14</b> (21 mg, 0.083 mmol) was suspended in EtOAc (1 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (117 μL, 0.8 mmol). The vial was sealed and irradiated for 30 min at 120 °C. After workup, the crude product was purified by reverse-phase HPLC (33–98% MeOH/water/0.1% formic acid) to give the title compound (<b>48</b>) (13 mg, 0.042 mmol, 51%). LC-MS <i>R</i><sub>t</sub> = 7.7 min; MH<sup>+</sup> 308; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 5.5 Hz, 1H), 7.12 (d, <i>J</i> = 5.5 Hz, 1H), 3.80 (q, <i>J</i> = 7.1 Hz, 2H), 3.66 (t, <i>J</i> = 7.1 Hz, 2H), 3.34 (s, 3H), 3.13 (s, 3H), 2.43–2.36 (m, 2H), 2.28 (s, 6H), 1.90–1.81 (m, 2H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H); ESI HRMS, found 308.1911 (C<sub>15</sub>H<sub>26</sub>N<sub>5</sub>S [M + H]<sup>+</sup> requires 308.1909).</div></div><div id="sec7_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i><sup>2</sup>-(1-Benzylpiperidin-4-yl)-<i>N</i><sup>4</sup>-ethyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylthieno[3,2-<i>d</i>]pyrimidine-2,4-diamine (<b>49</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM14</b> (140 mg, 0.61 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpiperidin-4-amine (500 mg, 2.4 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by flash column chromatography (EtOAc; 100%) to give the title compound (<b>49</b>) as a colorless oil (87 mg, 0.22 mmol, 36%). LC-MS <i>R</i><sub>t</sub> = 9.0 min; MH<sup>+</sup> 396; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.51 (d, <i>J</i> = 5.7 Hz, 1H), 7.36–7.22 (m, 5H), 7.12 (d, <i>J</i> = 5.7 Hz, 1H), 4.72–4.63 (m, 1H), 3.74 (q, <i>J</i> = 7.0 Hz, 2H), 3.52 (s, 2H), 3.30 (s, 3H), 3.06 (s, 2H), 3.02–2.96 (m, 2H), 2.13 (dt, <i>J</i> = 11.8, 2.5 Hz, 2H), 1.86 (dq, <i>J</i> = 12.1, 3.8 Hz, 2H), 1.72–1.76 (m, 2H), 1.24 (t, <i>J</i> = 7.0 Hz, 3H). ESI HRMS, found 396.2224 (C<sub>22</sub>H<sub>30</sub>N<sub>5</sub>S [M + H]<sup>+</sup> requires 396.2223).</div></div><div id="sec7_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 3-((6-(<i>tert</i>-Butyl)-2-(methyl(1-methylpiperidin-4-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>50</b>)</h4><div class="NLM_p last">Intermediate <b>IM15</b> (0.064 g, 0.21 mmol) was suspended in n-BuOH (1. mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpiperidin-4-amine (169 mg, 0.84 mmol). The vial was sealed and irradiated for 2 h at 200 °C. After workup, the crude product was purified by flash column chromatography (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 1:9) to give 3-((2-((1-benzylpiperidin-4-yl)(methyl)amino)-6-(<i>tert</i>-butyl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile as a yellow oil (58 mg, 0.12 mmol, 58%). This was debenzylated using 10% Pd/C (13 mg) and ammonium formate (77 mg) in EtOH (2.0 mL). The crude product (0.024 g, 0.06 mmol) was then methylated using formaldehyde (6 mg, 0.29 mmol), sodium triacetoxyborohydride (27 mg, 0.125 mmol), and acetic acid (7.1 μL, 0.125 mmol) according to general method D to give the product (9.0 mg, 0.020 mmol, 10%) after purification by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid). LC-MS <i>R</i><sub>t</sub> = 8.3 min; MH<sup>+</sup> 401; <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.45 (s, 1.5H), 6.99 (s, 1H), 5.00–4.92 (m, 1H)*, 4.08 (t, <i>J</i> = 6.6 Hz, 2H), 3.64–3.58 (m, 2H), 3.55 (s, 3H), 3.23–3.16 (m, 2H), 3.07 (s, 3H), 2.91 (t, <i>J</i> = 6.7 Hz, 2H), 2.89 (s, 3H), 2.22–2.12 (m, 2H), 2.01–1.97 (m, 2H), 1.46 (s, 9H);. ESI HRMS, found 401.2491 (C<sub>21</sub>H<sub>33</sub>N<sub>6</sub>S [M + H]<sup>+</sup> requires 401.2487). *Partially obscured by the water signal.</div></div><div id="sec7_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-((6-(<i>tert</i>-Butyl)-2-((3-(dimethylamino)propyl)(methyl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>51</b>)</h4><div class="NLM_p last">Intermediate <b>IM15</b> (42 mg, 0.14 mmol) was suspended in DMA (1.0 mL) in a microwave vial and treated with excess <i>N</i>,<i>N</i>,<i>N</i>′-trimethyl-1,3-propane-diamine (80 μL, 0.55 mmol). The vial was sealed and heated for 24 h at 120 °C. The reaction mixture was partitioned between EtOAc (20 mL) and 1 M NaOH solution (10 mL), and then the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by reverse-phase HPLC (30–98% MeOH/water/0.1% formic acid) to give the title compound (<b>51</b>) (4.0 mg, 0.01 mmol, 7%). LC-MS <i>R</i><sub>t</sub> = 10.7 min (30–98% MeCN/water/0.1% formic acid); <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 6.99 (s, 1H), 4.08 (t, <i>J</i> = 6.6 Hz, 2H), 3.72 (t, <i>J</i> = 6.3 Hz, 2H), 3.55 (s, 3H), 3.18 (s, 3H), 3.11 (t, <i>J =</i> 7.1 Hz, 2H), 2.91 (t, <i>J</i> = 6.6 Hz, 2H), 2.88 (s, 6H), 2.13–2.07 (m, 2H), 1.45 (s, 9H); ESI HRMS, found 389.2501 (C<sub>20</sub>H<sub>33</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 389.2487).</div></div><div id="sec7_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 3-((6-(<i>tert</i>-Butyl)-2-(methyl(1-methylpyrrolidin-3-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>52</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, ((6-(<i>tert</i>-butyl)-2-(methyl(pyrrolidin-3-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>53</b>, 8 mg, 0.02 mmol) was methylated using paraformaldehyde (∼2 mg, 4.0 equiv) and sodium triacetoxyborohydride (17 mg, 4.0 equiv) in DCE (5.0 mL). After workup, the crude product was purified by reverse-phase HPLC (20–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound as a colorless formate salt (3.1 mg, 0.007 mmol, 36%). LC-MS <i>R</i><sub>t</sub> = 9.4 min; MH<sup>+</sup> 387; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.54 (s, 3H), 7.01 (s, 1H), 5.13–5.05 (m, 1H), 4.05 (t, <i>J</i> = 6.6 Hz, 2H), 3.66–3.58 (m, 1H), 3.53 (s, 3H), 3.45–3.39 (m, 1H), 3.30–3.16 (m, 1H), 3.18 (s, 3H), 3.11–3.03 (m, 1H), 2.91–2.85 (m, 5H), 2.50–2.39 (m, 1H), 2.27–2.13 (m, 1H), 1.45 (s, 9H); ESI HRMS, found 387.2336 (C<sub>20</sub>H<sub>31</sub>N<sub>6</sub>S [M + H]<sup>+</sup> requires 387.2331).</div></div><div id="sec7_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 3-((6-(<i>tert</i>-Butyl)-2-(methyl(pyrrolidin-3-yl)amino)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>53</b>)</h4><div class="NLM_p last">A solution of 3-((2-((1-benzylpyrrolidin-3-yl)(methyl)amino)-6-(<i>tert</i>-butyl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>54</b>, 96 mg, 0.21 mmol) in EtOH (10 mL) was treated with an excess of ammonium formate (126 mg, 2 mmol) and a catalytic quantity of 10% Pd/C. The mixture was heated under reflux overnight, cooled to room temperature, filtered through celite, and evaporated under reduced pressure. The crude product was purified by reverse-phase HPLC (33–98% MeOH/water/0.1% formic acid), partially evaporated, and then lyophilized to give the title compound (<b>53</b>) as a colorless formate salt (9.7 mg, 0.023 mmol, 11%). LC-MS <i>R</i><sub>t</sub> = 9.6 min; MH<sup>+</sup> 373; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 2H), 7.05 (s, 1H), 5.16–5.09 (m, 1H), 4.05 (t, <i>J</i> = 6.6 Hz, 2H), 3.72–3.76 (m, 1H), 3.53 (s, 3H), 3.49–3.38 (m, 2H), 3.30–3.23 (m, 1H), 3.18 (s, 3H), 2.88 (t, <i>J</i> = 6.6 Hz, 2H), 2.42–2.32 (m, 1H), 2.27–2.16 (m, 1H), 1.44 (s, 9H); ESI HRMS, found 373.2188 (C<sub>19</sub>H<sub>29</sub>N<sub>6</sub>S [M + H]<sup>+</sup>, requires 373.2174).</div></div><div id="sec7_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-((2-((1-Benzylpyrrolidin-3-yl)(methyl)amino)-6-(<i>tert</i>-butyl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>54</b>)</h4><div class="NLM_p last">According to general method B for C<sub>2</sub> displacements, intermediate <b>IM15</b> (0.10 g, 0.32 mmol) was suspended in EtOAc (1.5 mL) in a microwave vial and treated with excess 1-benzyl-<i>N</i>-methylpyrrolidin-3-amine (250 μL, 1.3 mmol). The vial was sealed and irradiated for 90 min at 180 °C. After workup, the crude product was purified by flash column chromatography (EtOAc/hexane; 1:1 and then 1:0) to give the title compound (<b>54</b>) as a colorless oil (96 mg, 0.21 mmol, 65%). LC-MS <i>R</i><sub>t</sub> = 10.5 min; MH<sup>+</sup> 463; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38–7.22 (m, 5H), 6.94 (s, 1H), 5.55–5.46 (m, 1H), 3.95 (t, <i>J</i> = 6.6 Hz, 2H), 3.69 (d, <i>J</i> = 12.9 Hz, 1H), 3.57 (d, <i>J</i> = 12.9 Hz, 1H), 3.51 (s, 3H), 3.12 (s, 3H), 2.90–2.84 (m, 1H), 2.76 (t, <i>J</i> = 6.7 Hz, 2H), 2.70–2.56 (m, 2H), 2.48–2.36 (m, 1H), 2.26–2.16 (m, 1H), 1.98–1.82 (m, 1H), 1.42 (s, 9H); ESI HRMS found 463.2639 (C<sub>26</sub>H<sub>35</sub>N<sub>6</sub>S, [M + H]<sup>+</sup>, requires 463.2644).</div></div><div id="sec7_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-((6-Bromo-2-(methyl(1-methylpiperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>55</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM16</b> (25.0 mg, 0.077 mmol) and <i>N</i>,1-dimethylpiperidin-4-amine (39 mg, 0.31 mmol) were dissolved in <i>n</i>-BuOH (2.0 mL) and heated at 150 °C for 3 h. After cooling, the solvent was concentrated <i>in vacuo</i> and the residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>55</b> as a 50% formate salt (3.4 mg, 0.008 mmol, 10%). LC-MS <i>R</i><sub>t</sub> 6.73 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (0.5H, s), 7.95 (1H, d, <i>J</i> = 2.2 Hz), 7.57 (1H, dd, <i>J</i> = 9.0, 2.2 Hz), 7.39 (1H, d, <i>J</i> = 9.0 Hz), 4.97 (1H, m), 3.94 (2H, t, <i>J</i> = 7.0 Hz), 3.49–3.44 (5H, m), 3.09 (3H, s), 2.86 (2H, t, <i>J</i> = 7.0 Hz), 2.85–2.78 (2H, m), 2.68 (s, 3H), 2.45–2.36 (m, 2H), 1.86–1.82 (2H, m); ESI HRMS, found 417.1402 (C<sub>19</sub>H<sub>26</sub>N<sub>6</sub><sup>79</sup>Br [M + H]<sup>+</sup>, requires 417.1402).</div></div><div id="sec7_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 3-((6-Bromo-2-((3-(dimethylamino)propyl)(methyl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>56</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM16</b> (50.0 mg, 0.15 mmol) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (90 μL, 0.61 mmol) were dissolved in EtOAc (1.5 mL) and heated at 180 °C in a microwave for 90 min. After cooling, the solution was washed with H<sub>2</sub>O, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a yellow oil, which was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound <b>56</b> as a formate salt (11 mg, 0.024 mmol, 16%). LC-MS <i>R</i><sub>t</sub> 8.29 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 7.93 (1H, d, <i>J</i> = 2.2 Hz), 7.55 (1H, dd, <i>J</i> = 9.0, 2.2 Hz), 7.35 (1H, d, <i>J</i> = 9.0 Hz), 3.93 (2H, t, <i>J</i> = 6.9 Hz), 3.73 (2H, t, <i>J</i> = 7.1 Hz), 3.44 (3H, s), 3.18 (3H, s), 2.87 (2H, t, <i>J</i> = 6.9 Hz), 2.74–2.70 (2H, m), 2.51 (6H, s), 2.02–1.95 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.6, 162.7, 158.2, 153.8, 135.7, 128.1, 127.8, 118.5, 112.4, 112.3, 56.1, 48.7, 47.0, 43.8, 41.8, 35.3, 24.3, 15.6; ESI HRMS, found 405.1391 (C<sub>18</sub>H<sub>26</sub>N<sub>6</sub><sup>79</sup>Br [M + H]<sup>+</sup>, requires 405.1402).</div></div><div id="sec7_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-((6-Bromo-2-(methyl(1-methylpyrrolidin-3-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>57</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM16</b> (25.0 mg, 0.077 mmol) and <i>N</i><sup>1</sup>-dimethylpyrrolidin-3-amine (50 μL, 0.38 mmol) were dissolved in <i>n</i>-BuOH (2.0 mL) and heated at reflux for 3 h. After cooling, the solvent was concentrated <i>in vacuo</i> and the residue was dissolved in 5% MeOH and 95% H<sub>2</sub>O to give a suspension. After filtration, the residual solid was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>57</b> as a di-formate salt (11 mg, 0.024 mmol, 32%). LC-MS <i>R</i><sub>t</sub> 6.71 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 (2H, s), 7.99 (1H, d, <i>J</i> = 2.2 Hz), 7.59 (1H, dd, <i>J</i> = 8.9, 2.2 Hz), 7.37 (1H, d, <i>J</i> = 9.0 Hz), 5.63 (1H, p, <i>J</i> = 8.6 Hz), 3.97 (2H, td, <i>J</i> = 6.6, 2.0 Hz), 3.61–3.52 (1H, m), 3.49 (3H, s), 3.47–3.29 (3H, m), 3.17 (3H, s), 2.87 (2H, t, <i>J</i> = 6.6 Hz), 2.84 (3H, s), 2.37–2.31 (2H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.9, 162.4, 157.6, 153.0, 136.0, 128.0, 127.8, 118.5, 113.1, 112.7, 55.0, 54.7, 54.6, 48.8, 42.1, 41.1, 27.4, 15.7; ESI HRMS, found 403.1228 (C<sub>18</sub>H<sub>24</sub>N<sub>6</sub><sup>79</sup>Br [M + H]<sup>+</sup>, requires 403.1246).</div></div><div id="sec7_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 3-((6-Methoxy-2-(methyl(1-methylpiperidin-4-yl)amino)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>58</b>)</h4><div class="NLM_p last">3-((2-Chloro-6-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM17</b> (50.0 mg, 0.18 mmol) and <i>N</i>,1-dimethylpiperidin-4-amine (92 mg, 0.72 mmol) were dissolved in <i>n</i>-BuOH (2.0 mL) and heated at 120 °C for 3 h. After cooling, the reaction was concentrated <i>in vacuo</i> and the solid was dissolved in EtOAc and washed with H<sub>2</sub>O (5×). The solution was concentrated again, and the residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>58</b> as a di-formate salt (2.0 mg, 0.004 mmol, 2%). LC-MS <i>R</i><sub>t</sub> 6.18 min; <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.36 (s, 2H), 7.57 (d, <i>J</i> = 9.1 Hz, 1H), 7.45 (d, <i>J</i> = 2.7 Hz, 1H), 7.39 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 4.99–4.96 (1H, m)*, 4.09 (t, <i>J</i> = 6.8 Hz, 2H), 3.89 (s, 3H), 3.56 (s, 3H), 3.56–3.51 (2H, m), 3.13 (s, 3H), 3.13–3.03 (2H, m); 3.02 (t, <i>J</i> = 6.8 Hz, 3H), 2.82 (s, 3H), 2.19–2.09 (2H, m), 2.01–1.95 (2H, m); ESI HRMS, found 369.2393 (C<sub>20</sub>H<sub>29</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 369.2403). *Obscured by the H<sub>2</sub>O signal; the presence was confirmed by COSY coupling to multiplet at 2.19–2.09 Hz.</div></div><div id="sec7_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-6-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile (<b>59</b>)</h4><div class="NLM_p last">3-((2-Chloro-6-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM17</b> (50 mg, 0.18 mmol) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (106 μL, 0.72 mmol) were dissolved in EtOAc and heated at 180 °C in a microwave for 90 min. After cooling, the solution was washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a yellow oil, which was purified by reverse-phase HPLC (5–98% MeOH/water/0.1% formic acid) to give the title compound <b>59</b> (18 mg, 0.065 mmol, 36%). LC-MS <i>R</i><sub>t</sub> 7.22 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47 (1H, d, <i>J</i> = 9.1 Hz), 7.24 (1H, dd, <i>J</i> = 9.1, 2.8 Hz), 7.16 (1H, d, <i>J</i> = 2.8 Hz), 3.89 (2H, t, <i>J</i> = 6.9 Hz), 3.85 (3H, s), 3.72 (2H, t, <i>J</i> = 7.1 Hz), 3.38 (3H, s), 3.19 (3H, s), 2.87 (2H, t, <i>J</i> = 6.9 Hz), 2.65 (2H, t, <i>J</i> = 7.7 Hz), 2.46 (6H, s), 2.01–1.90 (2H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 163.7, 157.5, 153.3, 150.2, 127.6, 123.9, 118.7, 111.3, 105.4, 56.5, 55.9, 48.7, 47.1, 44.3, 41.3, 35.4, 24.7, 15.8; ESI HRMS, found 357.2386 (C<sub>19</sub>H<sub>29</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 357.2403).</div></div><div id="sec7_3_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-6-phenylquinazolin-4-yl)(methyl)amino)propanenitrile (<b>60</b>)</h4><div class="NLM_p last">3-((2-Chloro-6-phenylquinazolin-4-yl)(methyl)amino)propanenitrile <b>IM18</b> (10 mg, 0.031 mmol) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (18 μL, 0.12 mmol) were dissolved in <i>n</i>-BuOH (0.5 mL) and heated at 120 °C for 4 h. After cooling, the solution was diluted with EtOAc, washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (method C) to give the title compound <b>60</b> as a 0.5 formate salt (8 mg, 0.018 mmol, 61%). LC-MS <i>R</i><sub>t</sub> 8.87 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 0.5H), 8.01 (d, <i>J</i> = 2.0 Hz, 1H), 7.79 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.61–7.54 (m, 3H), 7.45 (dd, <i>J</i> = 8.4, 7.0 Hz, 2H), 7.37–7.31 (m, 1H), 3.97 (t, <i>J</i> = 6.9 Hz, 2H), 3.78 (t, <i>J</i> = 7.0 Hz, 2H), 3.50 (s, 3H), 3.22 (s, 3H), 2.90 (t, <i>J</i> = 6.9 Hz, 2H), 2.75 (t, <i>J</i> = 7.8 Hz, 2H), 2.53 (s, 6H), 2.09–1.97 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.7, 163.9, 158.2, 154.3, 140.9, 133.2, 132.1, 129.1, 127.2, 126.9, 126.6, 123.7, 118.6, 111.4, 56.2, 48.7, 47.0, 43.9, 41.9, 35.4, 24.5, 15.7; ESI HRMS, found 403.2619 (C<sub>24</sub>H<sub>31</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 403.2610).</div></div><div id="sec7_3_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-6-(<i>o</i>-tolyl)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>61</b>)</h4><div class="NLM_p last">3-((2-Chloro-6-(<i>o</i>-tolyl)quinazolin-4-yl)(methyl)amino)propanenitrile <b>IM19</b> (30 mg, 0.089 mmol) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (52 μL, 0.36 mmol) were dissolved in <i>n</i>-BuOH (0.5 mL) and heated at 120 °C for 4 h. After cooling, the solution was diluted with EtOAc, washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>61</b> as a di-formate salt (6.2 mg, 0.012 mmol, 14%). LC-MS <i>R</i><sub>t</sub> 9.04 min (5–98% MeCN/water/0.1% formic acid); MH<sup>+</sup> 417.4; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (3H, br s), 7.85 (d, <i>J</i> = 8.6 Hz, 1H), 7.83 (d, <i>J</i> = 1.9 Hz, 1H), 7.63 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.32–7.27 (m, 3H), 7.23–7.19 (m, 1H), 4.08 (t, <i>J</i> = 6.7 Hz, 2H), 3.87 (t, <i>J</i> = 7.1 Hz, 2H), 3.60 (s, 3H), 3.29 (s, 3H), 3.20–3.16 (m, 2H), 2.93 (t, <i>J</i> = 6.6 Hz, 2H), 2.80 (s, 6H), 2.27 (s, 3H), 2.20 (p, <i>J</i> = 7.6, 6.9 Hz, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.5, 162.8, 154.3, 140.3, 136.4, 135.7, 135.3, 130.7, 129.8, 127.9, 126.2, 126.0, 121.7, 117.9, 110.2, 54.7, 49.1, 47.1, 42.7, 42.3, 36.1, 23.0, 20.5, 15.5; ESI HRMS, found 417.2771 (C<sub>25</sub>H<sub>33</sub>N<sub>6</sub> [M + H]<sup>+</sup>, requires 417.2767).</div></div><div id="sec7_3_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-6-(4-methoxy-2-methylphenyl)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>62</b>)</h4><div class="NLM_p last">3-((2-Chloro-6-(4-methoxy-2-methylphenyl)quinazolin-4-yl)(methyl)amino)propanenitrile <b>IM20</b> (22 mg, 0.060 mmol) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine (36 μL, 0.24 mmol) were dissolved in <i>n</i>-BuOH (1 mL) and heated at 120 °C for 4 h. After cooling, the solution was diluted with EtOAc, washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give the title compound <b>62</b> as a formate salt (5.5 mg, 0.011 mmol, 19%). LC-MS <i>R</i><sub>t</sub> 9.49 min; MH<sup>+</sup> 447.4; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (1H, s), 8.06 (m, 1H), 7.79 (d, <i>J</i> = 1.8 Hz, 1H), 7.61 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.14 (d, <i>J</i> = 8.3 Hz, 1H), 6.85–6.81 (m, 2H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 3.91 (t, <i>J</i> = 7.1 Hz, 2H), 3.85 (s, 3H), 3.59 (s, 3H), 3.29 (s, 3H), 3.24–3.19 (s, 2H), 2.92 (t, <i>J</i> = 6.8 Hz, 2H), 2.81 (s, 6H), 2.26 (m, 5H).</div></div><div id="sec7_3_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 3-((2-((3-(Dimethylamino)propyl)(methyl)amino)-7-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile (<b>63</b>)</h4><div class="NLM_p last">3-((2-Chloro-7-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM21</b>) and <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>,<i>N</i><sup>3</sup>-trimethylpropane-1,3-diamine were dissolved in <i>n</i>-BuOH (1 mL) and heated at 120 °C for 4 h. After cooling, the solution was diluted with EtOAc, washed with H<sub>2</sub>O and then brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The residue was purified by reverse-phase HPLC (50–98% MeOH/water/0.1% formic acid) to give product <b>63</b> as a formate salt (17 mg, 0.042 mmol). LC-MS <i>R</i><sub>t</sub> 8.18 min; MH<sup>+</sup> 357.3; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.49 (s, 1H), 7.85 (br s, 2H), 7.74 (d, <i>J</i> = 9.2 Hz, 1H), 6.99 (d, <i>J</i> = 2.6 Hz, 1H), 6.70 (dd, <i>J</i> = 9.2, 2.6 Hz, 1H), 3.95 (t, <i>J</i> = 6.8 Hz, 2H), 3.88 (s, 3H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 3.45 (s, 3H), 3.20 (s, 3H), 2.99–2.92 (m, 2H), 2.86 (t, <i>J</i> = 6.8 Hz, 2H), 2.67 (s, 3H), 2.12–2.03 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.8, 163.4, 163.0, 157.3, 155.1, 127.1, 118.5, 112.8, 105.2, 104.2, 55.7, 55.3, 48.7, 46.8, 42.9, 41.9, 35.5, 23.4, 15.8; ESI HRMS, found 357.2397 (C<sub>19</sub>H<sub>29</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, requires 357.2403).</div></div><div id="sec7_3_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-(Ethyl(methyl)amino)-2-(methyl(1-methylpiperidin-4-yl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (<b>64</b>)</h4><div class="NLM_p last">According to general method D for reductive amination, 4-(ethyl(methyl)amino)-2-(methyl(piperidin-4-yl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (<b>67</b>) was reacted with paraformaldehyde. After purification by reverse-phase HPLC, product <b>64</b> was obtained (1.2 mg, 0.002 mmol, 31%). LC-MS <i>R</i><sub>t</sub> 8.11 min (83%); MH<sup>+</sup> 501.6; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (br s, 3H), 7.97 (d, <i>J</i> = 1.9 Hz, 1H), 7.83 (dd, <i>J</i> = 8.9, 1.9 Hz, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 1H), 5.08–4.95 (m, 1H), 3.60 (s, 3H), 3.59–3.50 (m, 4H), 3.25–3.15 (m, 2H), 3.15 (s, 3H), 3.11 (s, 3H), 2.98 (s, 3H), 2.18–2.03 (m, 2H), 1.96 (s, 3H), 1.58 (s, 3H), 1.34–1.26 (m, 7H); ESI HRMS, found 501.2746 (C<sub>24</sub>H<sub>37</sub>N<sub>8</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, requires 501.2760).</div></div><div id="sec7_3_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 4-(Ethyl(methyl)amino)-2-(methyl(piperidin-4-yl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (<b>65</b>)</h4><div class="NLM_p last">2-Chloro-4-(ethyl(methyl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (47 mg, 0.116 mmol, 1.0 equiv) and <i>N</i>-benzyl-<i>N</i>-methylpiperidin-4-amine (10 equiv) were combined in n-BuOH (1.0 mL) and stirred at 120 °C overnight. The reaction mixture was then concentrated <i>in vacuo</i>, and the crude residue was purified by flash column chromatography (CHCl<sub>3</sub>/MeOH/aq. NH<sub>3</sub>; 90:10:0.1) to give 2-((1-benzylpiperidin-4-yl)(methyl)amino)-4-(ethyl(methyl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide. This intermediate was debenzylated by dissolving it in 1 mL EtOH with ammonium formate (74 mg, 1.17 mmol, 10 equiv) and 10% Pd/C (13 mg) and then stirred at 80 °C overnight. The reaction mixture was then filtered through celite and concentrated <i>in vacuo</i>, before purification by reverse-phase HPLC to give product <b>65</b> as a light yellow oil (3.7 mg, 0.008 mmol, 7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25 (br, s, 3H), 7.99 (d, <i>J</i> = 1.9 Hz, 1H), 7.87 (dd, <i>J</i> = 8.9, 1.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 1H), 5.07–4.98 (m, 1H), 3.62 (s, 3H), 3.61–3.51 (m, 4H), 3.22–3.18 (m, 2H), 3.19 (s, 3H), 3.14 (s, 3H), 2.17–2.03 (m, 2H), 2.02–1.97 (m, 5H), 1.62 (s, 3H), 1.30 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec7_3_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-((3-(Dimethylamino)propyl)(methyl)amino)-4-(ethyl(methyl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (<b>66</b>)</h4><div class="NLM_p last">2-Chloro-4-(ethyl(methyl)amino)quinazoline-6-sulfonyl chloride (50 mg, 0.156 mmol), 1,3,5-trimethyl-1<i>H</i>-pyrazol-4-amine (22 mg, 0.172 mmol), and triethylamine (43 μL, 0.312 mmol) were dissolved in DMF (1.0 mL). After purification by flash column chromatography, 2-chloro-4-(ethyl(methyl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide and <i>N,N,N</i>-trimethylpropane-1,3-diamine (58 μL) were combined in n-BuOH (1.0 mL) and stirred at 120 °C overnight. The reaction mixture was then concentrated <i>in vacuo</i> and purified by reverse-phase HPLC to give the title compound <b>66</b> (6 mg, 0.012 mmol, 12%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (br, s, 2H), 8.00 (d, <i>J</i> = 2.0 Hz, 1H), 7.84 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 7.47 (d, <i>J</i> = 8.8 Hz, 1H), 3.78 (t, <i>J</i> = 6.4 Hz, 2H), 3.60 (s, 3H), 3.55 (q, <i>J</i> = 7.0 Hz, 2H), 3.22 (s, 3H), 3.18 (s, 3H), 3.10 (t, <i>J</i> = 7.0 Hz, 2H), 2.86 (s, 6H), 2.11 (qt, <i>J</i> = 6.5 Hz, 2H), 1.96 (s, 3H), 1.58 (s, 3H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H); ESI HRMS, found 489.2739 (C<sub>23</sub>H<sub>37</sub>N<sub>8</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, requires 489.2760).</div></div><div id="sec7_3_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-(Ethyl(methyl)amino)-2-(methyl(1-methylpyrrolidin-3-yl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide (<b>67</b>)</h4><div class="NLM_p last">2-Chloro-4-(ethyl(methyl)amino)quinazoline-6-sulfonyl chloride (50 mg, 0.156 mmol), 1,3,5-trimethyl-1<i>H</i>-pyrazol-4-amine (22 mg, 0.172 mmol), and triethylamine (43 μL, 0.312 mmol) were dissolved in DMF (1.0 mL). After purification by flash column chromatography, 2-chloro-4-(ethyl(methyl)amino)-<i>N</i>-(1,3,5-trimethyl-1<i>H</i>-pyrazol-4-yl)quinazoline-6-sulfonamide and <i>N-</i>dimethylpyrrolidin-3-amine (51 μL) were combined in n-BuOH (1.0 mL) and stirred at 120 °C overnight. The reaction mixture was then concentrated <i>in vacuo</i> and purified by reverse-phase HPLC to give the title compound <b>67</b> (5 mg, 0.01 mmol, 10%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (br, s, 2H), 8.02 (d, <i>J</i> = 2.0 Hz, 1H), 7.88 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 7.53 (d, <i>J</i> = 8.8 Hz, 1H), 5.07* (m, 1H), 3.93–3.80 (m, 1H), 3.68–3.63 (m, 1H), 3.63 (s, 3H), 3.56 (q, <i>J</i> = 6.9 Hz, 2H), 3.46–3.40 (m, 1H), 3.28 (s, 3H), 3.28–2.23 (m, 1H), 3.18 (s, 3H), 3.03 (s, 3H), 2.60–2.51 (m, 1H), 2.35–2.25 (m, 1H), 1.99 (s, 3H), 1.61 (s, 3H), 1.29 (t, <i>J</i> = 7.0 Hz, 3H); ESI HRMS, found 487.2597 (C<sub>23</sub>H<sub>35</sub>N<sub>8</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, requires 487.2604).*Obscured by the H<sub>2</sub>O signal.</div></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Synthesis of Intermediate Compounds</h3><div id="sec7_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM1</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (147 mg, 0.72 mmol) was treated with DIPEA (148 μL, 0.85 mmol) followed by 3-(methylamino)propanenitrile (67 μL, 0.71 mmol). After workup, the product, 3-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM1</b>), crystallized on evaporation of the solvent (173 mg, 0.68 mmol, 95%) without the need for further purification. Mp 156–158 °C; IR CN ν 2355 cm<sup>–1</sup>; MS (ESI) 253 (MH<sup>+</sup>); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 5.5 Hz, 1H), 7.45 (d, <i>J</i> = 5.5 Hz, 1H), 4.07 (t, <i>J</i> = 6.5 Hz, 2H), 3.73 (s, 3H), 2.90 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec7_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 3-((2-Chloroquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM2</b>)</h4><div class="NLM_p last">2,4-Dichloroquinazoline (0.7 g, 3.51 mmol) in DMF (3.0 mL) was treated with DIPEA (1.3 mL, 2.2 equiv) followed by 3-(methylamino)propanenitrile (720 μL, 2.2 equiv) and stirred at room temperature overnight. After the reaction was complete, H<sub>2</sub>O (50 mL) was added, and the resultant precipitate was collected by filtration and washed with water, giving the product (0.66 g, 2.68 mmol, 76%) without the need for further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 7.82 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.69 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 7.52 (ddd, <i>J</i> = 8.5, 7.0, 1.4 Hz, 1H), 4.03 (t, <i>J</i> = 6.8 Hz, 2H), 3.52 (s, 3H), 3.01 (t, <i>J</i> = 6.8 Hz, 2H).</div></div><div id="sec7_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 3-((2-Chloropyrido[2,3-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM3</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichloropyrido[2,3-<i>d</i>]pyrimidine (360 mg, 1.8 mmol) was treated with DIPEA (350 μL, 2.0 mmol) followed by 3-(methylamino)propanenitrile (170 μL, 1.8 mmol). After workup, the crude residue was purified by flash column chromatography (EtOAc/MeOH; 100:0 and then 90:10) to give the product, 3-((2-chloropyrido[2,3-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM3</b>), as a colorless solid (126 mg, 0.51 mmol, 28%). Mp 190–192 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 9.06 (dd, <i>J</i> = 4.4, 1.8 Hz, 1H), 8.50 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.42 (dd, <i>J</i> = 8.5, 4.4 Hz, 1H), 4.11 (t, <i>J</i> = 6.4 Hz, 2H), 3.72 (s, 3H), 2.99 (t, <i>J</i> = 6.4 Hz, 2H).</div></div><div id="sec7_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-((2-Chloro-7-methyl-7<i>H</i>-purin-6-yl)(methyl)amino)propanenitrile (<b>IM4</b>)</h4><div class="NLM_p last">A suspension of 2,6-dichloro-7-methyl-7<i>H</i>-purine (404 mg, 2.1 mmol, 1.0 equiv) in EtOAc/EtOH (10:1, 10 mL) was treated with DIPEA (1.2 equiv) followed by 3-(methylamino)propanenitrile (215 μL, 2.3 mmol, 1.2 equiv), and the reaction was heated under reflux for 4 h. The reaction mixture was cooled to room temperature and then washed with sodium carbonate solution (1 M, 10 mL), and the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The product, 3-((2-chloro-7-methyl-7<i>H</i>-purin-6-yl)(methyl)amino)propanenitrile (<b>IM4</b>), was obtained by flash column chromatography (EtOAc/MeOH; 95:5 and then 90:10) as a tan solid (300 mg, 1.2 mmol, 57%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 8.05 (s, 1H), 4.08 (s, 3H), 3.86 (t, <i>J</i> = 6.5 Hz, 2H), 3.33 (s, 3H), 2.86 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec7_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-Chloro-<i>N</i>-(2-methoxyethyl)-<i>N</i>-methylthieno[3,2-<i>d</i>]pyrimidin-4-amine (<b>IM5</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (146 mg, 0.71 mmol) was treated with DIPEA (148 μL, 0.85 mmol) followed by 2-methoxy-<i>N</i>-methylethanamine (63 mg, 0.71 mmol). After workup, the product, 2-chloro-<i>N</i>-(2-methoxyethyl)-<i>N</i>-methylthieno[3,2-<i>d</i>]pyrimidin-4-amine (<b>IM5</b>), crystallized on evaporation of the solvent (185 mg, 0.71 mmol, quant.) with no need for further purification. Mp 70–72 °C. MS (ESI) 258 (MH<sup>+</sup>); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (d, <i>J</i> = 5.4 Hz, 1H), 7.35 (d, <i>J</i> = 5.4 Hz, 1H), 3.99 (t, <i>J</i> = 5.4 Hz, 2H), 3.71 (t, <i>J</i> = 5.4 Hz, 2H), 3.56 (s, 3H), 3.39 (s, 3H).</div></div><div id="sec7_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol (<b>IM6</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (146 mg, 0.71 mmol) was treated with DIPEA (148 μL, 0.85 mmol) followed by 2-(methylamino)ethanol (53 mg, 0.71 mmol). After workup, the product, 2-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol (<b>IM6</b>), crystallized on evaporation of the solvent as a colorless solid (158 mg, 0.65 mmol, 91%) with no need for further purification. Mp 182–183 °C. MS (ESI) 244 (MH<sup>+</sup>); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 5.8 Hz, 1H), 7.35 (d, <i>J</i> = 5.8 Hz, 1H), 4.94 (br. s, 1H), 3.82 (t, <i>J</i> = 5.8 Hz, 2H), 3.67 (t, <i>J</i> = 5.8 Hz, 2H), 3.42 (s, 3H).</div></div><div id="sec7_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 3-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propan-1-ol (<b>IM7</b>)</h4><div class="NLM_p last">In an adaptation of general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol) was treated with DIPEA (348 μL, 2.0 mmol) followed by 3-(methylamino)propanol (195 μL, 2.0 mmol). After workup, the residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH; 20:1) to give the product, 2-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol (<b>IM7</b>), as a yellow solid (256 mg, 0.99 mmol, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (d, <i>J</i> = 5.5 Hz, 1H), 7.35 (d, <i>J</i> = 5.5 Hz, 1H), 3.89 (t, <i>J</i> = 5.5 Hz, 2H), 3.60 (t, <i>J</i> = 5.5 Hz, 2H), 3.50 (s, 3H), 1.94–1.84 (m, 2H).</div></div><div id="sec7_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 3-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propenamide (<b>IM8</b>)</h4><div class="NLM_p last">2,4-Dichlorothieno[3,2-<i>d</i>]pyrimidine (50 mg, 0.24 mmol) was dissolved in chlorosulfuric acid (1.0 mL, excess) and stirred at room temperature for 16 h. The reaction was then cooled to 0 °C, quenched with H<sub>2</sub>O, and extracted with EtOAc. The aqueous layer was neutralized with NaOH, and the resulting precipitate was collected by filtration to give the product, <b>IM8</b>, as a white solid (26 mg, 0.096 mmol, 40%). LC-MS <i>R</i><sub>t</sub> = 10.5 min; MH<sup>+</sup> 271/273; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>,) δ 8.29 (d, <i>J</i> = 5.5 Hz, 1H), 7.44 (s, 1H), 7.37 (d, <i>J</i> = 5.6 Hz, 1H), 6.94 (s, 1H), 3.94 (t, <i>J</i> = 7.1 Hz, 2H), 3.39 (s, 3H), 2.48 (d, <i>J</i> = 7.1 Hz, 2H).</div></div><div id="sec7_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> <i>N</i>-(2-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethyl)-<i>N</i>-methylacetamide (<b>IM9</b>)</h4><div class="NLM_p">Step 1: Using an adaptation of general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol) was treated with DIPEA (174 μL, 1.0 mmol) followed by <i>N</i>,<i>N</i>′-dimethylethylenediamine (1.0 mL, 9.3 mmol). After workup, the crude residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aq. NH<sub>3</sub>; 95:5:0.5–97:3:0.5) to give the product, <i>N</i>-(2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)-<i>N</i>,<i>N</i>′-dimethylethylenediamine (230 mg, 0.90 mmol, 90%). <sup>1</sup>H NMR (400 MHz, CDCl3), δ 7.78 (d, <i>J</i> = 5.5 Hz, 1H), 7.35 (d, <i>J</i> = 5.5 Hz, 1H), 3.96 (t, <i>J</i> = 6.5 Hz, 2H), 3.53 (s, 3H), 3.18 (s, 3H), 3.00 (t, <i>J</i> = 6.5 Hz, 2H), 2.55 (s, 3H).</div><div class="NLM_p last">Step 2: The product from Step 1 (230 mg, 0.9 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and treated with Et<sub>3</sub>N (73 μL, 1.0 mmol) followed by acetyl chloride (72 μL, 1.0 mmol). The reaction was stirred at room temperature for 1 h and worked up by washing the reaction mixture with sodium hydroxide solution (1 M, 10 mL) followed by extraction of the aqueous layer with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated under reduced pressure, and the crude residue was purified by flash column chromatography (EtOAc/MeOH; 95:5 and then 90:10) to give the product, <i>N</i>-(2-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethyl)-<i>N</i>-methylacetamide (<b>IM9</b>), as a low melting solid (70 mg, 0.23 mmol, 26%). <sup>1</sup>H NMR as a 3:1 mixture of rotamers (400 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 5.5 Hz, 0.3H), 7.69 (d, <i>J</i> = 5.5 Hz, 0.7H), 7.22 (d, <i>J</i> = 5.5 Hz, 0.3H), 7.19 (d, <i>J</i> = 5.5 Hz, 0.7H), 3.82 (t, <i>J</i> = 6.0 Hz, 1.4H), 3.75 (dd, <i>J</i> = 8.3, 6.0 Hz, 0.6H), 3.56 (t, <i>J</i> = 6.0 Hz, 1.4H), 3.51 (dd, <i>J</i> = 8.3, 6.0 Hz, 0.6H), 3.44 (s, 0.9H), 3.42 (s, 2.1H), 3.02 (s, 2.1H), 2.92 (s, 0.9H), 2.06 (s, 0.9H), 1.85 (s, 2.1H).</div></div><div id="sec7_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 3-((2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>IM10</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol) was treated with DIPEA (174 μL, 1.0 mmol) followed by <i>N</i>,<i>N</i>-dimethyl-3-(methylamino)propanamide (170 mg, 1.5 mmol). After workup, the residue was purified by flash column chromatography (EtOAc/MeOH; 100:0 and then 95:5) to give the product, 3-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)-<i>N</i>,<i>N</i>-dimethylpropanamide (<b>IM10</b>), as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (m, 1H), 7.41–7.32 (m, 1H), 4.10–4.03 (m, 2H), 3.57 (s, 3H), 3.11 (s, 3H), 2.98 (s, 3H), 2.83–2.76 (m, 2H).</div></div><div id="sec7_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (<i>S</i>)-(1-(2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)methanol (<b>IM11</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol) was treated with DIPEA (209 μL, 1.2 mmol) followed by (<i>S</i>)-pyrrolidin-2-ylmethanol (100 μL, 1.0 mmol). After workup, the crude residue was purified by column chromatography (EtOAc/hexane; 50:50–100:0) to give the product, (<i>S</i>)-(1-(2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)methanol (<b>IM11</b>), as a colorless solid (242 mg, 0.90 mmol, 90%). Mp 160–161 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 5.5 Hz, 1H), 7.33 (d, <i>J</i> = 5.5 Hz, 1H), 4.59 (dq, <i>J</i> = 7.0, 3.5 Hz, 1H), 4.10 (dd, <i>J</i> = 7.0, 4.5 Hz, 2H), 3.87 (dd, <i>J</i> = 11.5, 3.5 Hz, 1H), 3.79 (dd, <i>J</i> = 11.5, 7.0 Hz, 1H), 2.27–2.08 (m, 3H), 1.93 (td, <i>J</i> = 8.1, 7.0, 3.5 Hz, 1H).</div></div><div id="sec7_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (<i>S</i>)-2-Chloro-4-(2-(methoxymethyl)pyrrolidin-1-yl)thieno[3,2-<i>d</i>]pyrimidine (<b>IM12</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol) was treated with DIPEA (209 μL, 1.2 mmol) followed by (<i>S</i>)-2-(methoxymethyl)pyrrolidine (123 μL, 1.0 mmol). After workup, the product, (<i>S</i>)-2-chloro-4-(2-(methoxymethyl)pyrrolidin-1-yl)thieno[3,2-<i>d</i>]pyrimidine (<b>IM12</b>), crystallized on evaporation of the solvent as a colorless solid (250 mg, 0.88 mmol, 88%). Mp 110–112 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (d, <i>J</i> = 5.5 Hz, 1H), 7.35 (d, <i>J</i> = 5.5 Hz, 1H), 4.70 (td, <i>J</i> = 7.5, 3.0 Hz, 1H), 4.10–4.00 (m, 1H), 4.00–3.87 (m, 1H), 3.65 (dd, <i>J</i> = 9.5, 3.0 Hz, 1H), 3.63–3.53 (m, 1H), 3.40 (s, 3H), 2.32–2.13 (m, 2H), 2.13–2.01 (m, 2H).</div></div><div id="sec7_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (<i>S</i>)-2-(1-(2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)acetonitrile (<b>IM13</b>)</h4><div class="NLM_p last">A solution of 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (205 mg, 1.0 mmol, 1.0 equiv) in EtOAc (10 mL) was treated with DIPEA (1.2 equiv) followed by (<i>S</i>)-2-(pyrrolidin-2-yl)acetonitrile (125 mg, 1.1 mmol), and the reaction was heated under reflux for 4 h. The reaction mixture was cooled to room temperature and then washed with sodium hydroxide solution (1 M, 10 mL), and the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated under reduced pressure, and the residue was purified by flash column chromatography (DCM/hexane; 50:50–100:0 and then DCM/MeOH; 95:5) to give the product, (<i>S</i>)-(1-(2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)pyrrolidin-2-yl)methanol (<b>IM13</b>), as a yellow solid (115 mg, 0.41 mmol, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82 (d, <i>J</i> = 5.5 Hz, 1H), 7.35 (d, <i>J</i> = 5.5 Hz, 1H), 4.68 (tt, <i>J</i> = 7.0, 3.5 Hz, 1H), 4.17 (ddd, <i>J</i> = 9.0, 7.5, 4.5 Hz, 1H), 4.07 (dt, <i>J</i> = 9.0, 7.5 Hz, 1H), 3.13 (dd, <i>J</i> = 16.8, 7.0 Hz, 1H), 2.93 (dd, <i>J</i> = 16.8, 3.5 Hz, 1H), 2.48–2.23 (m, 2H), 2.17 (tdd, <i>J</i> = 10.9, 6.3, 3.5 Hz, 2H).</div></div><div id="sec7_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 2-Chloro-<i>N</i>-ethyl-<i>N</i>-methylthieno[3,2-<i>d</i>]pyrimidin-4-amine (<b>IM14</b>)</h4><div class="NLM_p last">Using general method A, 2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (307 mg, 1.5 mmol) was treated with DIPEA (313 μL, 1.8 mmol) followed by <i>N</i>-methylethanamine (128 μL, 1.5 mmol). After workup, the product, 2-((2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)ethanol (<b>IM14</b>), crystallized on evaporation of the solvent as a pale yellow solid (305 mg, 1.3 mmol, 89%) with no need for further purification. Mp 105–107 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (d, <i>J</i> = 5.8 Hz, 1H), 7.37 (d, <i>J</i> = 5.8 Hz, 1H), 3.88 (q, <i>J</i> = 7.1 Hz, 2H), 3.44 (s, 3H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec7_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 3-((6-(<i>tert</i>-Butyl)-2-chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM15</b>)</h4><div class="NLM_p last">To a solution of 6-(<i>tert</i>-butyl)-2,4-dichlorothieno[3,2-<i>d</i>]pyrimidine (233 mg, 0.9 mmol, 1.0 equiv) in DMF (2.0 mL) was added DIPEA (310 μL, 1.8 mmol, 2.0 equiv) followed by 3-(methylamino)propanenitrile (167 μL, 1.8 mmol, 2.0 equiv), and the reaction was stirred at room temperature overnight. The reaction mixture was washed with sodium hydroxide solution (1 M, 10 mL), and the aqueous layer was re-extracted with EtOAc (10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and then concentrated under reduced pressure. The crude product was purified by flash column chromatography by elution with ethyl acetate/hexane (2:1) giving the product (239 mg, 0.77 mmol, 86%).</div></div><div id="sec7_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM16</b>)</h4><div class="NLM_p last">To a suspension of 6-bromo-2,4-dichloroquinazoline (290 mg, 1.0 mmol) and 3-(methylamino)propanenitrile (195 μL, 2.1 mmol, 2.0 equiv) in DMF (3.0 mL) was added DIPEA (363 μL, 2.1 mmol, 2.0 equiv), and the solution was stirred at room temperature for 2 h. Water was added, and the solid formed was isolated by filtration, washed with water, and dried to give the product (156 mg, 0.48 mmol, 48%) as an orange powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 2.0 Hz, 1H), 7.82 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 2.0 Hz, 1H), 4.04 (t, <i>J</i> = 6.4 Hz, 2H), 3.67 (s, 3H), 2.94 (t, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec7_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-((2-Chloro-6-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM17</b>)</h4><div class="NLM_p last">To a suspension of 2,4-dichloro-6-methoxyquinazoline (90 mg, 0.39 mmol, 1.0 equiv) and 3-(methylamino)propanenitrile (74 μL, 0.8 mmol, 2.0 equiv) in DMF (1.0 mL) was added DIPEA (137 μL, 0.8 mmol, 2.0 equiv), and the solution was stirred at room temperature for 2 h. Water was added, and the solid formed was isolated by filtration, washed with water, and dried to give the product (50 mg, 46%) as a yellow powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (d, <i>J</i> = 9.2 Hz, 1H), 7.43 (dd, <i>J</i> = 9.2, 2.7 Hz, 1H), 7.36 (d, <i>J</i> = 2.7 Hz, 1H), 4.00 (t, <i>J</i> = 6.5 Hz, 2H), 3.91 (s, 3H), 3.61 (s, 3H), 2.94 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec7_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 3-((2-Chloro-6-phenylquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM18</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile (25 mg, 0.08 mmol, 1.0 equiv) and phenyl boronic acid (9.4 mg, 0.08 mmol, 1.0 equiv) were dissolved in DMF (1.0 mL), and Pd(OAc)<sub>2</sub> (1.0 mg, 0.004 mmol, 0.05 equiv) was added. A solution of Cs<sub>2</sub>CO<sub>3</sub> (50 mg, 0.15 mmol) in H<sub>2</sub>O (0.3 mL) was added and stirred at room temperature for 2 h. The solution was diluted with EtOAc (15 mL) and then washed with H<sub>2</sub>O (5 × 10 mL) and then brine (10 mL) before drying over MgSO<sub>4</sub>. The compound was purified by flash column chromatography (EtOAc/hexane 5:95–30:70) to give the product as a white solid (10 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.23 (d, <i>J</i> = 1.9 Hz, 1H), 8.00 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.91 (d, <i>J</i> = 8.7 Hz, 1H), 7.65–7.57 (m, 2H), 7.55–7.46 (m, 2H), 7.46–7.38 (m, 1H), 4.08 (t, <i>J</i> = 6.5 Hz, 2H), 3.72 (s, 3H), 2.97 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec7_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 3-((2-Chloro-6-phenylquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM19</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile (50 mg, 0.15 mmol, 1.0 equiv) and 2-methylphenyl boronic acid (21 mg, 0.15 mmol, 1.0 equiv) were dissolved in DMF (2.0 mL), and Pd(OAc)<sub>2</sub> (2.0 mg, 0.008 mmol, 0.05 equiv) was added. A solution of Cs<sub>2</sub>CO<sub>3</sub> (100 mg, 0.31 mmol) in H<sub>2</sub>O (0.6 mL) was added, and the solution was stirred at room temperature for 2 h. The solution was diluted with EtOAc (15 mL) and then washed with H<sub>2</sub>O (5 × 10 mL) and then brine (10 mL) before drying over MgSO<sub>4</sub>. The compound was purified by flash column chromatography (EtOAc/hexane 5:95–30:70) to give a colorless oil (34 mg, 0.10 mmol, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (d, <i>J</i> = 1.8 Hz, 1H), 7.87 (d, <i>J</i> = 8.6 Hz, 1H), 7.74 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.38–7.21 (m, 4H), 4.05 (t, <i>J</i> = 6.5 Hz, 2H), 3.65 (s, 3H), 2.96 (t, <i>J</i> = 6.5 Hz, 2H), 2.29 (s, 3H).</div></div><div id="sec7_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 3-((2-Chloro-6-(4-methoxy-2-methylphenyl)quinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM20</b>)</h4><div class="NLM_p last">3-((6-Bromo-2-chloroquinazolin-4-yl)(methyl)amino)propanenitrile (50 mg, 0.15 mmol, 1.0 equiv) and (4-methoxy-2-methylphenyl)boronic acid (25 mg, 0.15 mmol, 1.0 equiv) were dissolved in DMF (2.0 mL), and Pd(OAc)<sub>2</sub> (2.0 mg, 0.009 mmol, 0.06 equiv) was added. A solution of Cs<sub>2</sub>CO<sub>3</sub> (100 mg, 0.31 mmol) in H<sub>2</sub>O (0.6 mL) was added, and the solution was stirred at room temperature for 2 h. The solution was diluted with EtOAc (15 mL) and then washed with H<sub>2</sub>O (5 × 10 mL) and then brine (10 mL) before drying over MgSO<sub>4</sub>. The compound was purified by flash column chromatography (EtOAc/hexane 5:95–25:75) to give a white solid (22 mg, 0.06 mmol, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96 (dd, <i>J</i> = 1.8, 0.6 Hz, 1H), 7.84 (dd, <i>J</i> = 8.6, 0.6 Hz, 1H), 7.71 (dd, <i>J</i> = 8.6, 1.9 Hz, 1H), 7.18 (d, <i>J</i> = 8.3 Hz, 1H), 6.89–6.80 (m, 2H), 4.04 (t, <i>J</i> = 6.5 Hz, 2H), 3.85 (s, 3H), 3.64 (s, 3H), 2.95 (t, <i>J</i> = 6.5 Hz, 2H), 2.28 (s, 3H).</div></div><div id="sec7_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 3-((2-Chloro-7-methoxyquinazolin-4-yl)(methyl)amino)propanenitrile (<b>IM21</b>)</h4><div class="NLM_p last">To a suspension of 2,4-dichloro-7-methoxyquinazoline (30 mg, 0.13 mmol, 1.0 equiv) and 3-(methylamino)propanenitrile (25 μL, 0.26 mmol, 2.0 equiv) in DMF (0.5 mL) was added DIPEA (46 μL, 0.26 mmol, 2.0 equiv), and the solution was stirred at room temperature for 2 h. Water was added, and the solid formed was isolated by filtration, washed with water, and dried to give the product (10 mg, 0.036 mmol, 28%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 9.3 Hz, 1H), 7.18 (d, <i>J</i> = 2.7 Hz, 1H), 7.04 (dd, <i>J</i> = 9.4, 2.7 Hz, 1H), 4.02 (t, <i>J</i> = 6.5 Hz, 2H), 3.92 (s, 3H), 3.62 (s, 3H), 2.93 (t, <i>J</i> = 6.5 Hz, 2H).</div></div><div id="sec7_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 3-((2-Chloropyrimidin-4-yl)(methyl)amino)propanenitrile (<b>IM22</b>)</h4><div class="NLM_p last">3-(Methylamino)propanenitrile (571 μL, 6.7 mmol, 2.0 equiv) was added to a solution of 2,4-dichloropyrimidine (500 mg, 3.4 mmol, 1.0 equiv) and DIPEA (1.2 mL, 6.7 mmol, 2.0 equiv) in DMF (5.0 mL) and stirred at room temperature for 2 h. The solution was diluted with water and then extracted with EtOAc. The compound was purified by flash column chromatography (EtOAc/hexane 1:4) to give a solid (200 mg, 1.0 mmol 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.13 (d, <i>J</i> = 6.1 Hz, 1H), 6.40 (d, <i>J</i> = 6.1 Hz, 1H), 3.91 (t, <i>J</i> = 6.4 Hz, 2H), 3.20 (s, 3H), 2.75 (t, <i>J</i> = 6.4 Hz, 2H).</div></div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Biochemical Methods</h3><div id="sec7_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Protein Production and Crystallography</h4><div class="NLM_p last">Protein production and crystallization of <i>Lm</i>NMT-MyrCoA were as described in Brannigan et al. (2014).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Ligand compounds (25 mM stocks in 50% dimethyl sulfoxide, DMSO) were used at a final concentration of 2.5 mM to soak <i>Lm</i>NMT-MyrCoA crystals. X-ray diffraction data were collected on synchrotron beamlines at the Diamond Light Source (Didcot, U.K.) and processed using XDS<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and SCALA<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> implemented within <i>xia</i>2.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Data collection and refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Table S3</a>. For <i>R</i><sub>free</sub> calculations, 5% of the data were excluded. Cycles of refinement using maximum-likelihood methods implemented in REFMAC<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> were interspersed with model building and adjustment using COOT.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The final refined protein structure models display good geometry with typically only a single amino acid residue (His347) lying outside of the preferred region of the Ramachandran plot.</div></div><div id="sec7_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> CPM Assay</h4><div class="NLM_p last">The enzyme-based inhibitory potency of all derivatives was determined for <i>Ld</i>NMT, <i>Lm</i>NMT, and <i>Hs</i>NMT1 using the CPM assay format, as described previously.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Data is summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Table S1</a>, and the dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S6–S8</a>.</div></div><div id="sec7_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Alamar Blue-Based Assay</h4><div class="NLM_p">The assay was conducted as previously described and validated using amphotericin B and miltefosine as reference compounds. An Ethiopian strain of <i>L. donovani</i> (MHOM/ET/67/HU3, also known as LV9) was maintained in Rag-2<sup>–/–</sup> mice by serial passage. All experiments were approved by the University of York Animal Procedures and Ethics Committee and performed under the U.K. Home Office licence (“Immunology and Immunopathology of Leishmaniasis” Ref # PPL 60/4377). Isolation of amastigotes from infected spleens was performed by saponin lysis after homogenization, as previously described.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Afterward, <i>Ld</i> amastigotes were plated at 4 × 10<sup>5</sup> parasites per well in 96-well plates followed by the addition of the inhibitor concentrations in RPMI medium supplemented with 20% heat-inactivated fetal calf serum (FCS), 100 μM adenine, 20 mM 2-[<i>N</i>-morpholino] ethanesulfonic acid (pH 5.5), 5 μM hemin, 3 μM biopterin, 1 μM biotin, penicillin (100 U/mL), and streptomycin (100 μg/mL). After 72 h at 26 °C, 1/5 volume Alamar blue (Trek Diagnostics) was added. Fluorescence was measured after another 6 h using a POLARstar Optima (BMG Labtech) plate reader (ex. 544 nm, em. 590 nm).</div><div class="NLM_p last">Macrophages (BMDM) were differentiated from the bone marrow of 6–8 week old female BALB/c mice, as described previously,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and maintained at 37 °C and 5% CO<sub>2</sub> in DMEM (GIBCO) supplemented with 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine (GIBCO) and 4% L929-cell-conditioned medium. BMDMs were seeded at 4.2 × 10<sup>4</sup> cells per well in 96-well plates and adhered for at least 4 h. Subsequently, inhibitor concentrations were added for 72 h, followed by the addition of a 1/10 volume Alamar blue (Trek Diagnostics). Fluorescence was measured after 6 h as described above. Data is summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Table S2</a>, and the dose–response curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figures S9 and S10</a>.</div></div><div id="sec7_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Tagging Assay</h4><div class="NLM_p">Freshly isolated amastigotes (see above) were seeded at 7.5 × 10<sup>7</sup> parasites per mL and cultured in RPMI supplemented with 10% FCS and the corresponding inhibitor concentration. After 1 h at 37 °C, the parasites were collected by centrifugation (800<i>g</i>, 15 min, 4 °C) and resuspended in a fresh medium containing the inhibitor dilution and YnMyr or myristic acid (final concentration 50 μM). After 12 h, the parasites were pelleted and washed twice with cold phosphate-buffered saline (PBS). Subsequently, the cells were lysed on ice at 1 × 10<sup>9</sup> parasites per mL in lysis buffer (1% NP40, 1% sodium deoxycholate, 0.5% sodium dodecyl sulfate (SDS), 50 mM Tris (pH 7.4), 150 mM NaCl, EDTA-free protease inhibitor) by sonication (4 × 10 second burst, amplitude 45 with 1 min interval). All lysates were cleared by centrifugation (16 100<i>g</i>, 30 min, 4 °C), and protein concentrations were determined using the DC Protein Assay (Bio-Rad) following the manufacturer’s procedure.</div><div class="NLM_p last">Proteins were precipitated with chloroform/methanol (MeOH/CHCl<sub>3</sub>/H<sub>2</sub>O 4:1:3) and resuspended at 1 mg/mL in 1% SDS in PBS. Afterward, 1 μL AzTB<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (10 mM in DMSO, 0.1 mM final), 2 μL CuSO<sub>4</sub> (50 mM in H<sub>2</sub>O, 1 mM final), 2 μL Tris(2 carboxyethyl)phosphine hydrochloride (TCEP) (50 mM in H<sub>2</sub>O, 1 mM final), and 1 μL Tris[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]amine (TBTA) (10 mM in DMSO, 0.1 mM final) were mixed. Six microliters of this click mixture was added to 100 μL of lysate, and the click reaction was shaken for 1 h at room temperature. Subsequently, the proteins were precipitated again by methanol/chloroform precipitation. The protein pellet was air-dried and redissolved in PBS containing 0.2% SDS and 0.1 mM dithiothreitol (DTT) using sonication to a final protein concentration of 1 mg/mL. All samples were further analyzed by SDS-PAGE, and fluorescence was scanned using a Typhoon imager (GE Healthcare; excitation laser: 532 nm, emission filter: LPG (575–700 nm); PMT: 750 V). For Western blot, the proteins were transferred from gels to poly(vinylidene fluoride) membranes (Immobilon-P<sup>SQ</sup>, Millipore) using a semidry system (Invitrogen). Following blocking (5% milk in TBS-T buffer), the membranes were incubated for 1 h at room temperature with the primary and overnight at 4 °C with the secondary HRP-conjugated antibody. Detection was performed using a Luminata Crescendo Western HRP substrate (Millipore) according to the manufacturer’s instructions with a Fujifilm LAS 3000 imager.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00570" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00570?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00570</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Sequence alignment of L<i>m</i> and L<i>d</i>NMT; CPM data; Alamar blue-based assay data; X-ray diffraction data and refinement statistics; and HPLC traces of key compounds <b>1</b>, <b>43</b>, <b>50</b>, and <b>52</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular strings for final and intermediate compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">NMR files for final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf">jm0c00570_si_001.pdf (2.38 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_002.csv">jm0c00570_si_002.csv (6.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_003.pdf">jm0c00570_si_003.pdf (3.28 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factor files have been deposited in the Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9">6qd9</a> (<i>Lm</i>NMT-MyrCoA-<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qda">6qda</a> (<i>Lm</i>NMT-MyrCoA-<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb">6qdb</a> (<i>Lm</i>NMT-MyrCoA-<b>10</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc">6qdc</a> (<i>Lm</i>NMT-MyrCoA-<b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd">6qdd</a> (<i>Lm</i>NMT-MyrCoA-<b>43</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde">6qde</a> (<i>Lm</i>NMT-MyrCoA-<b>51</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf">6qdf</a> (<i>Lm</i>NMT-MyrCoA-<b>52</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg">6qdg</a> (<i>Lm</i>NMT-MyrCoA-<b>56</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh">6qdh</a> (<i>Lm</i>NMT-MyrCoA-<b>64</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00570" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward W. Tate</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2213-5814" title="Orcid link">http://orcid.org/0000-0003-2213-5814</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#492c673d283d2c092024392c3b20282567282a673c22"><span class="__cf_email__" data-cfemail="41246f3520352401282c31243328202d6f20226f342a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew S. Bell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0581-9387" title="Orcid link">http://orcid.org/0000-0002-0581-9387</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiyong Yu</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennie A. Hutton</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Megan H. Wright</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Leeds, Leeds, U.K. LS2 9JT</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2731-4707" title="Orcid link">http://orcid.org/0000-0003-2731-4707</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James A. Brannigan</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology Laboratory, York Biomedical Research Institute, Department
of Chemistry, University of York, York, U.K. YO10 5DD</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6597-8972" title="Orcid link">http://orcid.org/0000-0001-6597-8972</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Paape</span> - <span class="hlFld-Affiliation affiliation">Centre
for Immunology and Infection, York Biomedical Research Institute,
Department of Biology, University of York, York, U.K. YO10 5NG</span>; 
    <span>Present Address:
                        (D.P.) Adlai Nortye Biopharma, Hangzhou Economic & Technological Development Area, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shirley M. Roberts</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology Laboratory, York Biomedical Research Institute, Department
of Chemistry, University of York, York, U.K. YO10 5DD</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charlotte L. Sutherell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5987-4149" title="Orcid link">http://orcid.org/0000-0001-5987-4149</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Ritzefeld</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span>; 
    <span>Present Address:
                        (M.R.) Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, U.K</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9898-4110" title="Orcid link">http://orcid.org/0000-0002-9898-4110</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony J. Wilkinson</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology Laboratory, York Biomedical Research Institute, Department
of Chemistry, University of York, York, U.K. YO10 5DD</span>; 
    <span>Present Address:
                        (A.J.W.) Evotec, Hamburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah F. Smith</span> - <span class="hlFld-Affiliation affiliation">Centre
for Immunology and Infection, York Biomedical Research Institute,
Department of Biology, University of York, York, U.K. YO10 5NG</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin J. Leatherbarrow</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Imperial College London, Molecular
Sciences Research Hub, London, U.K. W12 0BZ</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e9075-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank the Diamond Light Source for synchrotron beamtime (proposals mx1221 and 7864). This work was supported by The Wellcome Trust (grant 087792) and the Engineering and Physical Sciences Research Council (grants EP/F500416/1 and EP/K039946/1).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">confidence interval</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">cutaneous leishmaniasis</p></td></tr><tr><td class="NLM_term">CPM</td><td class="NLM_def"><p class="first last">7-diethylamino-3-(4-maleimido-phenyl)-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term"><i>Ld</i></td><td class="NLM_def"><p class="first last">Leishmania donovani</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term"><i>Lm</i></td><td class="NLM_def"><p class="first last">Leishmania major</p></td></tr><tr><td class="NLM_term">MyrCoA</td><td class="NLM_def"><p class="first last">myristoyl-CoA</p></td></tr><tr><td class="NLM_term">nAUC</td><td class="NLM_def"><p class="first last">normalized area under the curve</p></td></tr><tr><td class="NLM_term">NMT</td><td class="NLM_def"><p class="first last"><i>N</i>-myristoyltransferase</p></td></tr><tr><td class="NLM_term">SSG</td><td class="NLM_def"><p class="first last">sodium stibogluconate</p></td></tr><tr><td class="NLM_term">VL</td><td class="NLM_def"><p class="first last">visceral leishmaniasis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i126">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Guerrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanilla-Cedillo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Esmenjaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenas, R.</span></span> <span> </span><span class="NLM_article-title">Leishmaniasis: A Review</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">750</span>, <span class="refDoi"> DOI: 10.12688/f1000research.11120.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.12688%2Ff1000research.11120.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=28649370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A280%3ADC%252BC1cjhslCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=750&author=E.+Torres-Guerreroauthor=M.+R.+Quintanilla-Cedilloauthor=J.+Ruiz-Esmenjaudauthor=R.+Arenas&title=Leishmaniasis%3A+A+Review&doi=10.12688%2Ff1000research.11120.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Leishmaniasis: a review</span></div><div class="casAuthors">Torres-Guerrero Edoardo; Ruiz-Esmenjaud Julieta; Arenas Roberto; Quintanilla-Cedillo Marco Romano</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">750</span>
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    </div><div class="casAbstract">Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly.  It is endemic in Asia, Africa, the Americas, and the Mediterranean region.  Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year.  Clinical features depend on the species of Leishmania involved and the immune response of the host.  Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes.  Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnQ1TOyDXtUq2q3xNe7a7QfW6udTcc2eZ9Dxctj8v0L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjhslCqug%253D%253D&md5=c0ac5d2b557277a2483d0a3e0e8a07a4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.11120.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.11120.1%26sid%3Dliteratum%253Aachs%26aulast%3DTorres-Guerrero%26aufirst%3DE.%26aulast%3DQuintanilla-Cedillo%26aufirst%3DM.%2BR.%26aulast%3DRuiz-Esmenjaud%26aufirst%3DJ.%26aulast%3DArenas%26aufirst%3DR.%26atitle%3DLeishmaniasis%253A%2520A%2520Review%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D750%26doi%3D10.12688%2Ff1000research.11120.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">WHO</span>, <span> </span><span class="NLM_article-title">Leishmaniasis</span>. <a href="https://www.who.int/news-room/fact-sheets/detail/leishmaniasis" class="extLink">https://www.who.int/news-room/fact-sheets/detail/leishmaniasis</a> (accessed 14 June, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=Leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DLeishmaniasis%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefnawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Muylder, G.</span></span> <span> </span><span class="NLM_article-title">Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.pt.2016.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=27993477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOis7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=162-174&author=A.+Hefnawyauthor=M.+Bergauthor=J.+C.+Dujardinauthor=G.+De+Muylder&title=Exploiting+Knowledge+on+Leishmania+Drug+Resistance+to+Support+the+Quest+for+New+Drugs&doi=10.1016%2Fj.pt.2016.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs</span></div><div class="casAuthors">Hefnawy, Aya; Berg, Maya; Dujardin, Jean-Claude; De Muylder, Geraldine</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-174</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  New drugs are needed to control leishmaniasis and efforts are currently on-going to counter the neglect of this disease.  We discuss here the utility and the impact of assocg. drug resistance (DR) studies to drug discovery pipelines.  We use as paradigm currently used drugs, antimonials and miltefosine, and complement our reflection by interviewing three experts in the field.  We suggest DR studies to be involved at two different stages of drug development: (i) the efficiency of novel compds. should be confirmed on sets of strains including recent clin. isolates with DR; (ii) exptl. DR should be generated to promising compds. at an early stage of their development, to further optimize them and monitor clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyIc1a5RfP27Vg90H21EOLACvtfcHk0lhkOG_4K3ttXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOis7vJ&md5=c67220deabbd3550081a4d310f77287f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DHefnawy%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DM.%26aulast%3DDujardin%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BMuylder%26aufirst%3DG.%26atitle%3DExploiting%2520Knowledge%2520on%2520Leishmania%2520Drug%2520Resistance%2520to%2520Support%2520the%2520Quest%2520for%2520New%2520Drugs%26jtitle%3DTrends%2520Parasitol.%26date%3D2017%26volume%3D33%26spage%3D162%26epage%3D174%26doi%3D10.1016%2Fj.pt.2016.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuno, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Potent and Selective Inhibitors of Candida Albicans N-Myristoyltransferase Based on the Benzothiazole Structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2509</span>– <span class="NLM_lpage">2522</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.bmc.2005.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=15755653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVart7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2509-2522&author=K.+Yamazakiauthor=Y.+Kanekoauthor=K.+Suwaauthor=S.+Ebaraauthor=K.+Nakazawaauthor=K.+Yasuno&title=Synthesis+of+Potent+and+Selective+Inhibitors+of+Candida+Albicans+N-Myristoyltransferase+Based+on+the+Benzothiazole+Structure&doi=10.1016%2Fj.bmc.2005.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure</span></div><div class="casAuthors">Yamazaki, Kazuo; Kaneko, Yasushi; Suwa, Kie; Ebara, Shinji; Nakazawa, Kyoko; Yasuno, Kazuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2509-2522</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Two parallel synthetic methods using solid-supported reagents were established to examine the rapid optimization of the weak hit compd. 2-diethylaminoethyl 2-cyclohexylcarbonylaminobenzothiazole-5-carboxylate.  Several compds. showed high potency in the low nanomolar range against N-myristoyltransferase.  The structure-activity relationship (SAR) and antifungal activities of a series of novel 2-aminobenzothiazole N-myristoyltransferase inhibitors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiovNeHmSaVbVg90H21EOLACvtfcHk0lhkOG_4K3ttXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVart7o%253D&md5=bf860571e821b3bf7d4e67a8473f6349</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DSuwa%26aufirst%3DK.%26aulast%3DEbara%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DK.%26aulast%3DYasuno%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Candida%2520Albicans%2520N-Myristoyltransferase%2520Based%2520on%2520the%2520Benzothiazole%2520Structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2509%26epage%3D2522%26doi%3D10.1016%2Fj.bmc.2005.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimi, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aalten, D. M. F.</span></span> <span> </span><span class="NLM_article-title">N -Myristoyltransferase Is a Cell Wall Target in Aspergillus Fumigatus</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1434</span>, <span class="refDoi"> DOI: 10.1021/cb5008647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5008647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1425-1434&author=W.+Fangauthor=D.+A.+Robinsonauthor=O.+G.+Raimiauthor=D.+E.+Blairauthor=J.+R.+Harrisonauthor=D.+E.+A.+Lockhartauthor=L.+S.+Torrieauthor=G.+F.+Rudaauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=D.+M.+F.+Van+Aalten&title=N+-Myristoyltransferase+Is+a+Cell+Wall+Target+in+Aspergillus+Fumigatus&doi=10.1021%2Fcb5008647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">N-Myristoyltransferase Is a Cell Wall Target in Aspergillus fumigatus</span></div><div class="casAuthors">Fang, Wenxia; Robinson, David A.; Raimi, Olawale G.; Blair, David E.; Harrison, Justin R.; Lockhart, Deborah E. A.; Torrie, Leah S.; Ruda, Gian Filippo; Wyatt, Paul G.; Gilbert, Ian H.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1425-1434</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of filamentous fungal infections relies on a limited repertoire of antifungal agents.  Compds. possessing novel modes of action are urgently required.  N-myristoylation is a ubiquitous modification of eukaryotic proteins.  The enzyme N-myristoyltransferase (NMT) has been considered a potential therapeutic target in protozoa and yeasts.  Here, we show that the filamentous fungal pathogen Aspergillus fumigatus possesses an active NMT enzyme that is essential for survival.  Surprisingly, partial repression of the gene revealed downstream effects of N-myristoylation on cell wall morphol.  Screening a library of inhibitors led to the discovery of a pyrazole sulfonamide compd. that inhibits the enzyme and is fungicidal under partially repressive nmt conditions.  Together with a crystallog. complex showing the inhibitor binding in the peptide substrate pocket, we provide evidence of NMT being a potential drug target in A. fumigatus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGSigS5kyRHrVg90H21EOLACvtfcHk0lgRwcZyjIp-Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCqu7k%253D&md5=4667bd95c423ab3d9df251cc6f0850e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb5008647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5008647%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DW.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DRaimi%26aufirst%3DO.%2BG.%26aulast%3DBlair%26aufirst%3DD.%2BE.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DLockhart%26aufirst%3DD.%2BE.%2BA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DN%2520-Myristoyltransferase%2520Is%2520a%2520Cell%2520Wall%2520Target%2520in%2520Aspergillus%2520Fumigatus%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1425%26epage%3D1434%26doi%3D10.1021%2Fcb5008647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowyer, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratne, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grainger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withers-Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramsinghe, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Molecules Incorporating a Benzothiazole Core Scaffold Inhibit the N-Myristoyltransferase of Plasmodium Falciparum</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1042/BJ20070692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1042%2FBJ20070692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=17714074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12htbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=173-180&author=P.+W.+Bowyerauthor=R.+S.+Gunaratneauthor=M.+Graingerauthor=C.+Withers-Martinezauthor=S.+R.+Wickramsingheauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrowauthor=K.+A.+Brownauthor=A.+A.+Holderauthor=D.+F.+Smith&title=Molecules+Incorporating+a+Benzothiazole+Core+Scaffold+Inhibit+the+N-Myristoyltransferase+of+Plasmodium+Falciparum&doi=10.1042%2FBJ20070692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum</span></div><div class="casAuthors">Bowyer, Paul W.; Gunaratne, Ruwani S.; Grainger, Munira; Withers-martinez, Chrislaine; Wickramsinghe, Sasala R.; Tate, Edward W.; Leatherbarrow, Robin J.; Brown, Katherine A.; Holder, Anthony A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Recombinant N-myristoyltransferase of Plasmodium falciparum (termed PfNMT) has been used in the development of a SPA (scintillation proximity assay) suitable for automation and high-throughput screening of inhibitors against this enzyme.  The ability to use the SPA has been facilitated by development of an expression and purifn. system which yields considerably improved quantities of sol. active recombinant PfNMT compared with previous studies.  Specifically, yields of pure protein have been increased from 12 μg/l-1 to >400 μg/l-1 by use of a synthetic gene with codon usage optimized for expression in an Escherichia coli host.  Preliminary small-scale piggyback' inhibitor studies using the SPA have identified a family of related mols. contg. a core benzothiazole scaffold with IC50 values <50 μM, which demonstrate selectivity over human NMT1.  Two of these compds., when tested against cultured parasites in vitro, reduced parasitemia by >80% at a concn. of 10 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8mk72sryUELVg90H21EOLACvtfcHk0lgRwcZyjIp-Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12htbvF&md5=961c56e6858fcfa4079b948ba73eef20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBJ20070692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070692%26sid%3Dliteratum%253Aachs%26aulast%3DBowyer%26aufirst%3DP.%2BW.%26aulast%3DGunaratne%26aufirst%3DR.%2BS.%26aulast%3DGrainger%26aufirst%3DM.%26aulast%3DWithers-Martinez%26aufirst%3DC.%26aulast%3DWickramsinghe%26aufirst%3DS.%2BR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DMolecules%2520Incorporating%2520a%2520Benzothiazole%2520Core%2520Scaffold%2520Inhibit%2520the%2520N-Myristoyltransferase%2520of%2520Plasmodium%2520Falciparum%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D173%26epage%3D180%26doi%3D10.1042%2FBJ20070692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozowski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Inhibitors of Plasmodium Falciparum N -Myristoyltransferase, a Promising Target for Antimalarial Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8879</span>– <span class="NLM_lpage">8890</span>, <span class="refDoi"> DOI: 10.1021/jm301160h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301160h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8879-8890&author=Z.+Yuauthor=J.+A.+Branniganauthor=D.+K.+Mossauthor=A.+M.+Brzozowskiauthor=A.+J.+Wilkinsonauthor=A.+A.+Holderauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=Design+and+Synthesis+of+Inhibitors+of+Plasmodium+Falciparum+N+-Myristoyltransferase%2C+a+Promising+Target+for+Antimalarial+Drug+Discovery&doi=10.1021%2Fjm301160h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhibitors of Plasmodium falciparum N-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery</span></div><div class="casAuthors">Yu, Zhiyong; Brannigan, James A.; Moss, David K.; Brzozowski, A. Marek; Wilkinson, Anthony J.; Holder, Anthony A.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8879-8890</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum, the most lethal species of parasites that cause malaria, is described.  Chem.-driven optimization of compd. I from a focused NMT inhibitor library led to the identification of two early lead compds. II and III, which showed good enzyme and cellular potency and excellent selectivity over human NMT.  These mols. provide a valuable starting point for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDwmbhk3x2uLVg90H21EOLACvtfcHk0lgqS2VsfDQRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtb7P&md5=3b349ac1ad5c8b8afb9e11ed8c7e2cfe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301160h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301160h%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DMoss%26aufirst%3DD.%2BK.%26aulast%3DBrzozowski%26aufirst%3DA.%2BM.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520N%2520-Myristoyltransferase%252C%2520a%2520Promising%2520Target%2520for%2520Antimalarial%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8879%26epage%3D8890%26doi%3D10.1021%2Fjm301160h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rackham, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangachari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of High Affinity Inhibitors of Plasmodium Falciparum and <i>Plasmodium Vivax</i> N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2773</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/jm500066b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500066b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Grsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2773-2788&author=M.+D.+Rackhamauthor=J.+A.+Branniganauthor=K.+Rangachariauthor=S.+Meisterauthor=A.+J.+Wilkinsonauthor=A.+A.+Holderauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Design+and+Synthesis+of+High+Affinity+Inhibitors+of+Plasmodium+Falciparum+and+Plasmodium+Vivax+N-Myristoyltransferases+Directed+by+Ligand+Efficiency+Dependent+Lipophilicity+%28LELP%29&doi=10.1021%2Fjm500066b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)</span></div><div class="casAuthors">Rackham, Mark D.; Brannigan, James A.; Rangachari, Kaveri; Meister, Stephan; Wilkinson, Anthony J.; Holder, Anthony A.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2773-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is an essential eukaryotic enzyme and an attractive drug target in parasitic infections such as malaria.  We have previously reported that 2-(3-(piperidin-4-yloxy)benzo[b]thiophen-2-yl)-5-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)-1,3,4-oxadiazole (34c) is a high affinity inhibitor of both Plasmodium falciparum and P. vivax NMT and displays activity in vivo against a rodent malaria model.  Here we describe the discovery of 34c through optimization of a previously described series.  Development, guided by targeting a ligand efficiency dependent lipophilicity (LELP) score of less than 10, yielded a 100-fold increase in enzyme affinity and a 100-fold drop in lipophilicity with the addn. of only two heavy atoms. 34c was found to be equipotent on chloroquine-sensitive and -resistant cell lines and on both blood and liver stage forms of the parasite.  These data further validate NMT as an exciting drug target in malaria and support 34c as an attractive tool for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFfIYppTWcLrVg90H21EOLACvtfcHk0lgqS2VsfDQRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Grsbg%253D&md5=517fb7c912426fc2812f19fa43daed1f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm500066b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500066b%26sid%3Dliteratum%253Aachs%26aulast%3DRackham%26aufirst%3DM.%2BD.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRangachari%26aufirst%3DK.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520High%2520Affinity%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520and%2520Plasmodium%2520Vivax%2520N-Myristoyltransferases%2520Directed%2520by%2520Ligand%2520Efficiency%2520Dependent%2520Lipophilicity%2520%2528LELP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2773%26epage%3D2788%26doi%3D10.1021%2Fjm500066b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlott, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayclin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reers, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuepfer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons-Abbott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">1000.e7</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.chembiol.2019.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=31080074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=991-1000.e7&author=A.+C.+Schlottauthor=S.+Mayclinauthor=A.+R.+Reersauthor=O.+Coburn-Flynnauthor=A.+S.+Bellauthor=J.+Greenauthor=E.+Knuepferauthor=D.+Charterauthor=R.+Bonnertauthor=B.+Campoauthor=J.+Burrowsauthor=S.+Lyons-Abbottauthor=B.+L.+Stakerauthor=C.+W.+Chungauthor=P.+J.+Mylerauthor=D.+A.+Fidockauthor=E.+W.+Tateauthor=A.+A.+Holder&title=Structure-Guided+Identification+of+Resistance+Breaking+Antimalarial+N-Myristoyltransferase+Inhibitors&doi=10.1016%2Fj.chembiol.2019.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Schlott, Anja C.; Mayclin, Stephen; Reers, Alexandra R.; Coburn-Flynn, Olivia; Bell, Andrew S.; Green, Judith; Knuepfer, Ellen; Charter, David; Bonnert, Roger; Campo, Brice; Burrows, Jeremy; Lyons-Abbott, Sally; Staker, Bart L.; Chung, Chun-Wa; Myler, Peter J.; Fidock, David A.; Tate, Edward W.; Holder, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">991-1000.e7</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The attachment of myristate to the N-terminal glycine of certain proteins is largely a co-translational modification catalyzed by N-myristoyltransferase (NMT), and involved in protein membrane-localization.  Pathogen NMT is a validated therapeutic target in numerous infectious diseases including malaria.  In Plasmodium falciparum, NMT substrates are important in essential processes including parasite gliding motility and host cell invasion.  Here, we generated parasites resistant to a particular NMT inhibitor series and show that resistance in an in vitro parasite growth assay is mediated by a single amino acid substitution in the NMT substrate-binding pocket.  The basis of resistance was validated and analyzed with a structure-guided approach using crystallog., in combination with enzyme activity, stability, and surface plasmon resonance assays, allowing identification of another inhibitor series unaffected by this substitution.  We suggest that resistance studies incorporated early in the drug development process help selection of drug combinations to impede rapid evolution of parasite resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ-7mY33rcILVg90H21EOLACvtfcHk0liwXh9q6Dn5mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOktLs%253D&md5=821549b1cfc56a643b68f0a464ba91c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DSchlott%26aufirst%3DA.%2BC.%26aulast%3DMayclin%26aufirst%3DS.%26aulast%3DReers%26aufirst%3DA.%2BR.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DKnuepfer%26aufirst%3DE.%26aulast%3DCharter%26aufirst%3DD.%26aulast%3DBonnert%26aufirst%3DR.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DLyons-Abbott%26aufirst%3DS.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26atitle%3DStructure-Guided%2520Identification%2520of%2520Resistance%2520Breaking%2520Antimalarial%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D991%26epage%3D1000.e7%26doi%3D10.1016%2Fj.chembiol.2019.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansell, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>Plasmodium Vivax</i> N -Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of Their Binding Mode</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3578</span>– <span class="NLM_lpage">3582</span>, <span class="refDoi"> DOI: 10.1021/jm300040p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300040p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3578-3582&author=V.+Goncalvesauthor=J.+A.+Branniganauthor=D.+Whalleyauthor=K.+H.+Ansellauthor=B.+Saxtyauthor=A.+A.+Holderauthor=A.+J.+Wilkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=Discovery+of+Plasmodium+Vivax+N+-Myristoyltransferase+Inhibitors%3A+Screening%2C+Synthesis%2C+and+Structural+Characterization+of+Their+Binding+Mode&doi=10.1021%2Fjm300040p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Plasmodium vivax N-Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode</span></div><div class="casAuthors">Goncalves, Victor; Brannigan, James A.; Whalley, David; Ansell, Keith H.; Saxty, Barbara; Holder, Anthony A.; Wilkinson, Anthony J.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3578-3582</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is a prospective drug target against parasitic protozoa.  Herein we report the successful discovery of a series of Plasmodium vivax NMT inhibitors by high-throughput screening.  A high-resoln. crystal structure of the hit compd. in complex with NMT was obtained, allowing understanding of its novel binding mode.  A set of analogs was designed and tested to define the chem. groups relevant for activity and selectivity.  Compd. 7 (I) was identified which exhibits micromolar activity against PvNMT, some selectivity over human NMT isoforms, and improved lead-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQffTqfTp5rLVg90H21EOLACvtfcHk0liwXh9q6Dn5mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVKgtbc%253D&md5=0e42a947e40a044763db187bea7fb76e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm300040p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300040p%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWhalley%26aufirst%3DD.%26aulast%3DAnsell%26aufirst%3DK.%2BH.%26aulast%3DSaxty%26aufirst%3DB.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520Plasmodium%2520Vivax%2520N%2520-Myristoyltransferase%2520Inhibitors%253A%2520Screening%252C%2520Synthesis%252C%2520and%2520Structural%2520Characterization%2520of%2520Their%2520Binding%2520Mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3578%26epage%3D3582%26doi%3D10.1021%2Fjm300040p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guther, M. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mpamhanga, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimi, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aalten, D. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Inhibitors as New Leads to Treat Sleeping Sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>464</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1038/nature08893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fnature08893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20360736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=728-732&author=J.+A.+Frearsonauthor=S.+Brandauthor=S.+P.+McElroyauthor=L.+A.+T.+Cleghornauthor=O.+Smidauthor=L.+Stojanovskiauthor=H.+P.+Priceauthor=M.+L.+S.+Gutherauthor=L.+S.+Torrieauthor=D.+A.+Robinsonauthor=I.+Hallyburtonauthor=C.+P.+Mpamhangaauthor=J.+A.+Branniganauthor=A.+J.+Wilkinsonauthor=M.+Hodgkinsonauthor=R.+Huiauthor=W.+Qiuauthor=O.+G.+Raimiauthor=D.+M.+F.+Van+Aaltenauthor=R.+Brenkauthor=I.+H.+Gilbertauthor=K.+D.+Readauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+F.+Smithauthor=P.+G.+Wyatt&title=N-Myristoyltransferase+Inhibitors+as+New+Leads+to+Treat+Sleeping+Sickness&doi=10.1038%2Fnature08893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">N-myristoyltransferase inhibitors as new leads to treat sleeping sickness</span></div><div class="casAuthors">Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Price, Helen P.; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brannigan, James A.; Wilkinson, Anthony J.; Hodgkinson, Michael; Hui, Raymond; Qiu, Wei; Raimi, Olawale G.; van Aalten, Daan M. F.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Smith, Deborah F.; Wyatt, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7289</span>),
    <span class="NLM_cas:pages">728-732</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">African sleeping sickness or human African trypanosomiasis, caused by Trypanosoma brucei spp., is responsible for ∼30,000 deaths each year.  Available treatments for this disease are poor, with unacceptable efficacy and safety profiles, particularly in the late stage of the disease when the parasite has infected the central nervous system.  Here we report the validation of a mol. target and the discovery of assocd. lead compds. with the potential to address this lack of suitable treatments.  Inhibition of this target-T. brucei N-myristoyltransferase-leads to rapid killing of trypanosomes both in vitro and in vivo and cures trypanosomiasis in mice.  These high-affinity inhibitors bind into the peptide substrate pocket of the enzyme and inhibit protein N-myristoylation in trypanosomes.  The compds. identified have promising pharmaceutical properties and represent an opportunity to develop oral drugs to treat this devastating disease.  Our studies validate T. brucei N-myristoyltransferase as a promising therapeutic target for human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKBgE_K-1Bz7Vg90H21EOLACvtfcHk0ljNabFx6rGVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVygsLc%253D&md5=5db60f35545c2d8ebaf3eb56c7a32a30</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08893%26sid%3Dliteratum%253Aachs%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DSmid%26aufirst%3DO.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DGuther%26aufirst%3DM.%2BL.%2BS.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DMpamhanga%26aufirst%3DC.%2BP.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHodgkinson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DRaimi%26aufirst%3DO.%2BG.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DN-Myristoyltransferase%2520Inhibitors%2520as%2520New%2520Leads%2520to%2520Treat%2520Sleeping%2520Sickness%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D728%26epage%3D732%26doi%3D10.1038%2Fnature08893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luksch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collie, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Development of Small-Molecule Trypanosoma Brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1002%2Fcmdc.201500301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=26395087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1821-1836&author=D.+Spinksauthor=V.+Smithauthor=S.+Thompsonauthor=D.+A.+Robinsonauthor=T.+Lukschauthor=A.+Smithauthor=L.+S.+Torrieauthor=S.+McElroyauthor=L.+Stojanovskiauthor=S.+Norvalauthor=I.+T.+Collieauthor=I.+Hallyburtonauthor=B.+Raoauthor=S.+Brandauthor=R.+Brenkauthor=J.+A.+Frearsonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Development+of+Small-Molecule+Trypanosoma+Brucei+N-Myristoyltransferase+Inhibitors%3A+Discovery+and+Optimisation+of+a+Novel+Binding+Mode&doi=10.1002%2Fcmdc.201500301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode</span></div><div class="casAuthors">Spinks, Daniel; Smith, Victoria; Thompson, Stephen; Robinson, David A.; Luksch, Torsten; Smith, Alasdair; Torrie, Leah S.; McElroy, Stuart; Stojanovski, Laste; Norval, Suzanne; Collie, Iain T.; Hallyburton, Irene; Rao, Bhavya; Brand, Stephen; Brenk, Ruth; Frearson, Julie A.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1821-1836</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The enzyme N-myristoyltransferase (NMT) from Trypanosoma brucei has been validated both chem. and biol. as a potential drug target for human African trypanosomiasis.  The authors previously reported the development of some very potent compds. based around a pyrazole sulfonamide series, derived from a high-throughput screen.  Herein the authors describe work around thiazolidinone and benzomorpholine scaffolds that were also identified in the screen.  An x-ray crystal structure of the thiazolidinone hit in Leishmania major NMT showed the compd. bound in the previously reported active site, utilizing a novel binding mode.  This provides potential for further optimization.  The benzomorpholinone was also found to bind in a similar region.  Using an x-ray crystallog./structure-based design approach, the benzomorpholinone series was further optimized, increasing activity against T. brucei NMT by >1000-fold.  A series of trypanocidal compds. were identified with suitable in vitro DMPK properties, including CNS exposure for further development.  Further work is required to increase selectivity over the human NMT isoform and activity against T. brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowp2OZofB8yLVg90H21EOLACvtfcHk0ljNabFx6rGVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb7N&md5=9be34bc0a319086eb5815e032ead0212</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500301%26sid%3Dliteratum%253Aachs%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DB.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDevelopment%2520of%2520Small-Molecule%2520Trypanosoma%2520Brucei%2520N-Myristoyltransferase%2520Inhibitors%253A%2520Discovery%2520and%2520Optimisation%2520of%2520a%2520Novel%2520Binding%2520Mode%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1821%26epage%3D1836%26doi%3D10.1002%2Fcmdc.201500301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma Brucei</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFShtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=427-441&author=M.+H.+Wrightauthor=D.+Paapeauthor=H.+P.+Priceauthor=D.+F.+Smithauthor=E.+W.+Tate&title=Global+Profiling+and+Inhibition+of+Protein+Lipidation+in+Vector+and+Host+Stages+of+the+Sleeping+Sickness+Parasite+Trypanosoma+Brucei&doi=10.1021%2Facsinfecdis.6b00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei</span></div><div class="casAuthors">Wright, Megan H.; Paape, Daniel; Price, Helen P.; Smith, Deborah F.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">427-441</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme N-myristoyltransferase (NMT) catalyzes the essential fatty acylation of substrate proteins with myristic acid in eukaryotes and is a validated drug target in the parasite Trypanosoma brucei, the causative agent of African trypanosomiasis (sleeping sickness).  N-Myristoylation typically mediates membrane localization of proteins and is essential to the function of many.  However, only a handful of proteins are exptl. validated as N-myristoylated in T. brucei.  Here, we perform metabolic labeling with an alkyne-tagged myristic acid analog, enabling the capture of lipidated proteins in insect and host life stages of T. brucei.  We further compare this with a longer chain palmitate analog to explore the chain length-specific incorporation of fatty acids into proteins.  Finally, we combine the alkynyl-myristate analog with NMT inhibitors and quant. chem. proteomics to globally define N-myristoylated proteins in the clin. relevant bloodstream form parasites.  This anal. reveals five ARF family small GTPases, calpain-like proteins, phosphatases, and many uncharacterized proteins as substrates of NMT in the parasite, providing a global view of the scope of this important protein modification and further evidence for the crucial and pleiotropic role of NMT in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr055pEEov8brVg90H21EOLACvtfcHk0li8rUi2ZUcpZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFShtLc%253D&md5=2489d0851db3a16b67e1efec6d8426b8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00034%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DGlobal%2520Profiling%2520and%2520Inhibition%2520of%2520Protein%2520Lipidation%2520in%2520Vector%2520and%2520Host%2520Stages%2520of%2520the%2520Sleeping%2520Sickness%2520Parasite%2520Trypanosoma%2520Brucei%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D427%26epage%3D441%26doi%3D10.1021%2Facsinfecdis.6b00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Derived Inhibitors of Human N-Myristoyltransferase Block Capsid Assembly and Replication of the Common Cold Virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+P%C3%A9rez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Gued%C3%A1nauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-Derived+Inhibitors+of+Human+N-Myristoyltransferase+Block+Capsid+Assembly+and+Replication+of+the+Common+Cold+Virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0li8rUi2ZUcpZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGued%25C3%25A1n%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-Derived%2520Inhibitors%2520of%2520Human%2520N-Myristoyltransferase%2520Block%2520Capsid%2520Assembly%2520and%2520Replication%2520of%2520the%2520Common%2520Cold%2520Virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbic
Ramljak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real-Hohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redlberger-Fritz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihovilovic, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, H.</span></span> <span> </span><span class="NLM_article-title">Cellular N-Myristoyltransferases Play a Crucial Picornavirus Genus-Specific Role in Viral Assembly, Virion Maturation, and Infectivity</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1007203</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1007203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.ppat.1007203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=30080883" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=I.+Corbic%0ARamljakauthor=J.+Stangerauthor=A.+Real-Hohnauthor=D.+Dreierauthor=L.+Wimmerauthor=M.+Redlberger-Fritzauthor=W.+Fischlauthor=K.+Klingelauthor=M.+D.+Mihovilovicauthor=D.+Blaasauthor=H.+Kowalski&title=Cellular+N-Myristoyltransferases+Play+a+Crucial+Picornavirus+Genus-Specific+Role+in+Viral+Assembly%2C+Virion+Maturation%2C+and+Infectivity&doi=10.1371%2Fjournal.ppat.1007203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1007203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1007203%26sid%3Dliteratum%253Aachs%26aulast%3DCorbic%2BRamljak%26aufirst%3DI.%26aulast%3DStanger%26aufirst%3DJ.%26aulast%3DReal-Hohn%26aufirst%3DA.%26aulast%3DDreier%26aufirst%3DD.%26aulast%3DWimmer%26aufirst%3DL.%26aulast%3DRedlberger-Fritz%26aufirst%3DM.%26aulast%3DFischl%26aufirst%3DW.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DBlaas%26aufirst%3DD.%26aulast%3DKowalski%26aufirst%3DH.%26atitle%3DCellular%2520N-Myristoyltransferases%2520Play%2520a%2520Crucial%2520Picornavirus%2520Genus-Specific%2520Role%2520in%2520Viral%2520Assembly%252C%2520Virion%2520Maturation%252C%2520and%2520Infectivity%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1007203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seaton, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Isozymes Exhibit Differential Specificity for Human Immunodeficiency Virus Type 1 Gag and Nef</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1099/vir.0.83412-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1099%2Fvir.0.83412-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=18089753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Wntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2008&pages=288-296&author=K.+E.+Seatonauthor=C.+D.+Smith&title=N-Myristoyltransferase+Isozymes+Exhibit+Differential+Specificity+for+Human+Immunodeficiency+Virus+Type+1+Gag+and+Nef&doi=10.1099%2Fvir.0.83412-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">N-myristoyltransferase isozymes exhibit differential specificity for Human immunodeficiency virus type 1 Gag and Nef</span></div><div class="casAuthors">Seaton, Kelly E.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">288-296</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Myristoylation of the human immunodeficiency virus type 1 (HIV-1) proteins Gag and Nef by N-myristoyltransferase (NMT) is a key process in retroviral replication and virulence, yet remains incompletely characterized.  Therefore, the roles of the two isoenzymes, NMT1 and NMT2, in myristoylating Gag and Nef were examd. using biochem. and mol. approaches.  Fluorescently labeled peptides corresponding to the N terminus of HIV-1 Gag or Nef were myristoylated by recombinant human NMT1 and NMT2.  Kinetic analyses indicated that NMT1 and NMT2 had 30- and 130-fold lower Km values for Nef than Gag, resp.  Values for Kcat indicated that, once Gag or Nef binds to the enzyme, myristoylation by NMT1 and NMT2 proceeds at comparable rates.  Furthermore, the catalytic efficiencies for the processing of Gag by NMT1 and NMT2 were equiv.  In contrast, NMT2 had approx. 5-fold higher catalytic efficiency for the myristoylation of Nef than NMT1.  Competition expts. confirmed that the Nef peptide acts as a competitive inhibitor for the myristoylation of Gag.  Expts. using full-length recombinant Nef protein also indicated a lower Km for Nef myristoylation by NMT2 than NMT1.  Small interfering RNAs were used to selectively deplete NMT1 and/or NMT2 from HEK293T cells expressing a recombinant Nef-sgGFP fusion protein.  Depletion of NMT1 had minimal effect on the intracellular distribution of Nef-sgGFP, whereas depletion of NMT2 altered distribution to a diffuse, widespread pattern, mimicking that of a myristoylation-deficient mutant of Nef-sgGFP.  Together, these findings indicate that Nef is preferentially myristoylated by NMT2, suggesting that selective inhibition of NMT2 may provide a novel means of blocking HIV virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk4o_H805gv7Vg90H21EOLACvtfcHk0lhEVCBFD4Y4Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Wntg%253D%253D&md5=ac74a45fb79eea2313ae6b643e442aa9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.83412-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.83412-0%26sid%3Dliteratum%253Aachs%26aulast%3DSeaton%26aufirst%3DK.%2BE.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DN-Myristoyltransferase%2520Isozymes%2520Exhibit%2520Differential%2520Specificity%2520for%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Gag%2520and%2520Nef%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2008%26volume%3D89%26spage%3D288%26epage%3D296%26doi%3D10.1099%2Fvir.0.83412-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2176</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00371</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00371" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFyks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2165-2176&author=E.+Thinonauthor=J.+Morales-Sanfrutosauthor=D.+J.+Mannauthor=E.+W.+Tate&title=N-Myristoyltransferase+Inhibition+Induces+ER-Stress%2C+Cell+Cycle+Arrest%2C+and+Apoptosis+in+Cancer+Cells&doi=10.1021%2Facschembio.6b00371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells</span></div><div class="casAuthors">Thinon, Emmanuelle; Morales-Sanfrutos, Julia; Mann, David J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2165-2176</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) covalently attaches a C14 fatty acid to the N-terminal glycine of proteins and has been proposed as a therapeutic target in cancer.  We have recently shown that selective NMT inhibition leads to dose-responsive loss of N-myristoylation on more than 100 protein targets in cells, and cytotoxicity in cancer cells.  N-myristoylation lies upstream of multiple pro-proliferative and oncogenic pathways, but to date the complex substrate specificity of NMT has limited detn. of which diseases are most likely to respond to a selective NMT inhibitor.  We describe here the phenotype of NMT inhibition in HeLa cells and show that cells die through apoptosis following or concurrent with accumulation in the G1 phase.  We used quant. proteomics to map protein expression changes for more than 2700 proteins in response to treatment with an NMT inhibitor in HeLa cells and obsd. down-regulation of proteins involved in cell cycle regulation and up-regulation of proteins involved in the endoplasmic reticulum stress and unfolded protein response, with similar results in breast (MCF-7, MDA-MB-231) and colon (HCT116) cancer cell lines.  This study describes the cellular response to NMT inhibition at the proteome level and provides a starting point for selective targeting of specific diseases with NMT inhibitors, potentially in combination with other targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsx982a2u77Vg90H21EOLACvtfcHk0lhEVCBFD4Y4Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFyks70%253D&md5=85f860a55bb8e14c8a8a25f693c92492</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00371%26sid%3Dliteratum%253Aachs%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DD.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DN-Myristoyltransferase%2520Inhibition%2520Induces%2520ER-Stress%252C%2520Cell%2520Cycle%2520Arrest%252C%2520and%2520Apoptosis%2520in%2520Cancer%2520Cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2165%26epage%3D2176%26doi%3D10.1021%2Facschembio.6b00371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrovandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grocin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier
da Silva, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzilius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buday, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanninger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohana, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">FSP1 Is a Glutathione-Independent Ferroptosis Suppressor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1707-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fs41586-019-1707-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=31634899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGns7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=693-698&author=S.+Dollauthor=F.+P.+Freitasauthor=R.+Shahauthor=M.+Aldrovandiauthor=M.+C.+da+Silvaauthor=I.+Ingoldauthor=A.+G.+Grocinauthor=T.+N.+Xavier%0Ada+Silvaauthor=E.+Panziliusauthor=C.+H.+Scheelauthor=A.+Mour%C3%A3oauthor=K.+Budayauthor=M.+Satoauthor=J.+Wanningerauthor=T.+Vignaneauthor=V.+Mohanaauthor=M.+Rehbergauthor=A.+Flatleyauthor=A.+Schepersauthor=A.+Kurzauthor=D.+Whiteauthor=M.+Sauerauthor=M.+Sattlerauthor=E.+W.+Tateauthor=W.+Schmitzauthor=A.+Schulzeauthor=V.+O%E2%80%99Donnellauthor=B.+Pronethauthor=G.+M.+Popowiczauthor=D.+A.+Prattauthor=J.+P.+F.+Angeliauthor=M.+Conrad&title=FSP1+Is+a+Glutathione-Independent+Ferroptosis+Suppressor&doi=10.1038%2Fs41586-019-1707-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">FSP1 is a glutathione-independent ferroptosis suppressor</span></div><div class="casAuthors">Doll, Sebastian; Freitas, Florencio Porto; Shah, Ron; Aldrovandi, Maceler; da Silva, Milene Costa; Ingold, Irina; Grocin, Andrea Goya; Xavier da Silva, Thamara Nishida; Panzilius, Elena; Scheel, Christina H.; Mourao, Andre; Buday, Katalin; Sato, Mami; Wanninger, Jonas; Vignane, Thibaut; Mohana, Vaishnavi; Rehberg, Markus; Flatley, Andrew; Schepers, Aloys; Kurz, Andreas; White, Daniel; Sauer, Markus; Sattler, Michael; Tate, Edward William; Schmitz, Werner; Schulze, Almut; O'Donnell, Valerie; Proneth, Bettina; Popowicz, Grzegorz M.; Pratt, Derek A.; Angeli, Jose Pedro Friedmann; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7784</span>),
    <span class="NLM_cas:pages">693-698</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ferroptosis is an iron-dependent form of necrotic cell death marked by oxidative damage to phospholipids1,2.  To date, ferroptosis has been thought to be controlled only by the phospholipid hydroperoxide-reducing enzyme glutathione peroxidase 4 (GPX4)3,4 and radical-trapping antioxidants5,6.  However, elucidation of the factors that underlie the sensitivity of a given cell type to ferroptosis7 is crucial to understand the pathophysiol. role of ferroptosis and how it may be exploited for the treatment of cancer.  Although metabolic constraints8 and phospholipid compn.9,10 contribute to ferroptosis sensitivity, no cell-autonomous mechanisms have been identified that account for the resistance of cells to ferroptosis.  Here we used an expression cloning approach to identify genes in human cancer cells that are able to complement the loss of GPX4.  We found that the flavoprotein apoptosis-inducing factor mitochondria-assocd. 2 (AIFM2) is a previously unrecognized anti-ferroptotic gene.  AIFM2, which we renamed ferroptosis suppressor protein 1 (FSP1) and which was initially described as a pro-apoptotic gene11, confers protection against ferroptosis elicited by GPX4 deletion.  We further demonstrate that the suppression of ferroptosis by FSP1 is mediated by ubiquinone (also known as coenzyme Q10, CoQ10): the reduced form, ubiquinol, traps lipid peroxyl radicals that mediate lipid peroxidn., whereas FSP1 catalyzes the regeneration of CoQ10 using NAD(P)H.  Pharmacol. targeting of FSP1 strongly synergizes with GPX4 inhibitors to trigger ferroptosis in a no. of cancer entities.  In conclusion, the FSP1-CoQ10-NAD(P)H pathway exists as a stand-alone parallel system, which cooperates with GPX4 and glutathione to suppress phospholipid peroxidn. and ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN0FWYxjRsH7Vg90H21EOLACvtfcHk0liSpHPluEIIqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGns7vN&md5=3ccdfb47945f58d40798f6fb0efd0439</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1707-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1707-0%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%26aufirst%3DS.%26aulast%3DFreitas%26aufirst%3DF.%2BP.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DAldrovandi%26aufirst%3DM.%26aulast%3Dda%2BSilva%26aufirst%3DM.%2BC.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DGrocin%26aufirst%3DA.%2BG.%26aulast%3DXavier%2Bda%2BSilva%26aufirst%3DT.%2BN.%26aulast%3DPanzilius%26aufirst%3DE.%26aulast%3DScheel%26aufirst%3DC.%2BH.%26aulast%3DMour%25C3%25A3o%26aufirst%3DA.%26aulast%3DBuday%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DWanninger%26aufirst%3DJ.%26aulast%3DVignane%26aufirst%3DT.%26aulast%3DMohana%26aufirst%3DV.%26aulast%3DRehberg%26aufirst%3DM.%26aulast%3DFlatley%26aufirst%3DA.%26aulast%3DSchepers%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DSauer%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSchmitz%26aufirst%3DW.%26aulast%3DSchulze%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DV.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DFSP1%2520Is%2520a%2520Glutathione-Independent%2520Ferroptosis%2520Suppressor%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D693%26epage%3D698%26doi%3D10.1038%2Fs41586-019-1707-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, G.</span></span> <span> </span><span class="NLM_article-title">The Leishmania ARL-1 and Golgi Traffic</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e1620</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0001620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pone.0001620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=18286177" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&author=A.+Sahinauthor=B.+Espiauauthor=E.+Tetaudauthor=A.+Cuvillierauthor=L.+Lartigueauthor=A.+Ambitauthor=D.+R.+Robinsonauthor=G.+Merlin&title=The+Leishmania+ARL-1+and+Golgi+Traffic&doi=10.1371%2Fjournal.pone.0001620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001620%26sid%3Dliteratum%253Aachs%26aulast%3DSahin%26aufirst%3DA.%26aulast%3DEspiau%26aufirst%3DB.%26aulast%3DTetaud%26aufirst%3DE.%26aulast%3DCuvillier%26aufirst%3DA.%26aulast%3DLartigue%26aufirst%3DL.%26aulast%3DAmbit%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DMerlin%26aufirst%3DG.%26atitle%3DThe%2520Leishmania%2520ARL-1%2520and%2520Golgi%2520Traffic%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26doi%3D10.1371%2Fjournal.pone.0001620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Toole, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seelenmeyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Trafficking and Release of Leishmania Metacyclic HASPB on Macrophage Invasion</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2012.01756.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1111%2Fj.1462-5822.2012.01756.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22256896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVarurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=740-761&author=L.+M.+Macleanauthor=P.+J.+O%E2%80%99Tooleauthor=M.+Starkauthor=J.+Marrisonauthor=C.+Seelenmeyerauthor=W.+Nickelauthor=D.+F.+Smith&title=Trafficking+and+Release+of+Leishmania+Metacyclic+HASPB+on+Macrophage+Invasion&doi=10.1111%2Fj.1462-5822.2012.01756.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion</span></div><div class="casAuthors">MacLean, Lorna M.; O'Toole, Peter J.; Stark, Meg; Marrison, Jo; Seelenmeyer, Claudia; Nickel, Walter; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">740-761</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Proteins of the Leishmania hydrophilic acylated surface protein B (HASPB) family are only expressed in infective parasites (both extra- and intracellular stages) and, together with the peripheral membrane protein SHERP (small hydrophilic endoplasmic reticulum-assocd. protein), are essential for parasite differentiation (metacyclogenesis) in the sand fly vector.  HASPB is a "non-classically" secreted protein, requiring N-terminal acylation for trafficking to and exposure on the plasma membrane.  Here, we use live cell imaging methods to further explore this pathway to the membrane and flagellum.  Unlike HASPB trafficking in transfected mammalian cells, we find no evidence for a phosphorylation-regulated recycling pathway in metacyclic parasites.  Once at the plasma membrane, HASPB18-GFP (green fluorescent protein) can undergo bidirectional movement within the inner leaflet of the membrane and on the flagellum.  Transfer of fluorescent protein between the flagellum and the plasma membrane is compromised, however, suggesting the presence of a diffusion barrier at the base of the Leishmania flagellum.  Full-length HASPB is released from the metacyclic parasite surface on to macrophages during phagocytosis but while expression is maintained in intracellular amastigotes, HASPB cannot be detected on the external surface in these cells.  Thus HASPB may be a dual function protein that is shed by the infective metacyclic but retained internally once Leishmania are taken up by macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCWkpSJ3iemrVg90H21EOLACvtfcHk0liSpHPluEIIqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVarurk%253D&md5=20b45fc567cc433601574e49e38fb582</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2012.01756.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2012.01756.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaclean%26aufirst%3DL.%2BM.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DP.%2BJ.%26aulast%3DStark%26aufirst%3DM.%26aulast%3DMarrison%26aufirst%3DJ.%26aulast%3DSeelenmeyer%26aufirst%3DC.%26aulast%3DNickel%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DTrafficking%2520and%2520Release%2520of%2520Leishmania%2520Metacyclic%2520HASPB%2520on%2520Macrophage%2520Invasion%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D740%26epage%3D761%26doi%3D10.1111%2Fj.1462-5822.2012.01756.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Kinetoplastid PPEF Phosphatases: Dual Acylated Proteins Expressed in the Endomembrane System of Leishmania</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.molbiopara.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=17169445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=22-34&author=E.+Millsauthor=H.+P.+Priceauthor=A.+Johnerauthor=J.+E.+Emersonauthor=D.+F.+Smith&title=Kinetoplastid+PPEF+Phosphatases%3A+Dual+Acylated+Proteins+Expressed+in+the+Endomembrane+System+of+Leishmania&doi=10.1016%2Fj.molbiopara.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetoplastid PPEF phosphatases: Dual acylated proteins expressed in the endomembrane system of Leishmania</span></div><div class="casAuthors">Mills, Elena; Price, Helen P.; Johner, Andrea; Emerson, Jenny E.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bioinformatic analyses have been used to identify potential downstream targets of the essential enzyme N-myristoyl transferase in the TriTryp species, Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.  These database searches predict ∼60 putative N-myristoylated proteins with high confidence, including both previously characterized and novel mols.  One of the latter is an N-myristoylated protein phosphatase which has high sequence similarity to the Protein Phosphatase with EF-Hand (PPEF) proteins identified in sensory cells of higher eukaryotes.  In L. major and T. brucei, the PPEF-like phosphatases are encoded by single-copy genes and are constitutively expressed in all parasite life cycle stages.  The N-terminus of LmPPEF is a substrate for N-myristoyl transferase and is also palmitoylated in vivo.  The wild-type protein has been localized to the endocytic system by immunofluorescence.  The catalytic and fused C-terminal domains of the kinetoplastid and other eukaryotic PPEFs share high sequence similarity, but unlike their higher eukaryotic relatives, the C-terminal parasite EF-hand domains are degenerate and do not bind calcium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr90KdS7aFqr7Vg90H21EOLACvtfcHk0lipe8lg7JHkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGmtg%253D%253D&md5=a1a5a3b49872993f1720b552b694e1b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DJohner%26aufirst%3DA.%26aulast%3DEmerson%26aufirst%3DJ.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DKinetoplastid%2520PPEF%2520Phosphatases%253A%2520Dual%2520Acylated%2520Proteins%2520Expressed%2520in%2520the%2520Endomembrane%2520System%2520of%2520Leishmania%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D152%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.molbiopara.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Global Analysis of Protein N-Myristoylation and Exploration of N-Myristoyltransferase as a Drug Target in the Neglected Human Pathogen <i>Leishmania Donovani</i></span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.chembiol.2015.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25728269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Omtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=342-354&author=M.+H.+Wrightauthor=D.+Paapeauthor=E.+M.+Storckauthor=R.+A.+Serwaauthor=D.+F.+Smithauthor=E.+W.+Tate&title=Global+Analysis+of+Protein+N-Myristoylation+and+Exploration+of+N-Myristoyltransferase+as+a+Drug+Target+in+the+Neglected+Human+Pathogen+Leishmania+Donovani&doi=10.1016%2Fj.chembiol.2015.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani</span></div><div class="casAuthors">Wright, Megan H.; Paape, Daniel; Storck, Elisabeth M.; Serwa, Remigiusz A.; Smith, Deborah F.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-354</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) modulates protein function through the attachment of the lipid myristate to the N terminus of target proteins, and is a promising drug target in eukaryotic parasites such as Leishmania donovani.  Only a small no. of NMT substrates have been characterized in Leishmania, and a global picture of N-myristoylation is lacking.  Here, the authors use metabolic tagging with an alkyne-functionalized myristic acid mimetic in live parasites followed by downstream click chem. and anal. to identify lipidated proteins in both the promastigote (extracellular) and amastigote (intracellular) life stages.  Quant. chem. proteomics is used to profile target engagement by NMT inhibitors, and to define the complement of N-myristoylated proteins.  The results provide new insight into the multiple pathways modulated by NMT and the pleiotropic effects of NMT inhibition.  This work constitutes the first global exptl. anal. of protein lipidation in Leishmania, and reveals the extent of NMT-related biol. yet to be explored for this neglected human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQ14re-03TrVg90H21EOLACvtfcHk0lipe8lg7JHkmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Omtr4%253D&md5=2c3bedfb259312deeac596c14729bbc3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DStorck%26aufirst%3DE.%2BM.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DGlobal%2520Analysis%2520of%2520Protein%2520N-Myristoylation%2520and%2520Exploration%2520of%2520N-Myristoyltransferase%2520as%2520a%2520Drug%2520Target%2520in%2520the%2520Neglected%2520Human%2520Pathogen%2520Leishmania%2520Donovani%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D342%26epage%3D354%26doi%3D10.1016%2Fj.chembiol.2015.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">New Developments in Probing and Targeting Protein Acylation in Malaria, Leishmaniasis and African Sleeping Sickness</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1017/S0031182017000282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1017%2FS0031182017000282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=28270257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A280%3ADC%252BC1czjvVyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=157-174&author=M.+Ritzefeldauthor=M.+H.+Wrightauthor=E.+W.+Tate&title=New+Developments+in+Probing+and+Targeting+Protein+Acylation+in+Malaria%2C+Leishmaniasis+and+African+Sleeping+Sickness&doi=10.1017%2FS0031182017000282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness</span></div><div class="casAuthors">Ritzefeld Markus; Tate Edward W; Wright Megan H</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-174</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Infections by protozoan parasites, such as Plasmodium falciparum or Leishmania donovani, have a significant health, social and economic impact and threaten billions of people living in tropical and sub-tropical regions of developing countries worldwide.  The increasing range of parasite strains resistant to frontline therapeutics makes the identification of novel drug targets and the development of corresponding inhibitors vital.  Post-translational modifications (PTMs) are important modulators of biology and inhibition of protein lipidation has emerged as a promising therapeutic strategy for treatment of parasitic diseases.  In this review we summarize the latest insights into protein lipidation in protozoan parasites.  We discuss how recent chemical proteomic approaches have delivered the first global overviews of protein lipidation in these organisms, contributing to our understanding of the role of this PTM in critical metabolic and cellular functions.  Additionally, we highlight the development of new small molecule inhibitors to target parasite acyl transferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx-0MJq_SKUD0SWnHPWbmmfW6udTcc2eZh9Lv3-KgT47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjvVyisQ%253D%253D&md5=ed44057998a3b429002b1e138e63058c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1017%2FS0031182017000282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182017000282%26sid%3Dliteratum%253Aachs%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DNew%2520Developments%2520in%2520Probing%2520and%2520Targeting%2520Protein%2520Acylation%2520in%2520Malaria%252C%2520Leishmaniasis%2520and%2520African%2520Sleeping%2520Sickness%26jtitle%3DParasitology%26date%3D2018%26volume%3D145%26spage%3D157%26epage%3D174%26doi%3D10.1017%2FS0031182017000282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doehl, J. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Genetic Validation of Leishmania Genes Essential for Amastigote Survival in Vivo Using N-Myristoyltransferase as a Model</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">132</span>, <span class="refDoi"> DOI: 10.1186/s13071-020-3999-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1186%2Fs13071-020-3999-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=32171322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1SmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=132&author=D.+Paapeauthor=C.+T.+Prendergastauthor=H.+P.+Priceauthor=J.+S.+P.+Doehlauthor=D.+F.+Smith&title=Genetic+Validation+of+Leishmania+Genes+Essential+for+Amastigote+Survival+in+Vivo+Using+N-Myristoyltransferase+as+a+Model&doi=10.1186%2Fs13071-020-3999-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model</span></div><div class="casAuthors">Paape, Daniel; Prendergast, Catriona T.; Price, Helen P.; Doehl, Johannes S. P.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Proving that specific genes are essential for the intracellular viability of Leishmania parasites within macrophages remains a challenge for the identification of suitable targets for drug development.  This is esp. evident in the absence of a robust inducible expression system or functioning RNAi machinery that works in all Leishmania species.  Currently, if a target gene of interest in extracellular parasites can only be deleted from its genomic locus in the presence of ectopic expression from a wild type copy, it is assumed that this gene will also be essential for viability in disease-promoting intracellular parasites.  However, functional essentiality must be proven independently in both life-cycle stages for robust validation of the gene of interest as a putative target for chem. intervention.  Methods: Here, we have used plasmid shuffle methods in vivo to provide supportive genetic evidence that N-myristoyltransferase (NMT) is essential for Leishmania viability throughout the parasite life-cycle.  Following confirmation of NMT essentiality in vector-transmitted promastigotes, a range of mutant parasites were used to infect mice prior to neg. selection pressure to test the hypothesis that NMT is also essential for parasite viability in an established infection.  Results: Ectopically-expressed NMT was only dispensable under neg. selection in the presence of another copy.  Total parasite burdens in animals subjected to neg. selection were comparable to control groups only if an addnl. NMT copy, not affected by the neg. selection, was expressed.  Conclusions: NMT is an essential gene in all parasite life-cycle stages, confirming its role as a genetically-validated target for drug development.[graphic not available: see fulltext].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMoS9IngMkD7Vg90H21EOLACvtfcHk0lgphJcpWUiSEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1SmtL8%253D&md5=e7df52a01258aacca3837689513202e9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2Fs13071-020-3999-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-020-3999-1%26sid%3Dliteratum%253Aachs%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DPrendergast%26aufirst%3DC.%2BT.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DDoehl%26aufirst%3DJ.%2BS.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DGenetic%2520Validation%2520of%2520Leishmania%2520Genes%2520Essential%2520for%2520Amastigote%2520Survival%2520in%2520Vivo%2520Using%2520N-Myristoyltransferase%2520as%2520a%2520Model%26jtitle%3DParasites%2520Vectors%26date%3D2020%26volume%3D13%26spage%3D132%26doi%3D10.1186%2Fs13071-020-3999-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corpas-Lopez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zander-Dinse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Validation of N-Myristoyltransferase as a Drug Target in <i>Leishmania Donovani</i></span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCisb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=111-122&author=V.+Corpas-Lopezauthor=S.+Monizauthor=M.+Thomasauthor=R.+J.+Wallauthor=L.+S.+Torrieauthor=D.+Zander-Dinseauthor=M.+Tintiauthor=S.+Brandauthor=L.+Stojanovskiauthor=S.+Manthriauthor=I.+Hallyburtonauthor=F.+Zuccottoauthor=P.+G.+Wyattauthor=M.+De+Ryckerauthor=D.+Hornauthor=M.+A.+J.+Fergusonauthor=J.+Closauthor=K.+D.+Readauthor=A.+H.+Fairlambauthor=I.+H.+Gilbertauthor=S.+Wyllie&title=Pharmacological+Validation+of+N-Myristoyltransferase+as+a+Drug+Target+in+Leishmania+Donovani&doi=10.1021%2Facsinfecdis.8b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani</span></div><div class="casAuthors">Corpas-Lopez, Victoriano; Moniz, Sonia; Thomas, Michael; Wall, Richard J.; Torrie, Leah S.; Zander-Dinse, Dorothea; Tinti, Michele; Brand, Stephen; Stojanovski, Laste; Manthri, Sujatha; Hallyburton, Irene; Zuccotto, Fabio; Wyatt, Paul G.; De Rycker, Manu; Horn, David; Ferguson, Michael A. J.; Clos, Joachim; Read, Kevin D.; Fairlamb, Alan H.; Gilbert, Ian H.; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-122</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL), caused by the protozoan parasites Leishmania donovani and L. infantum, is responsible for ∼30,000 deaths annually.  Available treatments are inadequate, and there is a pressing need for new therapeutics.  N-Myristoyltransferase (NMT) remains one of the few genetically validated drug targets in these parasites.  Here, the authors sought to pharmacol. validate this enzyme in Leishmania.  A focused set of 1600 pyrazolyl sulfonamide compds. was screened against L. major NMT in a robust high-throughput biochem. assay.  Several potent inhibitors were identified with marginal selectivity over the human enzyme.  There was little correlation between the enzyme potency of these inhibitors and their cellular activity against L. donovani axenic amastigotes, and this discrepancy could be due to poor cellular uptake due to the basicity of these compds.  Thus, a series of analogs were synthesized with less basic centers.  Although most of these compds. continued to suffer from relatively poor antileishmanial activity, the authors' most potent inhibitor of LmNMT (DDD100097, Ki of 0.34 nM) showed modest activity against L. donovani intracellular amastigotes (EC50 of 2.4 μM) and maintained a modest therapeutic window over the human enzyme.  Two unbiased approaches, namely, screening against the authors' cosmid-based overexpression library and thermal proteome profiling (TPP), confirm that DDD100097 (compd. 2) acts on-target within parasites.  Oral dosing with compd. 2 resulted in a 52% redn. in parasite burden in the authors' mouse model of VL.  Thus, NMT is now a pharmacol. validated target in Leishmania.  The challenge in finding drug candidates remains to identify alternative strategies to address the drop-off in activity between enzyme inhibition and in vitro activity while maintaining sufficient selectivity over the human enzyme, both issues that continue to plague studies in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtsAYd4MiZRLVg90H21EOLACvtfcHk0lgphJcpWUiSEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCisb%252FI&md5=5901cad939de2eb6beab6d4454e21acb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00226%26sid%3Dliteratum%253Aachs%26aulast%3DCorpas-Lopez%26aufirst%3DV.%26aulast%3DMoniz%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DZander-Dinse%26aufirst%3DD.%26aulast%3DTinti%26aufirst%3DM.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DClos%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DPharmacological%2520Validation%2520of%2520N-Myristoyltransferase%2520as%2520a%2520Drug%2520Target%2520in%2520Leishmania%2520Donovani%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D111%26epage%3D122%26doi%3D10.1021%2Facsinfecdis.8b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic Inhibitors of N-Myristoyltransferase from Human Malaria and Leishmaniasis Parasites</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">8132</span>– <span class="NLM_lpage">8137</span>, <span class="refDoi"> DOI: 10.1039/C4OB01669F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FC4OB01669F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25230674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=8132-8137&author=T.+O.+Olaleyeauthor=J.+A.+Branniganauthor=S.+M.+Robertsauthor=R.+J.+Leatherbarrowauthor=A.+J.+Wilkinsonauthor=E.+W.+Tate&title=Peptidomimetic+Inhibitors+of+N-Myristoyltransferase+from+Human+Malaria+and+Leishmaniasis+Parasites&doi=10.1039%2FC4OB01669F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites</span></div><div class="casAuthors">Olaleye, Tayo O.; Brannigan, James A.; Roberts, Shirley M.; Leatherbarrow, Robin J.; Wilkinson, Anthony J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">8132-8137</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) has been shown to be essential in Leishmania and subsequently validated as a drug target in Plasmodium.  Herein, we discuss the use of antifungal NMT inhibitors as a basis for inhibitor development resulting in the first sub-micromolar peptidomimetic inhibitors of Plasmodium and Leishmania NMTs.  High-resoln. structures of these inhibitors with Plasmodium and Leishmania NMTs permit a comparative anal. of binding modes, and provide the first crystal structure evidence for a ternary NMT-CoA/myristoylated peptide product complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMmfvqE4krX7Vg90H21EOLACvtfcHk0lg5JiDWSTdziQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeis7%252FI&md5=10d2396d56ad7c7b31168ba9fda5c36b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC4OB01669F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01669F%26sid%3Dliteratum%253Aachs%26aulast%3DOlaleye%26aufirst%3DT.%2BO.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DPeptidomimetic%2520Inhibitors%2520of%2520N-Myristoyltransferase%2520from%2520Human%2520Malaria%2520and%2520Leishmaniasis%2520Parasites%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D8132%26epage%3D8137%26doi%3D10.1039%2FC4OB01669F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rackham, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of High Affinity Inhibitors of <i>Leishmania Donovani</i> N-Myristoyltransferase</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1039/C5MD00241A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FC5MD00241A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=26962429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCgsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1761-1766&author=M.+D.+Rackhamauthor=Z.+Yuauthor=J.+A.+Branniganauthor=W.+P.+Healauthor=D.+Paapeauthor=K.+V.+Barkerauthor=A.+J.+Wilkinsonauthor=D.+F.+Smithauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Discovery+of+High+Affinity+Inhibitors+of+Leishmania+Donovani+N-Myristoyltransferase&doi=10.1039%2FC5MD00241A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase</span></div><div class="casAuthors">Rackham, Mark D.; Yu, Zhiyong; Brannigan, James A.; Heal, William P.; Paape, Daniel; Barker, K. Victoria; Wilkinson, Anthony J.; Smith, Deborah F.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1761-1766</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites.  Scaffold-hopping from published inhibitors yielded the serendipitous discovery of a chemotype selective for Leishmania donovani NMT; development led to high affinity inhibitors with excellent ligand efficiency.  The binding mode was characterised by crystallog. and provides a structural rationale for selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8wVOTTgUYwbVg90H21EOLACvtfcHk0lg5JiDWSTdziQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCgsLfN&md5=5d4e82aa0e296b9de25419e42da10c76</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC5MD00241A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00241A%26sid%3Dliteratum%253Aachs%26aulast%3DRackham%26aufirst%3DM.%2BD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DK.%2BV.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDiscovery%2520of%2520High%2520Affinity%2520Inhibitors%2520of%2520Leishmania%2520Donovani%2520N-Myristoyltransferase%26jtitle%3DMedchemcomm%26date%3D2015%26volume%3D6%26spage%3D1761%26epage%3D1766%26doi%3D10.1039%2FC5MD00241A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loesel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Plate-Based Diversity Subset Screening Generation 2: An Improved Paradigm for High-Throughput Screening of Large Compound Files</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9692-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1007%2Fs11030-016-9692-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=27631533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=789-803&author=A.+S.+Bellauthor=J.+Bradleyauthor=J.+R.+Everettauthor=J.+Loeselauthor=D.+McLoughlinauthor=J.+Millsauthor=M.+C.+Peakmanauthor=R.+E.+Sharpauthor=C.+Williamsauthor=H.+Zhu&title=Plate-Based+Diversity+Subset+Screening+Generation+2%3A+An+Improved+Paradigm+for+High-Throughput+Screening+of+Large+Compound+Files&doi=10.1007%2Fs11030-016-9692-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files</span></div><div class="casAuthors">Bell, Andrew S.; Bradley, Joseph; Everett, Jeremy R.; Loesel, Jens; McLoughlin, David; Mills, James; Peakman, Marie-Claire; Sharp, Robert E.; Williams, Christine; Zhu, Hongyao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">789-803</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) is an effective method for lead and probe discovery that is widely used in industry and academia to identify novel chem. matter and to initiate the drug discovery process.  However, HTS can be time consuming and costly and the use of subsets as an efficient alternative to screening entire compd. collections has been investigated.  Subsets may be selected on the basis of chem. diversity, mol. properties, biol. activity diversity or biol. target focus.  Previously, we described a novel form of subset screening: plate-based diversity subset (PBDS) screening, in which the screening subset is constructed by plate selection (rather than individual compd. cherry-picking), using algorithms that select for compd. quality and chem. diversity on a plate basis.  In this paper, we describe a second-generation approach to the construction of an updated subset: PBDS2, using both plate and individual compd. selection, that has an improved coverage of the chem. space of the screening file, while only selecting the same no. of plates for screening.  We describe the validation of PBDS2 and its successful use in hit and lead discovery.  PBDS2 screening became the default mode of singleton (one compd. per well) HTS for lead discovery in Pfizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWz1_6LByvVbVg90H21EOLACvtfcHk0lhpBli5PgXCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymtbbI&md5=c7c558015d75d1ef1c20f74400075ed9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9692-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9692-9%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DEverett%26aufirst%3DJ.%2BR.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DMcLoughlin%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DJ.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26aulast%3DSharp%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DPlate-Based%2520Diversity%2520Subset%2520Screening%2520Generation%25202%253A%2520An%2520Improved%2520Paradigm%2520for%2520High-Throughput%2520Screening%2520of%2520Large%2520Compound%2520Files%26jtitle%3DMol.%2520Diversity%26date%3D2016%26volume%3D20%26spage%3D789%26epage%3D803%26doi%3D10.1007%2Fs11030-016-9692-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibitors of Protozoan Protein N-Myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1625</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0001625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pntd.0001625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22545171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&author=A.+S.+Bellauthor=J.+E.+Millsauthor=G.+P.+Williamsauthor=J.+A.+Branniganauthor=A.+J.+Wilkinsonauthor=T.+Parkinsonauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tateauthor=A.+A.+Holderauthor=D.+F.+Smith&title=Selective+Inhibitors+of+Protozoan+Protein+N-Myristoyltransferases+as+Starting+Points+for+Tropical+Disease+Medicinal+Chemistry+Programs&doi=10.1371%2Fjournal.pntd.0001625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs</span></div><div class="casAuthors">Bell, Andrew S.; Mills, James E.; Williams, Gareth P.; Brannigan, James A.; Wilkinson, Anthony J.; Parkinson, Tanya; Leatherbarrow, Robin J.; Tate, Edward W.; Holder, Anthony A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1625</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inhibition of N-myristoyltransferase has been validated pre-clin. as a target for the treatment of fungal and trypanosome infections, using species-specific inhibitors.  In order to identify inhibitors of protozoan NMTs, we chose to screen a diverse subset of the Pfizer corporate collection against Plasmodium falciparum and Leishmania donovani NMTs.  Primary screening hits against either enzyme were tested for selectivity over both human NMT isoforms (Hs1 and Hs2) and for broad-spectrum anti-protozoan activity against the NMT from Trypanosoma brucei.  Anal. of the screening results has shown that structure-activity relationships (SAR) for Leishmania NMT are divergent from all other NMTs tested, a finding not predicted by sequence similarity calcns., resulting in the identification of four novel series of Leishmania-selective NMT inhibitors.  We found a strong overlap between the SARs for Plasmodium NMT and both human NMTs, suggesting that achieving an appropriate selectivity profile will be more challenging.  However, we did discover two novel series with selectivity for Plasmodium NMT over the other NMT orthologues in this study, and an addnl. two structurally distinct series with selectivity over Leishmania NMT.  We believe that release of results from this study into the public domain will accelerate the discovery of NMT inhibitors to treat malaria and leishmaniasis.  Our screening initiative is another example of how a tripartite partnership involving pharmaceutical industries, academic institutions and governmental/non-governmental organisations such as Medical Research Council and Wellcome Trust can stimulate research for neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSnKVEdu_4pLVg90H21EOLACvtfcHk0lhpBli5PgXCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOktbs%253D&md5=93ae0e5eda8a7cf1affcb8a26f4483f4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001625%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DG.%2BP.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DSelective%2520Inhibitors%2520of%2520Protozoan%2520Protein%2520N-Myristoyltransferases%2520as%2520Starting%2520Points%2520for%2520Tropical%2520Disease%2520Medicinal%2520Chemistry%2520Programs%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26doi%3D10.1371%2Fjournal.pntd.0001625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span> <span> </span><span class="NLM_article-title">Diverse Modes of Binding in Structures of Leishmania Major N-Myristoyltransferase with Selective Inhibitors</span>. <i>IUCrJ</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1107/S2052252514013001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS2052252514013001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25075346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=250-260&author=J.+A.+Branniganauthor=S.+M.+Robertsauthor=A.+S.+Bellauthor=J.+A.+Huttonauthor=M.+R.+Hodgkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrowauthor=D.+F.+Smithauthor=A.+J.+Wilkinson&title=Diverse+Modes+of+Binding+in+Structures+of+Leishmania+Major+N-Myristoyltransferase+with+Selective+Inhibitors&doi=10.1107%2FS2052252514013001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors</span></div><div class="casAuthors">Brannigan, James A.; Roberts, Shirley M.; Bell, Andrew S.; Hutton, Jennie A.; Hodgkinson, Michael R.; Tate, Edward W.; Leatherbarrow, Robin J.; Smith, Deborah F.; Wilkinson, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">250-260</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The leishmaniases are a spectrum of global diseases of poverty assocd. with immune dysfunction and are the cause of high morbidity.  Despite the long history of these diseases, no effective vaccine is available and the currently used drugs are variously compromised by moderate efficacy, complex side effects and the emergence of resistance.  It is therefore widely accepted that new therapies are needed.  N-Myristoyltransferase (NMT) has been validated pre-clin. as a target for the treatment of fungal and parasitic infections.  In a previously reported high-throughput screening program, a no. of hit compds. with activity against NMT from Leishmania donovani have been identified.  Here, high-resoln. crystal structures of representative compds. from four hit series in ternary complexes with myristoyl-CoA and NMT from the closely related L. major are reported.  The structures reveal that the inhibitors assoc. with the peptide-binding groove at a site adjacent to the bound myristoyl-CoA and the catalytic α-carboxylate of Leu421.  Each inhibitor makes extensive apolar contacts as well as a small no. of polar contacts with the protein.  Remarkably, the compds. exploit different features of the peptide-binding groove and collectively occupy a substantial vol. of this pocket, suggesting that there is potential for the design of chimaeric inhibitors with significantly enhanced binding.  Despite the high conservation of the active sites of the parasite and human NMTs, the inhibitors act selectively over the host enzyme.  The role of conformational flexibility in the side chain of Tyr217 in conferring selectivity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ-gxtPrLIabVg90H21EOLACvtfcHk0lhpBli5PgXCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnI&md5=b15cdf5bb8d37523f2459f938d430b8a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS2052252514013001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252514013001%26sid%3Dliteratum%253Aachs%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DHodgkinson%26aufirst%3DM.%2BR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26atitle%3DDiverse%2520Modes%2520of%2520Binding%2520in%2520Structures%2520of%2520Leishmania%2520Major%2520N-Myristoyltransferase%2520with%2520Selective%2520Inhibitors%26jtitle%3DIUCrJ%26date%3D2014%26volume%3D1%26spage%3D250%26epage%3D260%26doi%3D10.1107%2FS2052252514013001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waugh, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Potent and Selective Leishmania N-Myristoyltransferase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8664</span>– <span class="NLM_lpage">8670</span>, <span class="refDoi"> DOI: 10.1021/jm5011397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5011397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8664-8670&author=J.+A.+Huttonauthor=V.+Goncalvesauthor=J.+A.+Branniganauthor=D.+Paapeauthor=M.+H.+Wrightauthor=T.+M.+Waughauthor=S.+M.+Robertsauthor=A.+S.+Bellauthor=A.+J.+Wilkinsonauthor=D.+F.+Smithauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Structure-Based+Design+of+Potent+and+Selective+Leishmania+N-Myristoyltransferase+Inhibitors&doi=10.1021%2Fjm5011397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Selective Leishmania N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Hutton, Jennie A.; Goncalves, Victor; Brannigan, James A.; Paape, Daniel; Wright, Megan H.; Waugh, Thomas M.; Roberts, Shirley M.; Bell, Andrew S.; Wilkinson, Anthony J.; Smith, Deborah F.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8664-8670</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of LeishmaniaN-myristoyltransferase (NMT), a potential target for the treatment of leishmaniasis, obtained from a high-throughput screen, were resynthesized to validate activity.  Crystal structures bound to Leishmania major NMT were obtained, and the active diastereoisomer of one of the inhibitors was identified.  On the basis of structural insights, enzyme inhibition was increased 40-fold through hybridization of two distinct binding modes, resulting in novel, highly potent Leishmania donovani NMT inhibitors with good selectivity over the human enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QZaQ-6mXcLVg90H21EOLACvtfcHk0lh5PaT9GNLRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyjtbzN&md5=e9d662f2d180e001fa50fa1468e60a99</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm5011397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5011397%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DWaugh%26aufirst%3DT.%2BM.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520and%2520Selective%2520Leishmania%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8664%26epage%3D8670%26doi%3D10.1021%2Fjm5011397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-Myristoylation in Intracellular Leishmania Amastigotes</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e3363</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0003363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pntd.0003363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25522361" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&author=D.+Paapeauthor=A.+S.+Bellauthor=W.+P.+Healauthor=J.+A.+Huttonauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tateauthor=D.+F.+Smith&title=Using+a+Non-Image-Based+Medium-Throughput+Assay+for+Screening+Compounds+Targeting+N-Myristoylation+in+Intracellular+Leishmania+Amastigotes&doi=10.1371%2Fjournal.pntd.0003363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003363%26sid%3Dliteratum%253Aachs%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DUsing%2520a%2520Non-Image-Based%2520Medium-Throughput%2520Assay%2520for%2520Screening%2520Compounds%2520Targeting%2520N-Myristoylation%2520in%2520Intracellular%2520Leishmania%2520Amastigotes%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26doi%3D10.1371%2Fjournal.pntd.0003363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armarego, W. L. F.</span></span> <span> </span><span class="NLM_article-title">Quinazolines</span>. In  <i>Advances in Heterocyclic Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span>; <span class="NLM_string-name">Boulton, A. J.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1979</span>; Vol.  <span class="NLM_volume">24</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">62</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=1-62&author=W.+L.+F.+Armaregoauthor=A.+R.+Katritzky&author=A.+J.+Boulton&title=Advances+in+Heterocyclic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26atitle%3DQuinazolines%26btitle%3DAdvances%2520in%2520Heterocyclic%2520Chemistry%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26pub%3DAcademic%2520Press%26date%3D1979%26volume%3D24%26spage%3D1%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, C. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kanter, F. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jongejan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coruzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and QSAR of Quinazoline Sulfonamides As Highly Potent Human Histamine H4 Receptor Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2390</span>– <span class="NLM_lpage">2400</span>, <span class="refDoi"> DOI: 10.1021/jm901379s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901379s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2390-2400&author=R.+A.+Smitsauthor=M.+Adamiauthor=E.+P.+Istyastonoauthor=O.+P.+Zuiderveldauthor=C.+M.+E.+Van+Damauthor=F.+J.+J.+De+Kanterauthor=A.+Jongejanauthor=G.+Coruzziauthor=R.+Leursauthor=I.+J.+P.+De+Esch&title=Synthesis+and+QSAR+of+Quinazoline+Sulfonamides+As+Highly+Potent+Human+Histamine+H4+Receptor+Inverse+Agonists&doi=10.1021%2Fjm901379s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and QSAR of Quinazoline Sulfonamides As Highly Potent Human Histamine H4 Receptor Inverse Agonists</span></div><div class="casAuthors">Smits, Rogier A.; Adami, Maristella; Istyastono, Enade P.; Zuiderveld, Obbe P.; van Dam, Cindy M. E.; de Kanter, Frans J. J.; Jongejan, Aldo; Coruzzi, Gabriella; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2390-2400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hit optimization of the class of quinazoline-contg. histamine H4 receptor (H4R) ligands I (X = CH2, CH2CH2; R1 = 6-Cl, 6-I, 5-CF3, 6,7-Cl2, etc.; R2 = H2N, MeNH, Et2N, Me, 1-pyrrolidinyl, PhNMe, etc.) resulted in a sulfonamide substituted analog with high affinity for the H4R.  This moiety leads to improved physicochem. properties and is believed to probe a distinct H4R binding pocket that was previously identified using pharmacophore modeling.  By introducing a variety of sulfonamide substituents, the H4R affinity was optimized.  The interaction of the new ligands, in combination with a set of previously published quinazoline compds., was described by a QSAR equation.  Pharmacol. studies revealed that the sulfonamide analogs have excellent H4R affinity and behave as inverse agonists at the human H4R.  In vivo evaluation of the potent compd. I (X = CH2; R1 = 6-Cl; R2 = PhNH) (pKi = 8.31 ± 0.10) showed it to have anti-inflammatory activity in an animal model of acute inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIe7efwOjS07Vg90H21EOLACvtfcHk0lhLteUJS9GXCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGlsrc%253D&md5=0b50786b4a0e4514d55bb7af4fd2618b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm901379s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901379s%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DVan%2BDam%26aufirst%3DC.%2BM.%2BE.%26aulast%3DDe%2BKanter%26aufirst%3DF.%2BJ.%2BJ.%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DDe%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DSynthesis%2520and%2520QSAR%2520of%2520Quinazoline%2520Sulfonamides%2520As%2520Highly%2520Potent%2520Human%2520Histamine%2520H4%2520Receptor%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2390%26epage%3D2400%26doi%3D10.1021%2Fjm901379s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, M.</span></span> <span> </span><span class="NLM_article-title">Reaction of N-Substituted Cyclic Amines with 2,4-Dichloroquinazoline, 2,4- Dichloropyrimidine, and its 5-Methyl Derivative</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1039/p19920000919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2Fp19920000919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=919-922&author=K.+Yoshidaauthor=M.+Taguchi&title=Reaction+of+N-Substituted+Cyclic+Amines+with+2%2C4-Dichloroquinazoline%2C+2%2C4-+Dichloropyrimidine%2C+and+its+5-Methyl+Derivative&doi=10.1039%2Fp19920000919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fp19920000919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19920000919%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DM.%26atitle%3DReaction%2520of%2520N-Substituted%2520Cyclic%2520Amines%2520with%25202%252C4-Dichloroquinazoline%252C%25202%252C4-%2520Dichloropyrimidine%252C%2520and%2520its%25205-Methyl%2520Derivative%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1992%26volume%3D1%26spage%3D919%26epage%3D922%26doi%3D10.1039%2Fp19920000919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olofson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piteau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfroot, T.</span></span> <span> </span><span class="NLM_article-title">A New Reagent for the Selective, High-Yield n-Dealkylation of Tertiary Amines: Improved Syntheses of Naltrexone and Nalbuphine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1021/jo00185a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+for+the+Selective%2C+High-Yield+n-Dealkylation+of+Tertiary+Amines%3A+Improved+Syntheses+of+Naltrexone+and+Nalbuphine&doi=10.1021%2Fjo00185a072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A new reagent for the selective, high-yield N-dealkylation of tertiary amines:  improved syntheses of naltrexone and nalbuphine</span></div><div class="casAuthors">Olofson, R. A.; Martz, Jonathan T.; Senet, Jean Pierre; Piteau, Marc; Malfroot, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2081-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of tertiary amines with ClCO2CHClMe in ClCH2CH2Cl at reflux affords the intermediates, R2NCO2CHClMe (R = alkyl, R2 = cycloalkyl), which are converted to the desired salts, R2NH·HCl, just by heating in MeOH.  The N-dealkylation reagent is made in 96% yield by mixing MeCHO with COCl2 in the presence of an R4N+ Cl- catalyst.  The N-dealkylations are highly selective, mild, occur in high yield, and permit the presence of a variety of functionalities.  The process is exemplified by the conversion of glaucine (I) to the phenanthrene (II) in 89% yield and by the N-demethylations of arecoline, O-acetyltropine, and 6-acetylcodeine in yields of 95-97%.  The methodol. was used as part of a process for the transformation of oxycodone to the com. narcotic antagonist, naltrexone (58% overall yield) and to the prescription analgesic, nalbuphine (III) (69% overall yield).  Arom. tertiary amines also are N-dealkylated, although under more vigorous conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSuAJiJApjLVg90H21EOLACvtfcHk0lhLteUJS9GXCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D&md5=9402bfb15be7a0d057bfe7bf95bde7b6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520for%2520the%2520Selective%252C%2520High-Yield%2520n-Dealkylation%2520of%2520Tertiary%2520Amines%253A%2520Improved%2520Syntheses%2520of%2520Naltrexone%2520and%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D2081%26epage%3D2082%26doi%3D10.1021%2Fjo00185a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzarone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">A Fluorescence-Based Assay for N-Myristoyltransferase Activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.ab.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22051857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=342-344&author=V.+Goncalvesauthor=J.+A.+Branniganauthor=E.+Thinonauthor=T.+O.+Olaleyeauthor=R.+Serwaauthor=S.+Lanzaroneauthor=A.+J.+Wilkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=A+Fluorescence-Based+Assay+for+N-Myristoyltransferase+Activity&doi=10.1016%2Fj.ab.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based assay for N-myristoyltransferase activity</span></div><div class="casAuthors">Goncalves, Victor; Brannigan, James A.; Thinon, Emmanuelle; Olaleye, Tayo O.; Serwa, Remigiusz; Lanzarone, Salvatore; Wilkinson, Anthony J.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-344</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-myristoylation is the irreversible attachment of a C14 fatty acid, myristic acid, to the N-terminal glycine of a protein via formation of an amide bond.  This modification is catalyzed by myristoyl-CoA:protein N-myristoyltransferase (NMT), an enzyme ubiquitous in eukaryotes that is up-regulated in several cancers.  Here we report a sensitive fluorescence-based assay to study the enzymic activity of human NMT1 and NMT2 based on detection of CoA by 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CPM).  We also describe expression and characterization of NMT1 and NMT2 and assay validation with small mol. inhibitors.  This assay should be broadly applicable to NMTs from a range of organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8ouiGX0Ml7Vg90H21EOLACvtfcHk0lhLteUJS9GXCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVehtg%253D%253D&md5=b0b36c043d6947a0843e19eddb9d9f43</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DOlaleye%26aufirst%3DT.%2BO.%26aulast%3DSerwa%26aufirst%3DR.%26aulast%3DLanzarone%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DA%2520Fluorescence-Based%2520Assay%2520for%2520N-Myristoyltransferase%2520Activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D421%26spage%3D342%26epage%3D344%26doi%3D10.1016%2Fj.ab.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Questel, J. Y.</span></span> <span> </span><span class="NLM_article-title">Amino Nitrogen and Carbonyl Oxygen in Competitive Situations: Which Is the Best Hydrogen-Bond Acceptor Site?</span>. <i>CrystEngComm</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1039/B202248F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FB202248F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFKktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=326-335&author=N.+Ziaoauthor=C.+Laurenceauthor=J.+Y.+Le+Questel&title=Amino+Nitrogen+and+Carbonyl+Oxygen+in+Competitive+Situations%3A+Which+Is+the+Best+Hydrogen-Bond+Acceptor+Site%3F&doi=10.1039%2FB202248F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amino nitrogen and carbonyl oxygen in competitive situations: which is the best hydrogen-bond acceptor site?</span></div><div class="casAuthors">Ziao, Nahosse; Laurence, Christian; Le Questel, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">CrystEngComm</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">326-335</span>CODEN:
                <span class="NLM_cas:coden">CRECF4</span>;
        ISSN:<span class="NLM_cas:issn">1466-8033</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The relative H-bond acceptor abilities of amino N and carbonyl O in various chem. environments were studied using data retrieved from the Cambridge Structural Database (CSD) and via ab initio MO calcns.  Surveys of the CSD for H bonds between HX (X = N, O) donors and push-pull or satd. amino ketone and amino ester mol. fragments show that the H bonds are much more frequent on the O than on the amino N.  In the push-pull families, the H-bonding (HB) ability of the carbonyl O is increased by conjugation between the lone pair of the amino substituent and the C=O group, a behavior similar to resonance-assisted H bonding.  The unexpected behavior of twisted amides, in which only the amino N is involved in H bonding, is pointed out.  This unusual feature is explained by the disruption of conjugation between the amino lone pair and the carbonyl owing to the cyclization involving the amino moiety.  In aliph. systems, the amino N retains its HB ability but is still involved in a rather low no. of contacts.  This behavior reflects the sensitivity of the amino N to steric hindrance. The relative strengths of the H bonds on the carbonyl O in ketones and esters follow the exptl. order of H-bond basicity as obsd. in soln. through the pKHB scale.  Ab initio MO calcns. (B3LYP/6-31+G** level) of electrostatic and charge transfer descriptors also confirm the exptl. observations. pKa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorW-ZFotJZALVg90H21EOLACvtfcHk0li6a9QrVxmVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFKktr0%253D&md5=bd71a6177b58e4b599e26506953abc33</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB202248F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB202248F%26sid%3Dliteratum%253Aachs%26aulast%3DZiao%26aufirst%3DN.%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26atitle%3DAmino%2520Nitrogen%2520and%2520Carbonyl%2520Oxygen%2520in%2520Competitive%2520Situations%253A%2520Which%2520Is%2520the%2520Best%2520Hydrogen-Bond%2520Acceptor%2520Site%253F%26jtitle%3DCrystEngComm%26date%3D2002%26volume%3D4%26spage%3D326%26epage%3D335%26doi%3D10.1039%2FB202248F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/jm201091t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201091t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=140-152&author=S.+Brandauthor=L.+A.+T.+Cleghornauthor=S.+P.+McElroyauthor=D.+A.+Robinsonauthor=V.+C.+Smithauthor=I.+Hallyburtonauthor=J.+R.+Harrisonauthor=N.+R.+Norcrossauthor=D.+Spinksauthor=T.+Baylissauthor=S.+Norvalauthor=L.+Stojanovskiauthor=L.+S.+Torrieauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Discovery+of+a+Novel+Class+of+Orally+Active+Trypanocidal+N-Myristoyltransferase+Inhibitors&doi=10.1021%2Fjm201091t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Brand, Stephen; Cleghorn, Laura A. T.; McElroy, Stuart P.; Robinson, David A.; Smith, Victoria C.; Hallyburton, Irene; Harrison, Justin R.; Norcross, Neil R.; Spinks, Daniel; Bayliss, Tracy; Norval, Suzanne; Stojanovski, Laste; Torrie, Leah S.; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei.  We report the optimization of a high throughput screening hit (1) to give a lead mol. DDD85646 (63), which has potent activity against the enzyme (IC50 = 2 nM) and T. brucei (EC50 = 2 nM) in culture.  The compd. has good oral pharmacokinetics and cures rodent models of peripheral HAT infection.  This compd. provides an excellent tool for validation of T. brucei NMT as a drug target for HAT as well as a valuable lead for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCg4lhwv5cTrVg90H21EOLACvtfcHk0li6a9QrVxmVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK&md5=1479aed07e07e99f58de9012c7ec6631</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201091t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201091t%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Orally%2520Active%2520Trypanocidal%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D140%26epage%3D152%26doi%3D10.1021%2Fjm201091t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broncel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciepla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Reagents for Quantitative Proteome-Wide Analysis of Protein Modification in Human Cells and Dynamic Profiling of Protein Lipidation during Vertebrate Development</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5948</span>– <span class="NLM_lpage">5951</span>, <span class="refDoi"> DOI: 10.1002/anie.201500342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1002%2Fanie.201500342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25807930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlKht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=5948-5951&author=M.+Broncelauthor=R.+A.+Serwaauthor=P.+Cieplaauthor=E.+Krauseauthor=M.+J.+Dallmanauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Multifunctional+Reagents+for+Quantitative+Proteome-Wide+Analysis+of+Protein+Modification+in+Human+Cells+and+Dynamic+Profiling+of+Protein+Lipidation+during+Vertebrate+Development&doi=10.1002%2Fanie.201500342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Reagents for Quantitative Proteome-Wide Analysis of Protein Modification in Human Cells and Dynamic Profiling of Protein Lipidation During Vertebrate Development</span></div><div class="casAuthors">Broncel, Malgorzata; Serwa, Remigiusz A.; Ciepla, Paulina; Krause, Eberhard; Dallman, Margaret J.; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5948-5951</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Novel multifunctional reagents were applied in combination with a lipid probe for affinity enrichment of myristoylated proteins and direct detection of lipid-modified tryptic peptides by mass spectrometry.  This method enables high-confidence identification of the myristoylated proteome on an unprecedented scale in cell culture, and allowed the first quant. anal. of dynamic changes in protein lipidation during vertebrate embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepU8XZGNxbLVg90H21EOLACvtfcHk0li6a9QrVxmVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlKht7c%253D&md5=d78c278b1535bdb86a5b31c57313e39b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.201500342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201500342%26sid%3Dliteratum%253Aachs%26aulast%3DBroncel%26aufirst%3DM.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DCiepla%26aufirst%3DP.%26aulast%3DKrause%26aufirst%3DE.%26aulast%3DDallman%26aufirst%3DM.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DMultifunctional%2520Reagents%2520for%2520Quantitative%2520Proteome-Wide%2520Analysis%2520of%2520Protein%2520Modification%2520in%2520Human%2520Cells%2520and%2520Dynamic%2520Profiling%2520of%2520Protein%2520Lipidation%2520during%2520Vertebrate%2520Development%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D5948%26epage%3D5951%26doi%3D10.1002%2Fanie.201500342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Protein Labeling via Enzymatic N-Terminal Tagging and Elaboration by Click Chemistry</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/nprot.2011.425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fnprot.2011.425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=105-117&author=W.+P.+Healauthor=M.+H.+Wrightauthor=E.+Thinonauthor=E.+W.+Tate&title=Multifunctional+Protein+Labeling+via+Enzymatic+N-Terminal+Tagging+and+Elaboration+by+Click+Chemistry&doi=10.1038%2Fnprot.2011.425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional protein labeling via enzymatic N-terminal tagging and elaboration by click chemistry</span></div><div class="casAuthors">Heal, Wiliam P.; Wright, Megan H.; Thinon, Emmanuelle; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-117</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A protocol for selective and site-specific enzymic labeling of proteins is described.  The method exploits the protein co-/post-translational modification known as myristoylation, the transfer of myristic acid (a 14-carbon satd. fatty acid) to an N-terminal glycine catalyzed by the enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT).  Escherichia coli, having no endogenous NMT, is used for the coexpression of both the transferase and the target protein to be labeled, which participate in the in vivo N-terminal attachment of synthetically derived tagged analogs of myristic acid bearing a 'clickable' tag.  This tag is a functional group that can undergo bio-orthogonal ligation via 'click' chem., for example, an azide, and can be used as a handle for further site-specific labeling in vitro.  Here we provide protocols for in vivo N-terminal tagging of recombinant protein, and the synthesis and application of multifunctional reagents that enable protein labeling via click chem. for affinity purifn. and detection by fluorescence.  In addn. to general N-terminal protein labeling, the protocol would be of particular use in providing evidence for native myristoylation of proteins of interest, proof of activity/selectivity of NMTs and cross-species reactivity of NMTs without resorting to the use of radioactive isotopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoxNpNTi44lrVg90H21EOLACvtfcHk0lhiTOPxul4yQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kisbc%253D&md5=4fc52c6ad99164c10634be5f407a5679</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2011.425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2011.425%26sid%3Dliteratum%253Aachs%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DMultifunctional%2520Protein%2520Labeling%2520via%2520Enzymatic%2520N-Terminal%2520Tagging%2520and%2520Elaboration%2520by%2520Click%2520Chemistry%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D105%26epage%3D117%26doi%3D10.1038%2Fnprot.2011.425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title"><i>XDS</i></span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&issue=2&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lhiTOPxul4yQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and Assessment of Data Quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+Assessment+of+Data+Quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lhiTOPxul4yQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520Assessment%2520of%2520Data%2520Quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span> <span> </span><span class="NLM_article-title"><i>Xia2</i>: An Expert System for Macromolecular Crystallography Data Reduction</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1107/S0021889809045701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0021889809045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=186-190&author=G.+Winter&title=Xia2%3A+An+Expert+System+for+Macromolecular+Crystallography+Data+Reduction&doi=10.1107%2FS0021889809045701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">xia2: An expert system for macromolecular crystallography data reduction</span></div><div class="casAuthors">Winter, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-190, S186/1-S186/5</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An expert system for macromol. crystallog. data redn. is presented, which builds on existing software to automate the complete data redn. process from images to merged structure factor amplitudes.  This can automatically identify multi-wedge, multi-pass and multiwavelength data sets and includes explicit procedures to test for crystallog. special cases.  With the push towards high-throughput crystallog. at synchrotron beamlines and automation of structure soln., the ability to reduce data with no user input fills an important gap in the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi3u0ydXbSrVg90H21EOLACvtfcHk0lhiTOPxul4yQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D&md5=27771caa813f3e828abdf2a331ae55e3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889809045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889809045701%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DXia2%253A%2520An%2520Expert%2520System%2520for%2520Macromolecular%2520Crystallography%2520Data%2520Reduction%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2010%26volume%3D43%26spage%3D186%26epage%3D190%26doi%3D10.1107%2FS0021889809045701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liYQsWX7ClWcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and Development of COOT</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+COOT&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liYQsWX7ClWcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520COOT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kiall F. Suazo, Keun-Young Park, <span class="NLM_string-name hlFld-ContribAuthor">Mark D. Distefano</span>. </span><span class="cited-content_cbyCitation_article-title">A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (12)
                                     , 7178-7248. <a href="https://doi.org/10.1021/acs.chemrev.0c01108" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c01108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c01108%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DA%252BNot-So-Ancient%252BGrease%252BHistory%25253A%252BClick%252BChemistry%252Band%252BProtein%252BLipid%252BModifications%26aulast%3DSuazo%26aufirst%3DKiall%2BF.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11102020%26date%3D06042021%26volume%3D121%26issue%3D12%26spage%3D7178%26epage%3D7248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding pocket of compound <b>1</b> in <i>Lm</i>NMT. (A) Ribbon rendering of <i>Lm</i>NMT color ramped from amino (blue) to carboxy (red) terminus. The atoms of the myristoyl-CoA and <b>1</b> ligands are shown in space-filling representations and colored by atom types C (gray), O (red), N (blue), P (magenta), and S (yellow). (B) Structure of <b>1</b> (also known as IMP-083). (C) Cylinder rendering of the ligands emphasizing the proximal and distal binding sites for a pair of molecules of <b>1</b>, which pack against one another. (D) Binding pocket for <b>1</b> showing the Cα and side chains of <b>1</b>-interacting residues together with the C-terminal residue Leu421 whose α-carboxylate makes an ion-pairing interaction with the tertiary amino group of the proximal ligand. Water molecules in the neighborhood of <b>1</b> are shown as red spheres, and polar protein–ligand interactions are denoted by dashed lines. PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Correlation of <i>Lm</i>NMT-based and <i>Ld</i>NMT-based pIC<sub>50</sub> values obtained with the CPM assay. The Pearson coefficient (ρ) and P-value are shown. (B) Schematic representation of the SAR results. The four structural segments of the inhibitor are highlighted. All symbols are annotated in the lowest box.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Scheme for the Synthesis of 1 and Related Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine (1.0 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA, 1.2 equiv), EtOAc, room temperature (rt), 18 h; (ii) amine (4–10 equiv), EtOAc, microwave, 120–200 °C, 30–90 min; (iii) 1-chloroethyl chloroformate (1.0 equiv), DCE, reflux, 1 h; (iv) MeOH, reflux, 1 h; and (v) aldehyde (1.0 equiv), NaBH(OAc)<sub>3</sub>, DCE, rt 3–18 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the modes of binding of selected inhibitors with varied cores or C<sub>2</sub> substitution. MyrCoA is not shown in the binding site, for clarity. Stereo renderings can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S3</a>. (A) <b>1</b> and <b>3</b> emphasizing the highly similar binding modes of the proximal ligand pair, which differ only in the core substitution of the thienopyrimidine for a quinazoline. Protein carbons: light green or green; ligand carbons: gray, dark gray; and waters: crimson or red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, 6qda. (B) <b>1</b>, <b>10</b>, and <b>12</b> exploring <i>N</i>-substitutions on the piperidine ring. As before, the proximal ligands are closely superimposable. The same is true of the distal ligands, with the exception of the piperidine ring, which is significantly displaced in the ethyl-substituted <b>12</b>. Protein carbons: light green, green, lawn green; ligand carbons: gray, dark gray, light gray; and waters: crimson, red, violet red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb">6qdb</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc">6qdc</a>. (C) <b>1</b> and <b>2</b> probing the significance of linear versus cyclic amine extensions from C<sub>2</sub> of the core. The proximal ligand’s binding mode is altered in <b>2</b>, with tilting of the thienopyrimidine core, dual conformations of the C<sub>2</sub> amine extension, and repositioning of the C<sub>4</sub> aminopropionitrile. No distal ligand was observed in the <i>Lm</i>NMT complex with <b>2</b>. Protein carbons: light green or green; ligand carbons: gray, dark gray; and waters: crimson or red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9">6qd9</a>. (D) Chemical structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the modes of binding of selected inhibitors with varied C<sub>4</sub> or C<sub>6</sub> substitution. For clarity, MyrCoA is not shown in the binding site. Stereo renderings can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf" class="ext-link">Figure S4</a>. (A) <b>1</b> and <b>43</b> demonstrate similar binding interactions despite the rigidification of the aminopropionitrile. The distal ligand does not appear, and <b>43</b> demonstrates dual conformations of the C<sub>2</sub> substituent. Protein carbons: light green, green; ligand carbons: gray, dark gray; and waters: crimson, red, violet red. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd">6qdd</a>. (B) Chemical structures of relevant ligands. (C, D) <i>tert-</i>Butyl C<sub>6</sub> substitution is accommodated in the proximal ligands for <b>51</b> and <b>52</b>. However, the distal ligand conformation is inverted in <b>51</b> and dual C<sub>2</sub> conformations are observed in <b>52</b>, which is present at partial occupancy PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde">6qde</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf">6qdf</a>. (E) <b>2</b> and <b>56</b> have analogous binding modes with an additional hydrogen bond in <b>56</b> mediated by the bromine substituent. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg">6qdg</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Plot of pIC<sub>50</sub> against clog <i>P</i>. Diagonal lines represent areas of corresponding lipophilic efficiency (LipE) values. (B) Plot of LipE against selectivity (selectivity = IC<sub>50</sub> (<i>Hs</i>NMT)/IC<sub>50</sub> (<i>Ld</i>NMT)). (C) Schematic representation of fragment merging strategy between <b>3</b> and <b>DDD85646</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> to generate <b>64</b> and related analogues. (D) Crystal structure of <b>1</b> and <b>64</b> in complex with <i>Lm</i>NMT. <b>64</b> principally occupies the site of the proximal ligand in <b>1</b> extending through the sulfonamide group, which forms hydrogen bonds with the <i>Lm</i>NMT backbone amide. PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo">4cgo</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh">6qdh</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Plot of anti-<i>L. donovani</i> amastigote activity (pEC<sub>50</sub>) against macrophage toxicity (normalized area under the curve, nAUC). Thienopyrimidine <b>1</b> is highlighted in blue. (B) Plot of <i>Leishmania</i> NMT pIC<sub>50</sub> (either <i>Ld</i> or <i>Lm</i>) against cell-based pEC<sub>50</sub>. A significant correlation (ρ = 0.75, <i>P</i> = 0.0006) is evident if <b>26</b>, <b>52</b>, and <b>53</b> (highlighted in red) are excluded. Compound <b>1</b> is highlighted in blue. (C–E) In-gel fluorescence and anti-<i>Ld</i>NMT Western blot results for the cell-based tagging assay. (F) Fluorescence intensities of several individual bands between 25 and 15 kDa were quantified in (C–E) and normalized to the corresponding intensities of the control samples (without inhibitor) and the anti-<i>Ld</i>NMT blot results. Tagging IC<sub>50</sub> values (TC<sub>50</sub>) were extracted by nonlinear regression with a sigmoidal dose–response model (constraints: bottom = 0; top = 1.0) to the mean normalized intensity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/medium/jm0c00570_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison between ligands <b>1</b> and <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00570/20200716/images/large/jm0c00570_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00570&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i126">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Guerrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanilla-Cedillo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Esmenjaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenas, R.</span></span> <span> </span><span class="NLM_article-title">Leishmaniasis: A Review</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">750</span>, <span class="refDoi"> DOI: 10.12688/f1000research.11120.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.12688%2Ff1000research.11120.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=28649370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A280%3ADC%252BC1cjhslCqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=750&author=E.+Torres-Guerreroauthor=M.+R.+Quintanilla-Cedilloauthor=J.+Ruiz-Esmenjaudauthor=R.+Arenas&title=Leishmaniasis%3A+A+Review&doi=10.12688%2Ff1000research.11120.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Leishmaniasis: a review</span></div><div class="casAuthors">Torres-Guerrero Edoardo; Ruiz-Esmenjaud Julieta; Arenas Roberto; Quintanilla-Cedillo Marco Romano</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">750</span>
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    </div><div class="casAbstract">Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly.  It is endemic in Asia, Africa, the Americas, and the Mediterranean region.  Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year.  Clinical features depend on the species of Leishmania involved and the immune response of the host.  Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes.  Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnQ1TOyDXtUq2q3xNe7a7QfW6udTcc2eaUaUyhP5XpJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjhslCqug%253D%253D&md5=c0ac5d2b557277a2483d0a3e0e8a07a4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.11120.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.11120.1%26sid%3Dliteratum%253Aachs%26aulast%3DTorres-Guerrero%26aufirst%3DE.%26aulast%3DQuintanilla-Cedillo%26aufirst%3DM.%2BR.%26aulast%3DRuiz-Esmenjaud%26aufirst%3DJ.%26aulast%3DArenas%26aufirst%3DR.%26atitle%3DLeishmaniasis%253A%2520A%2520Review%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D750%26doi%3D10.12688%2Ff1000research.11120.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">WHO</span>, <span> </span><span class="NLM_article-title">Leishmaniasis</span>. <a href="https://www.who.int/news-room/fact-sheets/detail/leishmaniasis" class="extLink">https://www.who.int/news-room/fact-sheets/detail/leishmaniasis</a> (accessed 14 June, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=Leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DLeishmaniasis%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hefnawy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Muylder, G.</span></span> <span> </span><span class="NLM_article-title">Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2016.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.pt.2016.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=27993477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOis7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=162-174&author=A.+Hefnawyauthor=M.+Bergauthor=J.+C.+Dujardinauthor=G.+De+Muylder&title=Exploiting+Knowledge+on+Leishmania+Drug+Resistance+to+Support+the+Quest+for+New+Drugs&doi=10.1016%2Fj.pt.2016.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs</span></div><div class="casAuthors">Hefnawy, Aya; Berg, Maya; Dujardin, Jean-Claude; De Muylder, Geraldine</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-174</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  New drugs are needed to control leishmaniasis and efforts are currently on-going to counter the neglect of this disease.  We discuss here the utility and the impact of assocg. drug resistance (DR) studies to drug discovery pipelines.  We use as paradigm currently used drugs, antimonials and miltefosine, and complement our reflection by interviewing three experts in the field.  We suggest DR studies to be involved at two different stages of drug development: (i) the efficiency of novel compds. should be confirmed on sets of strains including recent clin. isolates with DR; (ii) exptl. DR should be generated to promising compds. at an early stage of their development, to further optimize them and monitor clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyIc1a5RfP27Vg90H21EOLACvtfcHk0lgBL2w21G8hNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOis7vJ&md5=c67220deabbd3550081a4d310f77287f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DHefnawy%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DM.%26aulast%3DDujardin%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BMuylder%26aufirst%3DG.%26atitle%3DExploiting%2520Knowledge%2520on%2520Leishmania%2520Drug%2520Resistance%2520to%2520Support%2520the%2520Quest%2520for%2520New%2520Drugs%26jtitle%3DTrends%2520Parasitol.%26date%3D2017%26volume%3D33%26spage%3D162%26epage%3D174%26doi%3D10.1016%2Fj.pt.2016.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuno, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Potent and Selective Inhibitors of Candida Albicans N-Myristoyltransferase Based on the Benzothiazole Structure</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2509</span>– <span class="NLM_lpage">2522</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.bmc.2005.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=15755653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVart7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2509-2522&author=K.+Yamazakiauthor=Y.+Kanekoauthor=K.+Suwaauthor=S.+Ebaraauthor=K.+Nakazawaauthor=K.+Yasuno&title=Synthesis+of+Potent+and+Selective+Inhibitors+of+Candida+Albicans+N-Myristoyltransferase+Based+on+the+Benzothiazole+Structure&doi=10.1016%2Fj.bmc.2005.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure</span></div><div class="casAuthors">Yamazaki, Kazuo; Kaneko, Yasushi; Suwa, Kie; Ebara, Shinji; Nakazawa, Kyoko; Yasuno, Kazuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2509-2522</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Two parallel synthetic methods using solid-supported reagents were established to examine the rapid optimization of the weak hit compd. 2-diethylaminoethyl 2-cyclohexylcarbonylaminobenzothiazole-5-carboxylate.  Several compds. showed high potency in the low nanomolar range against N-myristoyltransferase.  The structure-activity relationship (SAR) and antifungal activities of a series of novel 2-aminobenzothiazole N-myristoyltransferase inhibitors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiovNeHmSaVbVg90H21EOLACvtfcHk0lgBL2w21G8hNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVart7o%253D&md5=bf860571e821b3bf7d4e67a8473f6349</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DSuwa%26aufirst%3DK.%26aulast%3DEbara%26aufirst%3DS.%26aulast%3DNakazawa%26aufirst%3DK.%26aulast%3DYasuno%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Candida%2520Albicans%2520N-Myristoyltransferase%2520Based%2520on%2520the%2520Benzothiazole%2520Structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2509%26epage%3D2522%26doi%3D10.1016%2Fj.bmc.2005.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimi, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aalten, D. M. F.</span></span> <span> </span><span class="NLM_article-title">N -Myristoyltransferase Is a Cell Wall Target in Aspergillus Fumigatus</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1434</span>, <span class="refDoi"> DOI: 10.1021/cb5008647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5008647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1425-1434&author=W.+Fangauthor=D.+A.+Robinsonauthor=O.+G.+Raimiauthor=D.+E.+Blairauthor=J.+R.+Harrisonauthor=D.+E.+A.+Lockhartauthor=L.+S.+Torrieauthor=G.+F.+Rudaauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=D.+M.+F.+Van+Aalten&title=N+-Myristoyltransferase+Is+a+Cell+Wall+Target+in+Aspergillus+Fumigatus&doi=10.1021%2Fcb5008647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">N-Myristoyltransferase Is a Cell Wall Target in Aspergillus fumigatus</span></div><div class="casAuthors">Fang, Wenxia; Robinson, David A.; Raimi, Olawale G.; Blair, David E.; Harrison, Justin R.; Lockhart, Deborah E. A.; Torrie, Leah S.; Ruda, Gian Filippo; Wyatt, Paul G.; Gilbert, Ian H.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1425-1434</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of filamentous fungal infections relies on a limited repertoire of antifungal agents.  Compds. possessing novel modes of action are urgently required.  N-myristoylation is a ubiquitous modification of eukaryotic proteins.  The enzyme N-myristoyltransferase (NMT) has been considered a potential therapeutic target in protozoa and yeasts.  Here, we show that the filamentous fungal pathogen Aspergillus fumigatus possesses an active NMT enzyme that is essential for survival.  Surprisingly, partial repression of the gene revealed downstream effects of N-myristoylation on cell wall morphol.  Screening a library of inhibitors led to the discovery of a pyrazole sulfonamide compd. that inhibits the enzyme and is fungicidal under partially repressive nmt conditions.  Together with a crystallog. complex showing the inhibitor binding in the peptide substrate pocket, we provide evidence of NMT being a potential drug target in A. fumigatus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGSigS5kyRHrVg90H21EOLACvtfcHk0lgBL2w21G8hNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCqu7k%253D&md5=4667bd95c423ab3d9df251cc6f0850e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcb5008647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5008647%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DW.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DRaimi%26aufirst%3DO.%2BG.%26aulast%3DBlair%26aufirst%3DD.%2BE.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DLockhart%26aufirst%3DD.%2BE.%2BA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DN%2520-Myristoyltransferase%2520Is%2520a%2520Cell%2520Wall%2520Target%2520in%2520Aspergillus%2520Fumigatus%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1425%26epage%3D1434%26doi%3D10.1021%2Fcb5008647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowyer, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaratne, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grainger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withers-Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramsinghe, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Molecules Incorporating a Benzothiazole Core Scaffold Inhibit the N-Myristoyltransferase of Plasmodium Falciparum</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1042/BJ20070692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1042%2FBJ20070692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=17714074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12htbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=173-180&author=P.+W.+Bowyerauthor=R.+S.+Gunaratneauthor=M.+Graingerauthor=C.+Withers-Martinezauthor=S.+R.+Wickramsingheauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrowauthor=K.+A.+Brownauthor=A.+A.+Holderauthor=D.+F.+Smith&title=Molecules+Incorporating+a+Benzothiazole+Core+Scaffold+Inhibit+the+N-Myristoyltransferase+of+Plasmodium+Falciparum&doi=10.1042%2FBJ20070692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum</span></div><div class="casAuthors">Bowyer, Paul W.; Gunaratne, Ruwani S.; Grainger, Munira; Withers-martinez, Chrislaine; Wickramsinghe, Sasala R.; Tate, Edward W.; Leatherbarrow, Robin J.; Brown, Katherine A.; Holder, Anthony A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Recombinant N-myristoyltransferase of Plasmodium falciparum (termed PfNMT) has been used in the development of a SPA (scintillation proximity assay) suitable for automation and high-throughput screening of inhibitors against this enzyme.  The ability to use the SPA has been facilitated by development of an expression and purifn. system which yields considerably improved quantities of sol. active recombinant PfNMT compared with previous studies.  Specifically, yields of pure protein have been increased from 12 μg/l-1 to >400 μg/l-1 by use of a synthetic gene with codon usage optimized for expression in an Escherichia coli host.  Preliminary small-scale piggyback' inhibitor studies using the SPA have identified a family of related mols. contg. a core benzothiazole scaffold with IC50 values <50 μM, which demonstrate selectivity over human NMT1.  Two of these compds., when tested against cultured parasites in vitro, reduced parasitemia by >80% at a concn. of 10 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8mk72sryUELVg90H21EOLACvtfcHk0lhzGtEG_h4zFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12htbvF&md5=961c56e6858fcfa4079b948ba73eef20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBJ20070692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070692%26sid%3Dliteratum%253Aachs%26aulast%3DBowyer%26aufirst%3DP.%2BW.%26aulast%3DGunaratne%26aufirst%3DR.%2BS.%26aulast%3DGrainger%26aufirst%3DM.%26aulast%3DWithers-Martinez%26aufirst%3DC.%26aulast%3DWickramsinghe%26aufirst%3DS.%2BR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DMolecules%2520Incorporating%2520a%2520Benzothiazole%2520Core%2520Scaffold%2520Inhibit%2520the%2520N-Myristoyltransferase%2520of%2520Plasmodium%2520Falciparum%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D173%26epage%3D180%26doi%3D10.1042%2FBJ20070692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzozowski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Inhibitors of Plasmodium Falciparum N -Myristoyltransferase, a Promising Target for Antimalarial Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8879</span>– <span class="NLM_lpage">8890</span>, <span class="refDoi"> DOI: 10.1021/jm301160h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301160h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8879-8890&author=Z.+Yuauthor=J.+A.+Branniganauthor=D.+K.+Mossauthor=A.+M.+Brzozowskiauthor=A.+J.+Wilkinsonauthor=A.+A.+Holderauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=Design+and+Synthesis+of+Inhibitors+of+Plasmodium+Falciparum+N+-Myristoyltransferase%2C+a+Promising+Target+for+Antimalarial+Drug+Discovery&doi=10.1021%2Fjm301160h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Inhibitors of Plasmodium falciparum N-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery</span></div><div class="casAuthors">Yu, Zhiyong; Brannigan, James A.; Moss, David K.; Brzozowski, A. Marek; Wilkinson, Anthony J.; Holder, Anthony A.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8879-8890</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum, the most lethal species of parasites that cause malaria, is described.  Chem.-driven optimization of compd. I from a focused NMT inhibitor library led to the identification of two early lead compds. II and III, which showed good enzyme and cellular potency and excellent selectivity over human NMT.  These mols. provide a valuable starting point for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDwmbhk3x2uLVg90H21EOLACvtfcHk0lhzGtEG_h4zFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtb7P&md5=3b349ac1ad5c8b8afb9e11ed8c7e2cfe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm301160h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301160h%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DMoss%26aufirst%3DD.%2BK.%26aulast%3DBrzozowski%26aufirst%3DA.%2BM.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520N%2520-Myristoyltransferase%252C%2520a%2520Promising%2520Target%2520for%2520Antimalarial%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8879%26epage%3D8890%26doi%3D10.1021%2Fjm301160h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rackham, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangachari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of High Affinity Inhibitors of Plasmodium Falciparum and <i>Plasmodium Vivax</i> N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2773</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/jm500066b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500066b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Grsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2773-2788&author=M.+D.+Rackhamauthor=J.+A.+Branniganauthor=K.+Rangachariauthor=S.+Meisterauthor=A.+J.+Wilkinsonauthor=A.+A.+Holderauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Design+and+Synthesis+of+High+Affinity+Inhibitors+of+Plasmodium+Falciparum+and+Plasmodium+Vivax+N-Myristoyltransferases+Directed+by+Ligand+Efficiency+Dependent+Lipophilicity+%28LELP%29&doi=10.1021%2Fjm500066b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)</span></div><div class="casAuthors">Rackham, Mark D.; Brannigan, James A.; Rangachari, Kaveri; Meister, Stephan; Wilkinson, Anthony J.; Holder, Anthony A.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2773-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is an essential eukaryotic enzyme and an attractive drug target in parasitic infections such as malaria.  We have previously reported that 2-(3-(piperidin-4-yloxy)benzo[b]thiophen-2-yl)-5-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)-1,3,4-oxadiazole (34c) is a high affinity inhibitor of both Plasmodium falciparum and P. vivax NMT and displays activity in vivo against a rodent malaria model.  Here we describe the discovery of 34c through optimization of a previously described series.  Development, guided by targeting a ligand efficiency dependent lipophilicity (LELP) score of less than 10, yielded a 100-fold increase in enzyme affinity and a 100-fold drop in lipophilicity with the addn. of only two heavy atoms. 34c was found to be equipotent on chloroquine-sensitive and -resistant cell lines and on both blood and liver stage forms of the parasite.  These data further validate NMT as an exciting drug target in malaria and support 34c as an attractive tool for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFfIYppTWcLrVg90H21EOLACvtfcHk0lhcKiByCdapmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Grsbg%253D&md5=517fb7c912426fc2812f19fa43daed1f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm500066b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500066b%26sid%3Dliteratum%253Aachs%26aulast%3DRackham%26aufirst%3DM.%2BD.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRangachari%26aufirst%3DK.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520High%2520Affinity%2520Inhibitors%2520of%2520Plasmodium%2520Falciparum%2520and%2520Plasmodium%2520Vivax%2520N-Myristoyltransferases%2520Directed%2520by%2520Ligand%2520Efficiency%2520Dependent%2520Lipophilicity%2520%2528LELP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2773%26epage%3D2788%26doi%3D10.1021%2Fjm500066b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlott, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayclin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reers, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn-Flynn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuepfer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons-Abbott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">1000.e7</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.chembiol.2019.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=31080074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=991-1000.e7&author=A.+C.+Schlottauthor=S.+Mayclinauthor=A.+R.+Reersauthor=O.+Coburn-Flynnauthor=A.+S.+Bellauthor=J.+Greenauthor=E.+Knuepferauthor=D.+Charterauthor=R.+Bonnertauthor=B.+Campoauthor=J.+Burrowsauthor=S.+Lyons-Abbottauthor=B.+L.+Stakerauthor=C.+W.+Chungauthor=P.+J.+Mylerauthor=D.+A.+Fidockauthor=E.+W.+Tateauthor=A.+A.+Holder&title=Structure-Guided+Identification+of+Resistance+Breaking+Antimalarial+N-Myristoyltransferase+Inhibitors&doi=10.1016%2Fj.chembiol.2019.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Schlott, Anja C.; Mayclin, Stephen; Reers, Alexandra R.; Coburn-Flynn, Olivia; Bell, Andrew S.; Green, Judith; Knuepfer, Ellen; Charter, David; Bonnert, Roger; Campo, Brice; Burrows, Jeremy; Lyons-Abbott, Sally; Staker, Bart L.; Chung, Chun-Wa; Myler, Peter J.; Fidock, David A.; Tate, Edward W.; Holder, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">991-1000.e7</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The attachment of myristate to the N-terminal glycine of certain proteins is largely a co-translational modification catalyzed by N-myristoyltransferase (NMT), and involved in protein membrane-localization.  Pathogen NMT is a validated therapeutic target in numerous infectious diseases including malaria.  In Plasmodium falciparum, NMT substrates are important in essential processes including parasite gliding motility and host cell invasion.  Here, we generated parasites resistant to a particular NMT inhibitor series and show that resistance in an in vitro parasite growth assay is mediated by a single amino acid substitution in the NMT substrate-binding pocket.  The basis of resistance was validated and analyzed with a structure-guided approach using crystallog., in combination with enzyme activity, stability, and surface plasmon resonance assays, allowing identification of another inhibitor series unaffected by this substitution.  We suggest that resistance studies incorporated early in the drug development process help selection of drug combinations to impede rapid evolution of parasite resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ-7mY33rcILVg90H21EOLACvtfcHk0lhcKiByCdapmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOktLs%253D&md5=821549b1cfc56a643b68f0a464ba91c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DSchlott%26aufirst%3DA.%2BC.%26aulast%3DMayclin%26aufirst%3DS.%26aulast%3DReers%26aufirst%3DA.%2BR.%26aulast%3DCoburn-Flynn%26aufirst%3DO.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DKnuepfer%26aufirst%3DE.%26aulast%3DCharter%26aufirst%3DD.%26aulast%3DBonnert%26aufirst%3DR.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DLyons-Abbott%26aufirst%3DS.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26atitle%3DStructure-Guided%2520Identification%2520of%2520Resistance%2520Breaking%2520Antimalarial%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D991%26epage%3D1000.e7%26doi%3D10.1016%2Fj.chembiol.2019.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansell, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>Plasmodium Vivax</i> N -Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of Their Binding Mode</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3578</span>– <span class="NLM_lpage">3582</span>, <span class="refDoi"> DOI: 10.1021/jm300040p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300040p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVKgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3578-3582&author=V.+Goncalvesauthor=J.+A.+Branniganauthor=D.+Whalleyauthor=K.+H.+Ansellauthor=B.+Saxtyauthor=A.+A.+Holderauthor=A.+J.+Wilkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=Discovery+of+Plasmodium+Vivax+N+-Myristoyltransferase+Inhibitors%3A+Screening%2C+Synthesis%2C+and+Structural+Characterization+of+Their+Binding+Mode&doi=10.1021%2Fjm300040p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Plasmodium vivax N-Myristoyltransferase Inhibitors: Screening, Synthesis, and Structural Characterization of their Binding Mode</span></div><div class="casAuthors">Goncalves, Victor; Brannigan, James A.; Whalley, David; Ansell, Keith H.; Saxty, Barbara; Holder, Anthony A.; Wilkinson, Anthony J.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3578-3582</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is a prospective drug target against parasitic protozoa.  Herein we report the successful discovery of a series of Plasmodium vivax NMT inhibitors by high-throughput screening.  A high-resoln. crystal structure of the hit compd. in complex with NMT was obtained, allowing understanding of its novel binding mode.  A set of analogs was designed and tested to define the chem. groups relevant for activity and selectivity.  Compd. 7 (I) was identified which exhibits micromolar activity against PvNMT, some selectivity over human NMT isoforms, and improved lead-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQffTqfTp5rLVg90H21EOLACvtfcHk0lhstBmNn-fP8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVKgtbc%253D&md5=0e42a947e40a044763db187bea7fb76e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm300040p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300040p%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWhalley%26aufirst%3DD.%26aulast%3DAnsell%26aufirst%3DK.%2BH.%26aulast%3DSaxty%26aufirst%3DB.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DDiscovery%2520of%2520Plasmodium%2520Vivax%2520N%2520-Myristoyltransferase%2520Inhibitors%253A%2520Screening%252C%2520Synthesis%252C%2520and%2520Structural%2520Characterization%2520of%2520Their%2520Binding%2520Mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3578%26epage%3D3582%26doi%3D10.1021%2Fjm300040p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guther, M. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mpamhanga, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimi, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aalten, D. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Inhibitors as New Leads to Treat Sleeping Sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>464</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1038/nature08893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fnature08893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20360736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=728-732&author=J.+A.+Frearsonauthor=S.+Brandauthor=S.+P.+McElroyauthor=L.+A.+T.+Cleghornauthor=O.+Smidauthor=L.+Stojanovskiauthor=H.+P.+Priceauthor=M.+L.+S.+Gutherauthor=L.+S.+Torrieauthor=D.+A.+Robinsonauthor=I.+Hallyburtonauthor=C.+P.+Mpamhangaauthor=J.+A.+Branniganauthor=A.+J.+Wilkinsonauthor=M.+Hodgkinsonauthor=R.+Huiauthor=W.+Qiuauthor=O.+G.+Raimiauthor=D.+M.+F.+Van+Aaltenauthor=R.+Brenkauthor=I.+H.+Gilbertauthor=K.+D.+Readauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+F.+Smithauthor=P.+G.+Wyatt&title=N-Myristoyltransferase+Inhibitors+as+New+Leads+to+Treat+Sleeping+Sickness&doi=10.1038%2Fnature08893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">N-myristoyltransferase inhibitors as new leads to treat sleeping sickness</span></div><div class="casAuthors">Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Price, Helen P.; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brannigan, James A.; Wilkinson, Anthony J.; Hodgkinson, Michael; Hui, Raymond; Qiu, Wei; Raimi, Olawale G.; van Aalten, Daan M. F.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Smith, Deborah F.; Wyatt, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">464</span>
        (<span class="NLM_cas:issue">7289</span>),
    <span class="NLM_cas:pages">728-732</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">African sleeping sickness or human African trypanosomiasis, caused by Trypanosoma brucei spp., is responsible for ∼30,000 deaths each year.  Available treatments for this disease are poor, with unacceptable efficacy and safety profiles, particularly in the late stage of the disease when the parasite has infected the central nervous system.  Here we report the validation of a mol. target and the discovery of assocd. lead compds. with the potential to address this lack of suitable treatments.  Inhibition of this target-T. brucei N-myristoyltransferase-leads to rapid killing of trypanosomes both in vitro and in vivo and cures trypanosomiasis in mice.  These high-affinity inhibitors bind into the peptide substrate pocket of the enzyme and inhibit protein N-myristoylation in trypanosomes.  The compds. identified have promising pharmaceutical properties and represent an opportunity to develop oral drugs to treat this devastating disease.  Our studies validate T. brucei N-myristoyltransferase as a promising therapeutic target for human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKBgE_K-1Bz7Vg90H21EOLACvtfcHk0lhstBmNn-fP8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVygsLc%253D&md5=5db60f35545c2d8ebaf3eb56c7a32a30</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature08893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08893%26sid%3Dliteratum%253Aachs%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DSmid%26aufirst%3DO.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DGuther%26aufirst%3DM.%2BL.%2BS.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DMpamhanga%26aufirst%3DC.%2BP.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DHodgkinson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DR.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DRaimi%26aufirst%3DO.%2BG.%26aulast%3DVan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DN-Myristoyltransferase%2520Inhibitors%2520as%2520New%2520Leads%2520to%2520Treat%2520Sleeping%2520Sickness%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D728%26epage%3D732%26doi%3D10.1038%2Fnature08893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luksch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collie, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Development of Small-Molecule Trypanosoma Brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1836</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1002%2Fcmdc.201500301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=26395087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1821-1836&author=D.+Spinksauthor=V.+Smithauthor=S.+Thompsonauthor=D.+A.+Robinsonauthor=T.+Lukschauthor=A.+Smithauthor=L.+S.+Torrieauthor=S.+McElroyauthor=L.+Stojanovskiauthor=S.+Norvalauthor=I.+T.+Collieauthor=I.+Hallyburtonauthor=B.+Raoauthor=S.+Brandauthor=R.+Brenkauthor=J.+A.+Frearsonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Development+of+Small-Molecule+Trypanosoma+Brucei+N-Myristoyltransferase+Inhibitors%3A+Discovery+and+Optimisation+of+a+Novel+Binding+Mode&doi=10.1002%2Fcmdc.201500301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode</span></div><div class="casAuthors">Spinks, Daniel; Smith, Victoria; Thompson, Stephen; Robinson, David A.; Luksch, Torsten; Smith, Alasdair; Torrie, Leah S.; McElroy, Stuart; Stojanovski, Laste; Norval, Suzanne; Collie, Iain T.; Hallyburton, Irene; Rao, Bhavya; Brand, Stephen; Brenk, Ruth; Frearson, Julie A.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1821-1836</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The enzyme N-myristoyltransferase (NMT) from Trypanosoma brucei has been validated both chem. and biol. as a potential drug target for human African trypanosomiasis.  The authors previously reported the development of some very potent compds. based around a pyrazole sulfonamide series, derived from a high-throughput screen.  Herein the authors describe work around thiazolidinone and benzomorpholine scaffolds that were also identified in the screen.  An x-ray crystal structure of the thiazolidinone hit in Leishmania major NMT showed the compd. bound in the previously reported active site, utilizing a novel binding mode.  This provides potential for further optimization.  The benzomorpholinone was also found to bind in a similar region.  Using an x-ray crystallog./structure-based design approach, the benzomorpholinone series was further optimized, increasing activity against T. brucei NMT by >1000-fold.  A series of trypanocidal compds. were identified with suitable in vitro DMPK properties, including CNS exposure for further development.  Further work is required to increase selectivity over the human NMT isoform and activity against T. brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowp2OZofB8yLVg90H21EOLACvtfcHk0litqK7bPEHfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFCisb7N&md5=9be34bc0a319086eb5815e032ead0212</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500301%26sid%3Dliteratum%253Aachs%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DB.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDevelopment%2520of%2520Small-Molecule%2520Trypanosoma%2520Brucei%2520N-Myristoyltransferase%2520Inhibitors%253A%2520Discovery%2520and%2520Optimisation%2520of%2520a%2520Novel%2520Binding%2520Mode%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1821%26epage%3D1836%26doi%3D10.1002%2Fcmdc.201500301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma Brucei</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFShtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=427-441&author=M.+H.+Wrightauthor=D.+Paapeauthor=H.+P.+Priceauthor=D.+F.+Smithauthor=E.+W.+Tate&title=Global+Profiling+and+Inhibition+of+Protein+Lipidation+in+Vector+and+Host+Stages+of+the+Sleeping+Sickness+Parasite+Trypanosoma+Brucei&doi=10.1021%2Facsinfecdis.6b00034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei</span></div><div class="casAuthors">Wright, Megan H.; Paape, Daniel; Price, Helen P.; Smith, Deborah F.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">427-441</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme N-myristoyltransferase (NMT) catalyzes the essential fatty acylation of substrate proteins with myristic acid in eukaryotes and is a validated drug target in the parasite Trypanosoma brucei, the causative agent of African trypanosomiasis (sleeping sickness).  N-Myristoylation typically mediates membrane localization of proteins and is essential to the function of many.  However, only a handful of proteins are exptl. validated as N-myristoylated in T. brucei.  Here, we perform metabolic labeling with an alkyne-tagged myristic acid analog, enabling the capture of lipidated proteins in insect and host life stages of T. brucei.  We further compare this with a longer chain palmitate analog to explore the chain length-specific incorporation of fatty acids into proteins.  Finally, we combine the alkynyl-myristate analog with NMT inhibitors and quant. chem. proteomics to globally define N-myristoylated proteins in the clin. relevant bloodstream form parasites.  This anal. reveals five ARF family small GTPases, calpain-like proteins, phosphatases, and many uncharacterized proteins as substrates of NMT in the parasite, providing a global view of the scope of this important protein modification and further evidence for the crucial and pleiotropic role of NMT in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr055pEEov8brVg90H21EOLACvtfcHk0litqK7bPEHfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFShtLc%253D&md5=2489d0851db3a16b67e1efec6d8426b8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00034%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DGlobal%2520Profiling%2520and%2520Inhibition%2520of%2520Protein%2520Lipidation%2520in%2520Vector%2520and%2520Host%2520Stages%2520of%2520the%2520Sleeping%2520Sickness%2520Parasite%2520Trypanosoma%2520Brucei%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D427%26epage%3D441%26doi%3D10.1021%2Facsinfecdis.6b00034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swieboda, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Dorado, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedán, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asfor, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins-Navratilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuthill, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Fragment-Derived Inhibitors of Human N-Myristoyltransferase Block Capsid Assembly and Replication of the Common Cold Virus</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0039-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fs41557-018-0039-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=29760414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=599-606&author=A.+Mousnierauthor=A.+S.+Bellauthor=D.+P.+Swiebodaauthor=J.+Morales-Sanfrutosauthor=I.+P%C3%A9rez-Doradoauthor=J.+A.+Branniganauthor=J.+Newmanauthor=M.+Ritzefeldauthor=J.+A.+Huttonauthor=A.+Gued%C3%A1nauthor=A.+S.+Asforauthor=S.+W.+Robinsonauthor=I.+Hopkins-Navratilovaauthor=A.+J.+Wilkinsonauthor=S.+L.+Johnstonauthor=R.+J.+Leatherbarrowauthor=T.+J.+Tuthillauthor=R.+Solariauthor=E.+W.+Tate&title=Fragment-Derived+Inhibitors+of+Human+N-Myristoyltransferase+Block+Capsid+Assembly+and+Replication+of+the+Common+Cold+Virus&doi=10.1038%2Fs41557-018-0039-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus</span></div><div class="casAuthors">Mousnier, Aurelie; Bell, Andrew S.; Swieboda, Dawid P.; Morales-Sanfrutos, Julia; Perez-Dorado, Inmaculada; Brannigan, James A.; Newman, Joseph; Ritzefeld, Markus; Hutton, Jennie A.; Guedan, Anabel; Asfor, Amin S.; Robinson, Sean W.; Hopkins-Navratilova, Iva; Wilkinson, Anthony J.; Johnston, Sebastian L.; Leatherbarrow, Robin J.; Tuthill, Tobias J.; Solari, Roberto; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Rhinoviruses (RVs) are the pathogens most often responsible for the common cold, and are a frequent cause of exacerbations in asthma, chronic obstructive pulmonary disease and cystic fibrosis.  Here we report the discovery of IMP-1088, a picomolar dual inhibitor of the human N-myristoyltransferases NMT1 and NMT2, and use it to demonstrate that pharmacol. inhibition of host-cell N-myristoylation rapidly and completely prevents rhinoviral replication without inducing cytotoxicity.  The identification of cooperative binding between weak-binding fragments led to rapid inhibitor optimization through fragment reconstruction, structure-guided fragment linking and conformational control over linker geometry.  We show that inhibition of the co-translational myristoylation of a specific virus-encoded protein (VP0) by IMP-1088 potently blocks a key step in viral capsid assembly, to deliver a low nanomolar antiviral activity against multiple RV strains, poliovirus and foot and-mouth disease virus, and protection of cells against virus-induced killing, highlighting the potential of host myristoylation as a drug target in picornaviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfyeVtScn0oLVg90H21EOLACvtfcHk0litqK7bPEHfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KktLY%253D&md5=4142792d359c5344041c1f28b7cb813f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0039-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0039-2%26sid%3Dliteratum%253Aachs%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DSwieboda%26aufirst%3DD.%2BP.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Dorado%26aufirst%3DI.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGued%25C3%25A1n%26aufirst%3DA.%26aulast%3DAsfor%26aufirst%3DA.%2BS.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DHopkins-Navratilova%26aufirst%3DI.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DJohnston%26aufirst%3DS.%2BL.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTuthill%26aufirst%3DT.%2BJ.%26aulast%3DSolari%26aufirst%3DR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DFragment-Derived%2520Inhibitors%2520of%2520Human%2520N-Myristoyltransferase%2520Block%2520Capsid%2520Assembly%2520and%2520Replication%2520of%2520the%2520Common%2520Cold%2520Virus%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D599%26epage%3D606%26doi%3D10.1038%2Fs41557-018-0039-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbic
Ramljak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Real-Hohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redlberger-Fritz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihovilovic, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, H.</span></span> <span> </span><span class="NLM_article-title">Cellular N-Myristoyltransferases Play a Crucial Picornavirus Genus-Specific Role in Viral Assembly, Virion Maturation, and Infectivity</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1007203</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1007203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.ppat.1007203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=30080883" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=I.+Corbic%0ARamljakauthor=J.+Stangerauthor=A.+Real-Hohnauthor=D.+Dreierauthor=L.+Wimmerauthor=M.+Redlberger-Fritzauthor=W.+Fischlauthor=K.+Klingelauthor=M.+D.+Mihovilovicauthor=D.+Blaasauthor=H.+Kowalski&title=Cellular+N-Myristoyltransferases+Play+a+Crucial+Picornavirus+Genus-Specific+Role+in+Viral+Assembly%2C+Virion+Maturation%2C+and+Infectivity&doi=10.1371%2Fjournal.ppat.1007203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1007203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1007203%26sid%3Dliteratum%253Aachs%26aulast%3DCorbic%2BRamljak%26aufirst%3DI.%26aulast%3DStanger%26aufirst%3DJ.%26aulast%3DReal-Hohn%26aufirst%3DA.%26aulast%3DDreier%26aufirst%3DD.%26aulast%3DWimmer%26aufirst%3DL.%26aulast%3DRedlberger-Fritz%26aufirst%3DM.%26aulast%3DFischl%26aufirst%3DW.%26aulast%3DKlingel%26aufirst%3DK.%26aulast%3DMihovilovic%26aufirst%3DM.%2BD.%26aulast%3DBlaas%26aufirst%3DD.%26aulast%3DKowalski%26aufirst%3DH.%26atitle%3DCellular%2520N-Myristoyltransferases%2520Play%2520a%2520Crucial%2520Picornavirus%2520Genus-Specific%2520Role%2520in%2520Viral%2520Assembly%252C%2520Virion%2520Maturation%252C%2520and%2520Infectivity%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1007203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seaton, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Isozymes Exhibit Differential Specificity for Human Immunodeficiency Virus Type 1 Gag and Nef</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1099/vir.0.83412-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1099%2Fvir.0.83412-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=18089753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Wntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2008&pages=288-296&author=K.+E.+Seatonauthor=C.+D.+Smith&title=N-Myristoyltransferase+Isozymes+Exhibit+Differential+Specificity+for+Human+Immunodeficiency+Virus+Type+1+Gag+and+Nef&doi=10.1099%2Fvir.0.83412-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">N-myristoyltransferase isozymes exhibit differential specificity for Human immunodeficiency virus type 1 Gag and Nef</span></div><div class="casAuthors">Seaton, Kelly E.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">288-296</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Myristoylation of the human immunodeficiency virus type 1 (HIV-1) proteins Gag and Nef by N-myristoyltransferase (NMT) is a key process in retroviral replication and virulence, yet remains incompletely characterized.  Therefore, the roles of the two isoenzymes, NMT1 and NMT2, in myristoylating Gag and Nef were examd. using biochem. and mol. approaches.  Fluorescently labeled peptides corresponding to the N terminus of HIV-1 Gag or Nef were myristoylated by recombinant human NMT1 and NMT2.  Kinetic analyses indicated that NMT1 and NMT2 had 30- and 130-fold lower Km values for Nef than Gag, resp.  Values for Kcat indicated that, once Gag or Nef binds to the enzyme, myristoylation by NMT1 and NMT2 proceeds at comparable rates.  Furthermore, the catalytic efficiencies for the processing of Gag by NMT1 and NMT2 were equiv.  In contrast, NMT2 had approx. 5-fold higher catalytic efficiency for the myristoylation of Nef than NMT1.  Competition expts. confirmed that the Nef peptide acts as a competitive inhibitor for the myristoylation of Gag.  Expts. using full-length recombinant Nef protein also indicated a lower Km for Nef myristoylation by NMT2 than NMT1.  Small interfering RNAs were used to selectively deplete NMT1 and/or NMT2 from HEK293T cells expressing a recombinant Nef-sgGFP fusion protein.  Depletion of NMT1 had minimal effect on the intracellular distribution of Nef-sgGFP, whereas depletion of NMT2 altered distribution to a diffuse, widespread pattern, mimicking that of a myristoylation-deficient mutant of Nef-sgGFP.  Together, these findings indicate that Nef is preferentially myristoylated by NMT2, suggesting that selective inhibition of NMT2 may provide a novel means of blocking HIV virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk4o_H805gv7Vg90H21EOLACvtfcHk0liyrc1pB4JA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Wntg%253D%253D&md5=ac74a45fb79eea2313ae6b643e442aa9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.83412-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.83412-0%26sid%3Dliteratum%253Aachs%26aulast%3DSeaton%26aufirst%3DK.%2BE.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DN-Myristoyltransferase%2520Isozymes%2520Exhibit%2520Differential%2520Specificity%2520for%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Gag%2520and%2520Nef%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2008%26volume%3D89%26spage%3D288%26epage%3D296%26doi%3D10.1099%2Fvir.0.83412-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2176</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00371</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00371" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFyks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2165-2176&author=E.+Thinonauthor=J.+Morales-Sanfrutosauthor=D.+J.+Mannauthor=E.+W.+Tate&title=N-Myristoyltransferase+Inhibition+Induces+ER-Stress%2C+Cell+Cycle+Arrest%2C+and+Apoptosis+in+Cancer+Cells&doi=10.1021%2Facschembio.6b00371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells</span></div><div class="casAuthors">Thinon, Emmanuelle; Morales-Sanfrutos, Julia; Mann, David J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2165-2176</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) covalently attaches a C14 fatty acid to the N-terminal glycine of proteins and has been proposed as a therapeutic target in cancer.  We have recently shown that selective NMT inhibition leads to dose-responsive loss of N-myristoylation on more than 100 protein targets in cells, and cytotoxicity in cancer cells.  N-myristoylation lies upstream of multiple pro-proliferative and oncogenic pathways, but to date the complex substrate specificity of NMT has limited detn. of which diseases are most likely to respond to a selective NMT inhibitor.  We describe here the phenotype of NMT inhibition in HeLa cells and show that cells die through apoptosis following or concurrent with accumulation in the G1 phase.  We used quant. proteomics to map protein expression changes for more than 2700 proteins in response to treatment with an NMT inhibitor in HeLa cells and obsd. down-regulation of proteins involved in cell cycle regulation and up-regulation of proteins involved in the endoplasmic reticulum stress and unfolded protein response, with similar results in breast (MCF-7, MDA-MB-231) and colon (HCT116) cancer cell lines.  This study describes the cellular response to NMT inhibition at the proteome level and provides a starting point for selective targeting of specific diseases with NMT inhibitors, potentially in combination with other targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsx982a2u77Vg90H21EOLACvtfcHk0liyrc1pB4JA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFyks70%253D&md5=85f860a55bb8e14c8a8a25f693c92492</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00371%26sid%3Dliteratum%253Aachs%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DD.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DN-Myristoyltransferase%2520Inhibition%2520Induces%2520ER-Stress%252C%2520Cell%2520Cycle%2520Arrest%252C%2520and%2520Apoptosis%2520in%2520Cancer%2520Cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D2165%26epage%3D2176%26doi%3D10.1021%2Facschembio.6b00371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrovandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingold, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grocin, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier
da Silva, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzilius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buday, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanninger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohana, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proneth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span> <span> </span><span class="NLM_article-title">FSP1 Is a Glutathione-Independent Ferroptosis Suppressor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1707-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fs41586-019-1707-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=31634899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGns7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=693-698&author=S.+Dollauthor=F.+P.+Freitasauthor=R.+Shahauthor=M.+Aldrovandiauthor=M.+C.+da+Silvaauthor=I.+Ingoldauthor=A.+G.+Grocinauthor=T.+N.+Xavier%0Ada+Silvaauthor=E.+Panziliusauthor=C.+H.+Scheelauthor=A.+Mour%C3%A3oauthor=K.+Budayauthor=M.+Satoauthor=J.+Wanningerauthor=T.+Vignaneauthor=V.+Mohanaauthor=M.+Rehbergauthor=A.+Flatleyauthor=A.+Schepersauthor=A.+Kurzauthor=D.+Whiteauthor=M.+Sauerauthor=M.+Sattlerauthor=E.+W.+Tateauthor=W.+Schmitzauthor=A.+Schulzeauthor=V.+O%E2%80%99Donnellauthor=B.+Pronethauthor=G.+M.+Popowiczauthor=D.+A.+Prattauthor=J.+P.+F.+Angeliauthor=M.+Conrad&title=FSP1+Is+a+Glutathione-Independent+Ferroptosis+Suppressor&doi=10.1038%2Fs41586-019-1707-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">FSP1 is a glutathione-independent ferroptosis suppressor</span></div><div class="casAuthors">Doll, Sebastian; Freitas, Florencio Porto; Shah, Ron; Aldrovandi, Maceler; da Silva, Milene Costa; Ingold, Irina; Grocin, Andrea Goya; Xavier da Silva, Thamara Nishida; Panzilius, Elena; Scheel, Christina H.; Mourao, Andre; Buday, Katalin; Sato, Mami; Wanninger, Jonas; Vignane, Thibaut; Mohana, Vaishnavi; Rehberg, Markus; Flatley, Andrew; Schepers, Aloys; Kurz, Andreas; White, Daniel; Sauer, Markus; Sattler, Michael; Tate, Edward William; Schmitz, Werner; Schulze, Almut; O'Donnell, Valerie; Proneth, Bettina; Popowicz, Grzegorz M.; Pratt, Derek A.; Angeli, Jose Pedro Friedmann; Conrad, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7784</span>),
    <span class="NLM_cas:pages">693-698</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ferroptosis is an iron-dependent form of necrotic cell death marked by oxidative damage to phospholipids1,2.  To date, ferroptosis has been thought to be controlled only by the phospholipid hydroperoxide-reducing enzyme glutathione peroxidase 4 (GPX4)3,4 and radical-trapping antioxidants5,6.  However, elucidation of the factors that underlie the sensitivity of a given cell type to ferroptosis7 is crucial to understand the pathophysiol. role of ferroptosis and how it may be exploited for the treatment of cancer.  Although metabolic constraints8 and phospholipid compn.9,10 contribute to ferroptosis sensitivity, no cell-autonomous mechanisms have been identified that account for the resistance of cells to ferroptosis.  Here we used an expression cloning approach to identify genes in human cancer cells that are able to complement the loss of GPX4.  We found that the flavoprotein apoptosis-inducing factor mitochondria-assocd. 2 (AIFM2) is a previously unrecognized anti-ferroptotic gene.  AIFM2, which we renamed ferroptosis suppressor protein 1 (FSP1) and which was initially described as a pro-apoptotic gene11, confers protection against ferroptosis elicited by GPX4 deletion.  We further demonstrate that the suppression of ferroptosis by FSP1 is mediated by ubiquinone (also known as coenzyme Q10, CoQ10): the reduced form, ubiquinol, traps lipid peroxyl radicals that mediate lipid peroxidn., whereas FSP1 catalyzes the regeneration of CoQ10 using NAD(P)H.  Pharmacol. targeting of FSP1 strongly synergizes with GPX4 inhibitors to trigger ferroptosis in a no. of cancer entities.  In conclusion, the FSP1-CoQ10-NAD(P)H pathway exists as a stand-alone parallel system, which cooperates with GPX4 and glutathione to suppress phospholipid peroxidn. and ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN0FWYxjRsH7Vg90H21EOLACvtfcHk0lgeeKzyjrKQ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGns7vN&md5=3ccdfb47945f58d40798f6fb0efd0439</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1707-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1707-0%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%26aufirst%3DS.%26aulast%3DFreitas%26aufirst%3DF.%2BP.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DAldrovandi%26aufirst%3DM.%26aulast%3Dda%2BSilva%26aufirst%3DM.%2BC.%26aulast%3DIngold%26aufirst%3DI.%26aulast%3DGrocin%26aufirst%3DA.%2BG.%26aulast%3DXavier%2Bda%2BSilva%26aufirst%3DT.%2BN.%26aulast%3DPanzilius%26aufirst%3DE.%26aulast%3DScheel%26aufirst%3DC.%2BH.%26aulast%3DMour%25C3%25A3o%26aufirst%3DA.%26aulast%3DBuday%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DWanninger%26aufirst%3DJ.%26aulast%3DVignane%26aufirst%3DT.%26aulast%3DMohana%26aufirst%3DV.%26aulast%3DRehberg%26aufirst%3DM.%26aulast%3DFlatley%26aufirst%3DA.%26aulast%3DSchepers%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DSauer%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSchmitz%26aufirst%3DW.%26aulast%3DSchulze%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DV.%26aulast%3DProneth%26aufirst%3DB.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DConrad%26aufirst%3DM.%26atitle%3DFSP1%2520Is%2520a%2520Glutathione-Independent%2520Ferroptosis%2520Suppressor%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D693%26epage%3D698%26doi%3D10.1038%2Fs41586-019-1707-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetaud, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvillier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, G.</span></span> <span> </span><span class="NLM_article-title">The Leishmania ARL-1 and Golgi Traffic</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e1620</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0001620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pone.0001620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=18286177" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&author=A.+Sahinauthor=B.+Espiauauthor=E.+Tetaudauthor=A.+Cuvillierauthor=L.+Lartigueauthor=A.+Ambitauthor=D.+R.+Robinsonauthor=G.+Merlin&title=The+Leishmania+ARL-1+and+Golgi+Traffic&doi=10.1371%2Fjournal.pone.0001620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001620%26sid%3Dliteratum%253Aachs%26aulast%3DSahin%26aufirst%3DA.%26aulast%3DEspiau%26aufirst%3DB.%26aulast%3DTetaud%26aufirst%3DE.%26aulast%3DCuvillier%26aufirst%3DA.%26aulast%3DLartigue%26aufirst%3DL.%26aulast%3DAmbit%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DMerlin%26aufirst%3DG.%26atitle%3DThe%2520Leishmania%2520ARL-1%2520and%2520Golgi%2520Traffic%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26doi%3D10.1371%2Fjournal.pone.0001620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Toole, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seelenmeyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Trafficking and Release of Leishmania Metacyclic HASPB on Macrophage Invasion</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2012.01756.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1111%2Fj.1462-5822.2012.01756.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22256896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVarurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=740-761&author=L.+M.+Macleanauthor=P.+J.+O%E2%80%99Tooleauthor=M.+Starkauthor=J.+Marrisonauthor=C.+Seelenmeyerauthor=W.+Nickelauthor=D.+F.+Smith&title=Trafficking+and+Release+of+Leishmania+Metacyclic+HASPB+on+Macrophage+Invasion&doi=10.1111%2Fj.1462-5822.2012.01756.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion</span></div><div class="casAuthors">MacLean, Lorna M.; O'Toole, Peter J.; Stark, Meg; Marrison, Jo; Seelenmeyer, Claudia; Nickel, Walter; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">740-761</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Proteins of the Leishmania hydrophilic acylated surface protein B (HASPB) family are only expressed in infective parasites (both extra- and intracellular stages) and, together with the peripheral membrane protein SHERP (small hydrophilic endoplasmic reticulum-assocd. protein), are essential for parasite differentiation (metacyclogenesis) in the sand fly vector.  HASPB is a "non-classically" secreted protein, requiring N-terminal acylation for trafficking to and exposure on the plasma membrane.  Here, we use live cell imaging methods to further explore this pathway to the membrane and flagellum.  Unlike HASPB trafficking in transfected mammalian cells, we find no evidence for a phosphorylation-regulated recycling pathway in metacyclic parasites.  Once at the plasma membrane, HASPB18-GFP (green fluorescent protein) can undergo bidirectional movement within the inner leaflet of the membrane and on the flagellum.  Transfer of fluorescent protein between the flagellum and the plasma membrane is compromised, however, suggesting the presence of a diffusion barrier at the base of the Leishmania flagellum.  Full-length HASPB is released from the metacyclic parasite surface on to macrophages during phagocytosis but while expression is maintained in intracellular amastigotes, HASPB cannot be detected on the external surface in these cells.  Thus HASPB may be a dual function protein that is shed by the infective metacyclic but retained internally once Leishmania are taken up by macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCWkpSJ3iemrVg90H21EOLACvtfcHk0lgeeKzyjrKQ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVarurk%253D&md5=20b45fc567cc433601574e49e38fb582</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2012.01756.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2012.01756.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaclean%26aufirst%3DL.%2BM.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DP.%2BJ.%26aulast%3DStark%26aufirst%3DM.%26aulast%3DMarrison%26aufirst%3DJ.%26aulast%3DSeelenmeyer%26aufirst%3DC.%26aulast%3DNickel%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DTrafficking%2520and%2520Release%2520of%2520Leishmania%2520Metacyclic%2520HASPB%2520on%2520Macrophage%2520Invasion%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D740%26epage%3D761%26doi%3D10.1111%2Fj.1462-5822.2012.01756.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Kinetoplastid PPEF Phosphatases: Dual Acylated Proteins Expressed in the Endomembrane System of Leishmania</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.molbiopara.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=17169445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=22-34&author=E.+Millsauthor=H.+P.+Priceauthor=A.+Johnerauthor=J.+E.+Emersonauthor=D.+F.+Smith&title=Kinetoplastid+PPEF+Phosphatases%3A+Dual+Acylated+Proteins+Expressed+in+the+Endomembrane+System+of+Leishmania&doi=10.1016%2Fj.molbiopara.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetoplastid PPEF phosphatases: Dual acylated proteins expressed in the endomembrane system of Leishmania</span></div><div class="casAuthors">Mills, Elena; Price, Helen P.; Johner, Andrea; Emerson, Jenny E.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bioinformatic analyses have been used to identify potential downstream targets of the essential enzyme N-myristoyl transferase in the TriTryp species, Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.  These database searches predict ∼60 putative N-myristoylated proteins with high confidence, including both previously characterized and novel mols.  One of the latter is an N-myristoylated protein phosphatase which has high sequence similarity to the Protein Phosphatase with EF-Hand (PPEF) proteins identified in sensory cells of higher eukaryotes.  In L. major and T. brucei, the PPEF-like phosphatases are encoded by single-copy genes and are constitutively expressed in all parasite life cycle stages.  The N-terminus of LmPPEF is a substrate for N-myristoyl transferase and is also palmitoylated in vivo.  The wild-type protein has been localized to the endocytic system by immunofluorescence.  The catalytic and fused C-terminal domains of the kinetoplastid and other eukaryotic PPEFs share high sequence similarity, but unlike their higher eukaryotic relatives, the C-terminal parasite EF-hand domains are degenerate and do not bind calcium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr90KdS7aFqr7Vg90H21EOLACvtfcHk0lgeeKzyjrKQ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslGmtg%253D%253D&md5=a1a5a3b49872993f1720b552b694e1b1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DE.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DJohner%26aufirst%3DA.%26aulast%3DEmerson%26aufirst%3DJ.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DKinetoplastid%2520PPEF%2520Phosphatases%253A%2520Dual%2520Acylated%2520Proteins%2520Expressed%2520in%2520the%2520Endomembrane%2520System%2520of%2520Leishmania%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2007%26volume%3D152%26spage%3D22%26epage%3D34%26doi%3D10.1016%2Fj.molbiopara.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Global Analysis of Protein N-Myristoylation and Exploration of N-Myristoyltransferase as a Drug Target in the Neglected Human Pathogen <i>Leishmania Donovani</i></span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2015.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.chembiol.2015.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25728269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Omtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=342-354&author=M.+H.+Wrightauthor=D.+Paapeauthor=E.+M.+Storckauthor=R.+A.+Serwaauthor=D.+F.+Smithauthor=E.+W.+Tate&title=Global+Analysis+of+Protein+N-Myristoylation+and+Exploration+of+N-Myristoyltransferase+as+a+Drug+Target+in+the+Neglected+Human+Pathogen+Leishmania+Donovani&doi=10.1016%2Fj.chembiol.2015.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani</span></div><div class="casAuthors">Wright, Megan H.; Paape, Daniel; Storck, Elisabeth M.; Serwa, Remigiusz A.; Smith, Deborah F.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-354</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) modulates protein function through the attachment of the lipid myristate to the N terminus of target proteins, and is a promising drug target in eukaryotic parasites such as Leishmania donovani.  Only a small no. of NMT substrates have been characterized in Leishmania, and a global picture of N-myristoylation is lacking.  Here, the authors use metabolic tagging with an alkyne-functionalized myristic acid mimetic in live parasites followed by downstream click chem. and anal. to identify lipidated proteins in both the promastigote (extracellular) and amastigote (intracellular) life stages.  Quant. chem. proteomics is used to profile target engagement by NMT inhibitors, and to define the complement of N-myristoylated proteins.  The results provide new insight into the multiple pathways modulated by NMT and the pleiotropic effects of NMT inhibition.  This work constitutes the first global exptl. anal. of protein lipidation in Leishmania, and reveals the extent of NMT-related biol. yet to be explored for this neglected human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQ14re-03TrVg90H21EOLACvtfcHk0ljfa02NG4OqsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Omtr4%253D&md5=2c3bedfb259312deeac596c14729bbc3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DStorck%26aufirst%3DE.%2BM.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DGlobal%2520Analysis%2520of%2520Protein%2520N-Myristoylation%2520and%2520Exploration%2520of%2520N-Myristoyltransferase%2520as%2520a%2520Drug%2520Target%2520in%2520the%2520Neglected%2520Human%2520Pathogen%2520Leishmania%2520Donovani%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D342%26epage%3D354%26doi%3D10.1016%2Fj.chembiol.2015.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">New Developments in Probing and Targeting Protein Acylation in Malaria, Leishmaniasis and African Sleeping Sickness</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1017/S0031182017000282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1017%2FS0031182017000282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=28270257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A280%3ADC%252BC1czjvVyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=157-174&author=M.+Ritzefeldauthor=M.+H.+Wrightauthor=E.+W.+Tate&title=New+Developments+in+Probing+and+Targeting+Protein+Acylation+in+Malaria%2C+Leishmaniasis+and+African+Sleeping+Sickness&doi=10.1017%2FS0031182017000282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness</span></div><div class="casAuthors">Ritzefeld Markus; Tate Edward W; Wright Megan H</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-174</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Infections by protozoan parasites, such as Plasmodium falciparum or Leishmania donovani, have a significant health, social and economic impact and threaten billions of people living in tropical and sub-tropical regions of developing countries worldwide.  The increasing range of parasite strains resistant to frontline therapeutics makes the identification of novel drug targets and the development of corresponding inhibitors vital.  Post-translational modifications (PTMs) are important modulators of biology and inhibition of protein lipidation has emerged as a promising therapeutic strategy for treatment of parasitic diseases.  In this review we summarize the latest insights into protein lipidation in protozoan parasites.  We discuss how recent chemical proteomic approaches have delivered the first global overviews of protein lipidation in these organisms, contributing to our understanding of the role of this PTM in critical metabolic and cellular functions.  Additionally, we highlight the development of new small molecule inhibitors to target parasite acyl transferases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx-0MJq_SKUD0SWnHPWbmmfW6udTcc2eY3EzQpC5skXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czjvVyisQ%253D%253D&md5=ed44057998a3b429002b1e138e63058c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1017%2FS0031182017000282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182017000282%26sid%3Dliteratum%253Aachs%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DNew%2520Developments%2520in%2520Probing%2520and%2520Targeting%2520Protein%2520Acylation%2520in%2520Malaria%252C%2520Leishmaniasis%2520and%2520African%2520Sleeping%2520Sickness%26jtitle%3DParasitology%26date%3D2018%26volume%3D145%26spage%3D157%26epage%3D174%26doi%3D10.1017%2FS0031182017000282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doehl, J. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Genetic Validation of Leishmania Genes Essential for Amastigote Survival in Vivo Using N-Myristoyltransferase as a Model</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">132</span>, <span class="refDoi"> DOI: 10.1186/s13071-020-3999-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1186%2Fs13071-020-3999-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=32171322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1SmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=132&author=D.+Paapeauthor=C.+T.+Prendergastauthor=H.+P.+Priceauthor=J.+S.+P.+Doehlauthor=D.+F.+Smith&title=Genetic+Validation+of+Leishmania+Genes+Essential+for+Amastigote+Survival+in+Vivo+Using+N-Myristoyltransferase+as+a+Model&doi=10.1186%2Fs13071-020-3999-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model</span></div><div class="casAuthors">Paape, Daniel; Prendergast, Catriona T.; Price, Helen P.; Doehl, Johannes S. P.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Background: Proving that specific genes are essential for the intracellular viability of Leishmania parasites within macrophages remains a challenge for the identification of suitable targets for drug development.  This is esp. evident in the absence of a robust inducible expression system or functioning RNAi machinery that works in all Leishmania species.  Currently, if a target gene of interest in extracellular parasites can only be deleted from its genomic locus in the presence of ectopic expression from a wild type copy, it is assumed that this gene will also be essential for viability in disease-promoting intracellular parasites.  However, functional essentiality must be proven independently in both life-cycle stages for robust validation of the gene of interest as a putative target for chem. intervention.  Methods: Here, we have used plasmid shuffle methods in vivo to provide supportive genetic evidence that N-myristoyltransferase (NMT) is essential for Leishmania viability throughout the parasite life-cycle.  Following confirmation of NMT essentiality in vector-transmitted promastigotes, a range of mutant parasites were used to infect mice prior to neg. selection pressure to test the hypothesis that NMT is also essential for parasite viability in an established infection.  Results: Ectopically-expressed NMT was only dispensable under neg. selection in the presence of another copy.  Total parasite burdens in animals subjected to neg. selection were comparable to control groups only if an addnl. NMT copy, not affected by the neg. selection, was expressed.  Conclusions: NMT is an essential gene in all parasite life-cycle stages, confirming its role as a genetically-validated target for drug development.[graphic not available: see fulltext].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMoS9IngMkD7Vg90H21EOLACvtfcHk0ljfa02NG4OqsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1SmtL8%253D&md5=e7df52a01258aacca3837689513202e9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2Fs13071-020-3999-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-020-3999-1%26sid%3Dliteratum%253Aachs%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DPrendergast%26aufirst%3DC.%2BT.%26aulast%3DPrice%26aufirst%3DH.%2BP.%26aulast%3DDoehl%26aufirst%3DJ.%2BS.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DGenetic%2520Validation%2520of%2520Leishmania%2520Genes%2520Essential%2520for%2520Amastigote%2520Survival%2520in%2520Vivo%2520Using%2520N-Myristoyltransferase%2520as%2520a%2520Model%26jtitle%3DParasites%2520Vectors%26date%3D2020%26volume%3D13%26spage%3D132%26doi%3D10.1186%2Fs13071-020-3999-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corpas-Lopez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zander-Dinse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Validation of N-Myristoyltransferase as a Drug Target in <i>Leishmania Donovani</i></span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCisb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=111-122&author=V.+Corpas-Lopezauthor=S.+Monizauthor=M.+Thomasauthor=R.+J.+Wallauthor=L.+S.+Torrieauthor=D.+Zander-Dinseauthor=M.+Tintiauthor=S.+Brandauthor=L.+Stojanovskiauthor=S.+Manthriauthor=I.+Hallyburtonauthor=F.+Zuccottoauthor=P.+G.+Wyattauthor=M.+De+Ryckerauthor=D.+Hornauthor=M.+A.+J.+Fergusonauthor=J.+Closauthor=K.+D.+Readauthor=A.+H.+Fairlambauthor=I.+H.+Gilbertauthor=S.+Wyllie&title=Pharmacological+Validation+of+N-Myristoyltransferase+as+a+Drug+Target+in+Leishmania+Donovani&doi=10.1021%2Facsinfecdis.8b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani</span></div><div class="casAuthors">Corpas-Lopez, Victoriano; Moniz, Sonia; Thomas, Michael; Wall, Richard J.; Torrie, Leah S.; Zander-Dinse, Dorothea; Tinti, Michele; Brand, Stephen; Stojanovski, Laste; Manthri, Sujatha; Hallyburton, Irene; Zuccotto, Fabio; Wyatt, Paul G.; De Rycker, Manu; Horn, David; Ferguson, Michael A. J.; Clos, Joachim; Read, Kevin D.; Fairlamb, Alan H.; Gilbert, Ian H.; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-122</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL), caused by the protozoan parasites Leishmania donovani and L. infantum, is responsible for ∼30,000 deaths annually.  Available treatments are inadequate, and there is a pressing need for new therapeutics.  N-Myristoyltransferase (NMT) remains one of the few genetically validated drug targets in these parasites.  Here, the authors sought to pharmacol. validate this enzyme in Leishmania.  A focused set of 1600 pyrazolyl sulfonamide compds. was screened against L. major NMT in a robust high-throughput biochem. assay.  Several potent inhibitors were identified with marginal selectivity over the human enzyme.  There was little correlation between the enzyme potency of these inhibitors and their cellular activity against L. donovani axenic amastigotes, and this discrepancy could be due to poor cellular uptake due to the basicity of these compds.  Thus, a series of analogs were synthesized with less basic centers.  Although most of these compds. continued to suffer from relatively poor antileishmanial activity, the authors' most potent inhibitor of LmNMT (DDD100097, Ki of 0.34 nM) showed modest activity against L. donovani intracellular amastigotes (EC50 of 2.4 μM) and maintained a modest therapeutic window over the human enzyme.  Two unbiased approaches, namely, screening against the authors' cosmid-based overexpression library and thermal proteome profiling (TPP), confirm that DDD100097 (compd. 2) acts on-target within parasites.  Oral dosing with compd. 2 resulted in a 52% redn. in parasite burden in the authors' mouse model of VL.  Thus, NMT is now a pharmacol. validated target in Leishmania.  The challenge in finding drug candidates remains to identify alternative strategies to address the drop-off in activity between enzyme inhibition and in vitro activity while maintaining sufficient selectivity over the human enzyme, both issues that continue to plague studies in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtsAYd4MiZRLVg90H21EOLACvtfcHk0ljpcBhhgbteJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCisb%252FI&md5=5901cad939de2eb6beab6d4454e21acb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00226%26sid%3Dliteratum%253Aachs%26aulast%3DCorpas-Lopez%26aufirst%3DV.%26aulast%3DMoniz%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DZander-Dinse%26aufirst%3DD.%26aulast%3DTinti%26aufirst%3DM.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DClos%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DPharmacological%2520Validation%2520of%2520N-Myristoyltransferase%2520as%2520a%2520Drug%2520Target%2520in%2520Leishmania%2520Donovani%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D111%26epage%3D122%26doi%3D10.1021%2Facsinfecdis.8b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Peptidomimetic Inhibitors of N-Myristoyltransferase from Human Malaria and Leishmaniasis Parasites</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">8132</span>– <span class="NLM_lpage">8137</span>, <span class="refDoi"> DOI: 10.1039/C4OB01669F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FC4OB01669F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25230674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=8132-8137&author=T.+O.+Olaleyeauthor=J.+A.+Branniganauthor=S.+M.+Robertsauthor=R.+J.+Leatherbarrowauthor=A.+J.+Wilkinsonauthor=E.+W.+Tate&title=Peptidomimetic+Inhibitors+of+N-Myristoyltransferase+from+Human+Malaria+and+Leishmaniasis+Parasites&doi=10.1039%2FC4OB01669F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites</span></div><div class="casAuthors">Olaleye, Tayo O.; Brannigan, James A.; Roberts, Shirley M.; Leatherbarrow, Robin J.; Wilkinson, Anthony J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">8132-8137</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) has been shown to be essential in Leishmania and subsequently validated as a drug target in Plasmodium.  Herein, we discuss the use of antifungal NMT inhibitors as a basis for inhibitor development resulting in the first sub-micromolar peptidomimetic inhibitors of Plasmodium and Leishmania NMTs.  High-resoln. structures of these inhibitors with Plasmodium and Leishmania NMTs permit a comparative anal. of binding modes, and provide the first crystal structure evidence for a ternary NMT-CoA/myristoylated peptide product complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMmfvqE4krX7Vg90H21EOLACvtfcHk0ljpcBhhgbteJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeis7%252FI&md5=10d2396d56ad7c7b31168ba9fda5c36b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC4OB01669F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01669F%26sid%3Dliteratum%253Aachs%26aulast%3DOlaleye%26aufirst%3DT.%2BO.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DPeptidomimetic%2520Inhibitors%2520of%2520N-Myristoyltransferase%2520from%2520Human%2520Malaria%2520and%2520Leishmaniasis%2520Parasites%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D8132%26epage%3D8137%26doi%3D10.1039%2FC4OB01669F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rackham, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of High Affinity Inhibitors of <i>Leishmania Donovani</i> N-Myristoyltransferase</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1039/C5MD00241A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FC5MD00241A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=26962429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCgsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1761-1766&author=M.+D.+Rackhamauthor=Z.+Yuauthor=J.+A.+Branniganauthor=W.+P.+Healauthor=D.+Paapeauthor=K.+V.+Barkerauthor=A.+J.+Wilkinsonauthor=D.+F.+Smithauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Discovery+of+High+Affinity+Inhibitors+of+Leishmania+Donovani+N-Myristoyltransferase&doi=10.1039%2FC5MD00241A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase</span></div><div class="casAuthors">Rackham, Mark D.; Yu, Zhiyong; Brannigan, James A.; Heal, William P.; Paape, Daniel; Barker, K. Victoria; Wilkinson, Anthony J.; Smith, Deborah F.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1761-1766</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites.  Scaffold-hopping from published inhibitors yielded the serendipitous discovery of a chemotype selective for Leishmania donovani NMT; development led to high affinity inhibitors with excellent ligand efficiency.  The binding mode was characterised by crystallog. and provides a structural rationale for selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8wVOTTgUYwbVg90H21EOLACvtfcHk0ljpcBhhgbteJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCgsLfN&md5=5d4e82aa0e296b9de25419e42da10c76</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC5MD00241A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00241A%26sid%3Dliteratum%253Aachs%26aulast%3DRackham%26aufirst%3DM.%2BD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DBarker%26aufirst%3DK.%2BV.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DDiscovery%2520of%2520High%2520Affinity%2520Inhibitors%2520of%2520Leishmania%2520Donovani%2520N-Myristoyltransferase%26jtitle%3DMedchemcomm%26date%3D2015%26volume%3D6%26spage%3D1761%26epage%3D1766%26doi%3D10.1039%2FC5MD00241A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loesel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Plate-Based Diversity Subset Screening Generation 2: An Improved Paradigm for High-Throughput Screening of Large Compound Files</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9692-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1007%2Fs11030-016-9692-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=27631533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=789-803&author=A.+S.+Bellauthor=J.+Bradleyauthor=J.+R.+Everettauthor=J.+Loeselauthor=D.+McLoughlinauthor=J.+Millsauthor=M.+C.+Peakmanauthor=R.+E.+Sharpauthor=C.+Williamsauthor=H.+Zhu&title=Plate-Based+Diversity+Subset+Screening+Generation+2%3A+An+Improved+Paradigm+for+High-Throughput+Screening+of+Large+Compound+Files&doi=10.1007%2Fs11030-016-9692-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files</span></div><div class="casAuthors">Bell, Andrew S.; Bradley, Joseph; Everett, Jeremy R.; Loesel, Jens; McLoughlin, David; Mills, James; Peakman, Marie-Claire; Sharp, Robert E.; Williams, Christine; Zhu, Hongyao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">789-803</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) is an effective method for lead and probe discovery that is widely used in industry and academia to identify novel chem. matter and to initiate the drug discovery process.  However, HTS can be time consuming and costly and the use of subsets as an efficient alternative to screening entire compd. collections has been investigated.  Subsets may be selected on the basis of chem. diversity, mol. properties, biol. activity diversity or biol. target focus.  Previously, we described a novel form of subset screening: plate-based diversity subset (PBDS) screening, in which the screening subset is constructed by plate selection (rather than individual compd. cherry-picking), using algorithms that select for compd. quality and chem. diversity on a plate basis.  In this paper, we describe a second-generation approach to the construction of an updated subset: PBDS2, using both plate and individual compd. selection, that has an improved coverage of the chem. space of the screening file, while only selecting the same no. of plates for screening.  We describe the validation of PBDS2 and its successful use in hit and lead discovery.  PBDS2 screening became the default mode of singleton (one compd. per well) HTS for lead discovery in Pfizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWz1_6LByvVbVg90H21EOLACvtfcHk0lhaQlO6VHmW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymtbbI&md5=c7c558015d75d1ef1c20f74400075ed9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9692-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9692-9%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DEverett%26aufirst%3DJ.%2BR.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DMcLoughlin%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DJ.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26aulast%3DSharp%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DPlate-Based%2520Diversity%2520Subset%2520Screening%2520Generation%25202%253A%2520An%2520Improved%2520Paradigm%2520for%2520High-Throughput%2520Screening%2520of%2520Large%2520Compound%2520Files%26jtitle%3DMol.%2520Diversity%26date%3D2016%26volume%3D20%26spage%3D789%26epage%3D803%26doi%3D10.1007%2Fs11030-016-9692-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibitors of Protozoan Protein N-Myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1625</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0001625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pntd.0001625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22545171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&author=A.+S.+Bellauthor=J.+E.+Millsauthor=G.+P.+Williamsauthor=J.+A.+Branniganauthor=A.+J.+Wilkinsonauthor=T.+Parkinsonauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tateauthor=A.+A.+Holderauthor=D.+F.+Smith&title=Selective+Inhibitors+of+Protozoan+Protein+N-Myristoyltransferases+as+Starting+Points+for+Tropical+Disease+Medicinal+Chemistry+Programs&doi=10.1371%2Fjournal.pntd.0001625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs</span></div><div class="casAuthors">Bell, Andrew S.; Mills, James E.; Williams, Gareth P.; Brannigan, James A.; Wilkinson, Anthony J.; Parkinson, Tanya; Leatherbarrow, Robin J.; Tate, Edward W.; Holder, Anthony A.; Smith, Deborah F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1625</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inhibition of N-myristoyltransferase has been validated pre-clin. as a target for the treatment of fungal and trypanosome infections, using species-specific inhibitors.  In order to identify inhibitors of protozoan NMTs, we chose to screen a diverse subset of the Pfizer corporate collection against Plasmodium falciparum and Leishmania donovani NMTs.  Primary screening hits against either enzyme were tested for selectivity over both human NMT isoforms (Hs1 and Hs2) and for broad-spectrum anti-protozoan activity against the NMT from Trypanosoma brucei.  Anal. of the screening results has shown that structure-activity relationships (SAR) for Leishmania NMT are divergent from all other NMTs tested, a finding not predicted by sequence similarity calcns., resulting in the identification of four novel series of Leishmania-selective NMT inhibitors.  We found a strong overlap between the SARs for Plasmodium NMT and both human NMTs, suggesting that achieving an appropriate selectivity profile will be more challenging.  However, we did discover two novel series with selectivity for Plasmodium NMT over the other NMT orthologues in this study, and an addnl. two structurally distinct series with selectivity over Leishmania NMT.  We believe that release of results from this study into the public domain will accelerate the discovery of NMT inhibitors to treat malaria and leishmaniasis.  Our screening initiative is another example of how a tripartite partnership involving pharmaceutical industries, academic institutions and governmental/non-governmental organisations such as Medical Research Council and Wellcome Trust can stimulate research for neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSnKVEdu_4pLVg90H21EOLACvtfcHk0lhaQlO6VHmW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOktbs%253D&md5=93ae0e5eda8a7cf1affcb8a26f4483f4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001625%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DG.%2BP.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DHolder%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DSelective%2520Inhibitors%2520of%2520Protozoan%2520Protein%2520N-Myristoyltransferases%2520as%2520Starting%2520Points%2520for%2520Tropical%2520Disease%2520Medicinal%2520Chemistry%2520Programs%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26doi%3D10.1371%2Fjournal.pntd.0001625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span> <span> </span><span class="NLM_article-title">Diverse Modes of Binding in Structures of Leishmania Major N-Myristoyltransferase with Selective Inhibitors</span>. <i>IUCrJ</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1107/S2052252514013001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS2052252514013001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25075346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=250-260&author=J.+A.+Branniganauthor=S.+M.+Robertsauthor=A.+S.+Bellauthor=J.+A.+Huttonauthor=M.+R.+Hodgkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrowauthor=D.+F.+Smithauthor=A.+J.+Wilkinson&title=Diverse+Modes+of+Binding+in+Structures+of+Leishmania+Major+N-Myristoyltransferase+with+Selective+Inhibitors&doi=10.1107%2FS2052252514013001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors</span></div><div class="casAuthors">Brannigan, James A.; Roberts, Shirley M.; Bell, Andrew S.; Hutton, Jennie A.; Hodgkinson, Michael R.; Tate, Edward W.; Leatherbarrow, Robin J.; Smith, Deborah F.; Wilkinson, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">250-260</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The leishmaniases are a spectrum of global diseases of poverty assocd. with immune dysfunction and are the cause of high morbidity.  Despite the long history of these diseases, no effective vaccine is available and the currently used drugs are variously compromised by moderate efficacy, complex side effects and the emergence of resistance.  It is therefore widely accepted that new therapies are needed.  N-Myristoyltransferase (NMT) has been validated pre-clin. as a target for the treatment of fungal and parasitic infections.  In a previously reported high-throughput screening program, a no. of hit compds. with activity against NMT from Leishmania donovani have been identified.  Here, high-resoln. crystal structures of representative compds. from four hit series in ternary complexes with myristoyl-CoA and NMT from the closely related L. major are reported.  The structures reveal that the inhibitors assoc. with the peptide-binding groove at a site adjacent to the bound myristoyl-CoA and the catalytic α-carboxylate of Leu421.  Each inhibitor makes extensive apolar contacts as well as a small no. of polar contacts with the protein.  Remarkably, the compds. exploit different features of the peptide-binding groove and collectively occupy a substantial vol. of this pocket, suggesting that there is potential for the design of chimaeric inhibitors with significantly enhanced binding.  Despite the high conservation of the active sites of the parasite and human NMTs, the inhibitors act selectively over the host enzyme.  The role of conformational flexibility in the side chain of Tyr217 in conferring selectivity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ-gxtPrLIabVg90H21EOLACvtfcHk0lifg6136WjiJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrnI&md5=b15cdf5bb8d37523f2459f938d430b8a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS2052252514013001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252514013001%26sid%3Dliteratum%253Aachs%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DHodgkinson%26aufirst%3DM.%2BR.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26atitle%3DDiverse%2520Modes%2520of%2520Binding%2520in%2520Structures%2520of%2520Leishmania%2520Major%2520N-Myristoyltransferase%2520with%2520Selective%2520Inhibitors%26jtitle%3DIUCrJ%26date%3D2014%26volume%3D1%26spage%3D250%26epage%3D260%26doi%3D10.1107%2FS2052252514013001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waugh, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Potent and Selective Leishmania N-Myristoyltransferase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8664</span>– <span class="NLM_lpage">8670</span>, <span class="refDoi"> DOI: 10.1021/jm5011397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5011397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8664-8670&author=J.+A.+Huttonauthor=V.+Goncalvesauthor=J.+A.+Branniganauthor=D.+Paapeauthor=M.+H.+Wrightauthor=T.+M.+Waughauthor=S.+M.+Robertsauthor=A.+S.+Bellauthor=A.+J.+Wilkinsonauthor=D.+F.+Smithauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tate&title=Structure-Based+Design+of+Potent+and+Selective+Leishmania+N-Myristoyltransferase+Inhibitors&doi=10.1021%2Fjm5011397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Potent and Selective Leishmania N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Hutton, Jennie A.; Goncalves, Victor; Brannigan, James A.; Paape, Daniel; Wright, Megan H.; Waugh, Thomas M.; Roberts, Shirley M.; Bell, Andrew S.; Wilkinson, Anthony J.; Smith, Deborah F.; Leatherbarrow, Robin J.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8664-8670</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of LeishmaniaN-myristoyltransferase (NMT), a potential target for the treatment of leishmaniasis, obtained from a high-throughput screen, were resynthesized to validate activity.  Crystal structures bound to Leishmania major NMT were obtained, and the active diastereoisomer of one of the inhibitors was identified.  On the basis of structural insights, enzyme inhibition was increased 40-fold through hybridization of two distinct binding modes, resulting in novel, highly potent Leishmania donovani NMT inhibitors with good selectivity over the human enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QZaQ-6mXcLVg90H21EOLACvtfcHk0lifg6136WjiJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyjtbzN&md5=e9d662f2d180e001fa50fa1468e60a99</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm5011397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5011397%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DWaugh%26aufirst%3DT.%2BM.%26aulast%3DRoberts%26aufirst%3DS.%2BM.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520and%2520Selective%2520Leishmania%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8664%26epage%3D8670%26doi%3D10.1021%2Fjm5011397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paape, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. F.</span></span> <span> </span><span class="NLM_article-title">Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-Myristoylation in Intracellular Leishmania Amastigotes</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e3363</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0003363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1371%2Fjournal.pntd.0003363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25522361" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&author=D.+Paapeauthor=A.+S.+Bellauthor=W.+P.+Healauthor=J.+A.+Huttonauthor=R.+J.+Leatherbarrowauthor=E.+W.+Tateauthor=D.+F.+Smith&title=Using+a+Non-Image-Based+Medium-Throughput+Assay+for+Screening+Compounds+Targeting+N-Myristoylation+in+Intracellular+Leishmania+Amastigotes&doi=10.1371%2Fjournal.pntd.0003363"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003363%26sid%3Dliteratum%253Aachs%26aulast%3DPaape%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DHutton%26aufirst%3DJ.%2BA.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSmith%26aufirst%3DD.%2BF.%26atitle%3DUsing%2520a%2520Non-Image-Based%2520Medium-Throughput%2520Assay%2520for%2520Screening%2520Compounds%2520Targeting%2520N-Myristoylation%2520in%2520Intracellular%2520Leishmania%2520Amastigotes%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26doi%3D10.1371%2Fjournal.pntd.0003363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armarego, W. L. F.</span></span> <span> </span><span class="NLM_article-title">Quinazolines</span>. In  <i>Advances in Heterocyclic Chemistry</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritzky, A. R.</span>; <span class="NLM_string-name">Boulton, A. J.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1979</span>; Vol.  <span class="NLM_volume">24</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">62</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=1-62&author=W.+L.+F.+Armaregoauthor=A.+R.+Katritzky&author=A.+J.+Boulton&title=Advances+in+Heterocyclic+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26atitle%3DQuinazolines%26btitle%3DAdvances%2520in%2520Heterocyclic%2520Chemistry%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26pub%3DAcademic%2520Press%26date%3D1979%26volume%3D24%26spage%3D1%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dam, C. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kanter, F. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jongejan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coruzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and QSAR of Quinazoline Sulfonamides As Highly Potent Human Histamine H4 Receptor Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2390</span>– <span class="NLM_lpage">2400</span>, <span class="refDoi"> DOI: 10.1021/jm901379s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901379s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2390-2400&author=R.+A.+Smitsauthor=M.+Adamiauthor=E.+P.+Istyastonoauthor=O.+P.+Zuiderveldauthor=C.+M.+E.+Van+Damauthor=F.+J.+J.+De+Kanterauthor=A.+Jongejanauthor=G.+Coruzziauthor=R.+Leursauthor=I.+J.+P.+De+Esch&title=Synthesis+and+QSAR+of+Quinazoline+Sulfonamides+As+Highly+Potent+Human+Histamine+H4+Receptor+Inverse+Agonists&doi=10.1021%2Fjm901379s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and QSAR of Quinazoline Sulfonamides As Highly Potent Human Histamine H4 Receptor Inverse Agonists</span></div><div class="casAuthors">Smits, Rogier A.; Adami, Maristella; Istyastono, Enade P.; Zuiderveld, Obbe P.; van Dam, Cindy M. E.; de Kanter, Frans J. J.; Jongejan, Aldo; Coruzzi, Gabriella; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2390-2400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hit optimization of the class of quinazoline-contg. histamine H4 receptor (H4R) ligands I (X = CH2, CH2CH2; R1 = 6-Cl, 6-I, 5-CF3, 6,7-Cl2, etc.; R2 = H2N, MeNH, Et2N, Me, 1-pyrrolidinyl, PhNMe, etc.) resulted in a sulfonamide substituted analog with high affinity for the H4R.  This moiety leads to improved physicochem. properties and is believed to probe a distinct H4R binding pocket that was previously identified using pharmacophore modeling.  By introducing a variety of sulfonamide substituents, the H4R affinity was optimized.  The interaction of the new ligands, in combination with a set of previously published quinazoline compds., was described by a QSAR equation.  Pharmacol. studies revealed that the sulfonamide analogs have excellent H4R affinity and behave as inverse agonists at the human H4R.  In vivo evaluation of the potent compd. I (X = CH2; R1 = 6-Cl; R2 = PhNH) (pKi = 8.31 ± 0.10) showed it to have anti-inflammatory activity in an animal model of acute inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIe7efwOjS07Vg90H21EOLACvtfcHk0li_k7AaCLKBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGlsrc%253D&md5=0b50786b4a0e4514d55bb7af4fd2618b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm901379s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901379s%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DVan%2BDam%26aufirst%3DC.%2BM.%2BE.%26aulast%3DDe%2BKanter%26aufirst%3DF.%2BJ.%2BJ.%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DDe%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DSynthesis%2520and%2520QSAR%2520of%2520Quinazoline%2520Sulfonamides%2520As%2520Highly%2520Potent%2520Human%2520Histamine%2520H4%2520Receptor%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2390%26epage%3D2400%26doi%3D10.1021%2Fjm901379s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, M.</span></span> <span> </span><span class="NLM_article-title">Reaction of N-Substituted Cyclic Amines with 2,4-Dichloroquinazoline, 2,4- Dichloropyrimidine, and its 5-Methyl Derivative</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1039/p19920000919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2Fp19920000919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=919-922&author=K.+Yoshidaauthor=M.+Taguchi&title=Reaction+of+N-Substituted+Cyclic+Amines+with+2%2C4-Dichloroquinazoline%2C+2%2C4-+Dichloropyrimidine%2C+and+its+5-Methyl+Derivative&doi=10.1039%2Fp19920000919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fp19920000919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19920000919%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DM.%26atitle%3DReaction%2520of%2520N-Substituted%2520Cyclic%2520Amines%2520with%25202%252C4-Dichloroquinazoline%252C%25202%252C4-%2520Dichloropyrimidine%252C%2520and%2520its%25205-Methyl%2520Derivative%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1992%26volume%3D1%26spage%3D919%26epage%3D922%26doi%3D10.1039%2Fp19920000919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olofson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piteau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfroot, T.</span></span> <span> </span><span class="NLM_article-title">A New Reagent for the Selective, High-Yield n-Dealkylation of Tertiary Amines: Improved Syntheses of Naltrexone and Nalbuphine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2081</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1021/jo00185a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00185a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=2081-2082&author=R.+A.+Olofsonauthor=J.+T.+Martzauthor=J.+P.+Senetauthor=M.+Piteauauthor=T.+Malfroot&title=A+New+Reagent+for+the+Selective%2C+High-Yield+n-Dealkylation+of+Tertiary+Amines%3A+Improved+Syntheses+of+Naltrexone+and+Nalbuphine&doi=10.1021%2Fjo00185a072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A new reagent for the selective, high-yield N-dealkylation of tertiary amines:  improved syntheses of naltrexone and nalbuphine</span></div><div class="casAuthors">Olofson, R. A.; Martz, Jonathan T.; Senet, Jean Pierre; Piteau, Marc; Malfroot, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2081-2</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Reaction of tertiary amines with ClCO2CHClMe in ClCH2CH2Cl at reflux affords the intermediates, R2NCO2CHClMe (R = alkyl, R2 = cycloalkyl), which are converted to the desired salts, R2NH·HCl, just by heating in MeOH.  The N-dealkylation reagent is made in 96% yield by mixing MeCHO with COCl2 in the presence of an R4N+ Cl- catalyst.  The N-dealkylations are highly selective, mild, occur in high yield, and permit the presence of a variety of functionalities.  The process is exemplified by the conversion of glaucine (I) to the phenanthrene (II) in 89% yield and by the N-demethylations of arecoline, O-acetyltropine, and 6-acetylcodeine in yields of 95-97%.  The methodol. was used as part of a process for the transformation of oxycodone to the com. narcotic antagonist, naltrexone (58% overall yield) and to the prescription analgesic, nalbuphine (III) (69% overall yield).  Arom. tertiary amines also are N-dealkylated, although under more vigorous conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcSuAJiJApjLVg90H21EOLACvtfcHk0li_k7AaCLKBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktlyks7k%253D&md5=9402bfb15be7a0d057bfe7bf95bde7b6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00185a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00185a072%26sid%3Dliteratum%253Aachs%26aulast%3DOlofson%26aufirst%3DR.%2BA.%26aulast%3DMartz%26aufirst%3DJ.%2BT.%26aulast%3DSenet%26aufirst%3DJ.%2BP.%26aulast%3DPiteau%26aufirst%3DM.%26aulast%3DMalfroot%26aufirst%3DT.%26atitle%3DA%2520New%2520Reagent%2520for%2520the%2520Selective%252C%2520High-Yield%2520n-Dealkylation%2520of%2520Tertiary%2520Amines%253A%2520Improved%2520Syntheses%2520of%2520Naltrexone%2520and%2520Nalbuphine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D2081%26epage%3D2082%26doi%3D10.1021%2Fjo00185a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzarone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leatherbarrow, R. J.</span></span> <span> </span><span class="NLM_article-title">A Fluorescence-Based Assay for N-Myristoyltransferase Activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1016%2Fj.ab.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=22051857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=342-344&author=V.+Goncalvesauthor=J.+A.+Branniganauthor=E.+Thinonauthor=T.+O.+Olaleyeauthor=R.+Serwaauthor=S.+Lanzaroneauthor=A.+J.+Wilkinsonauthor=E.+W.+Tateauthor=R.+J.+Leatherbarrow&title=A+Fluorescence-Based+Assay+for+N-Myristoyltransferase+Activity&doi=10.1016%2Fj.ab.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based assay for N-myristoyltransferase activity</span></div><div class="casAuthors">Goncalves, Victor; Brannigan, James A.; Thinon, Emmanuelle; Olaleye, Tayo O.; Serwa, Remigiusz; Lanzarone, Salvatore; Wilkinson, Anthony J.; Tate, Edward W.; Leatherbarrow, Robin J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-344</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-myristoylation is the irreversible attachment of a C14 fatty acid, myristic acid, to the N-terminal glycine of a protein via formation of an amide bond.  This modification is catalyzed by myristoyl-CoA:protein N-myristoyltransferase (NMT), an enzyme ubiquitous in eukaryotes that is up-regulated in several cancers.  Here we report a sensitive fluorescence-based assay to study the enzymic activity of human NMT1 and NMT2 based on detection of CoA by 7-diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin (CPM).  We also describe expression and characterization of NMT1 and NMT2 and assay validation with small mol. inhibitors.  This assay should be broadly applicable to NMTs from a range of organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8ouiGX0Ml7Vg90H21EOLACvtfcHk0li_k7AaCLKBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVehtg%253D%253D&md5=b0b36c043d6947a0843e19eddb9d9f43</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%26aufirst%3DV.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DOlaleye%26aufirst%3DT.%2BO.%26aulast%3DSerwa%26aufirst%3DR.%26aulast%3DLanzarone%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DA.%2BJ.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DLeatherbarrow%26aufirst%3DR.%2BJ.%26atitle%3DA%2520Fluorescence-Based%2520Assay%2520for%2520N-Myristoyltransferase%2520Activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D421%26spage%3D342%26epage%3D344%26doi%3D10.1016%2Fj.ab.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Questel, J. Y.</span></span> <span> </span><span class="NLM_article-title">Amino Nitrogen and Carbonyl Oxygen in Competitive Situations: Which Is the Best Hydrogen-Bond Acceptor Site?</span>. <i>CrystEngComm</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1039/B202248F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1039%2FB202248F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFKktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=326-335&author=N.+Ziaoauthor=C.+Laurenceauthor=J.+Y.+Le+Questel&title=Amino+Nitrogen+and+Carbonyl+Oxygen+in+Competitive+Situations%3A+Which+Is+the+Best+Hydrogen-Bond+Acceptor+Site%3F&doi=10.1039%2FB202248F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amino nitrogen and carbonyl oxygen in competitive situations: which is the best hydrogen-bond acceptor site?</span></div><div class="casAuthors">Ziao, Nahosse; Laurence, Christian; Le Questel, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">CrystEngComm</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">326-335</span>CODEN:
                <span class="NLM_cas:coden">CRECF4</span>;
        ISSN:<span class="NLM_cas:issn">1466-8033</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The relative H-bond acceptor abilities of amino N and carbonyl O in various chem. environments were studied using data retrieved from the Cambridge Structural Database (CSD) and via ab initio MO calcns.  Surveys of the CSD for H bonds between HX (X = N, O) donors and push-pull or satd. amino ketone and amino ester mol. fragments show that the H bonds are much more frequent on the O than on the amino N.  In the push-pull families, the H-bonding (HB) ability of the carbonyl O is increased by conjugation between the lone pair of the amino substituent and the C=O group, a behavior similar to resonance-assisted H bonding.  The unexpected behavior of twisted amides, in which only the amino N is involved in H bonding, is pointed out.  This unusual feature is explained by the disruption of conjugation between the amino lone pair and the carbonyl owing to the cyclization involving the amino moiety.  In aliph. systems, the amino N retains its HB ability but is still involved in a rather low no. of contacts.  This behavior reflects the sensitivity of the amino N to steric hindrance. The relative strengths of the H bonds on the carbonyl O in ketones and esters follow the exptl. order of H-bond basicity as obsd. in soln. through the pKHB scale.  Ab initio MO calcns. (B3LYP/6-31+G** level) of electrostatic and charge transfer descriptors also confirm the exptl. observations. pKa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorW-ZFotJZALVg90H21EOLACvtfcHk0lgd6atZPcsKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFKktr0%253D&md5=bd71a6177b58e4b599e26506953abc33</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FB202248F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB202248F%26sid%3Dliteratum%253Aachs%26aulast%3DZiao%26aufirst%3DN.%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26atitle%3DAmino%2520Nitrogen%2520and%2520Carbonyl%2520Oxygen%2520in%2520Competitive%2520Situations%253A%2520Which%2520Is%2520the%2520Best%2520Hydrogen-Bond%2520Acceptor%2520Site%253F%26jtitle%3DCrystEngComm%26date%3D2002%26volume%3D4%26spage%3D326%26epage%3D335%26doi%3D10.1039%2FB202248F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/jm201091t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201091t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=140-152&author=S.+Brandauthor=L.+A.+T.+Cleghornauthor=S.+P.+McElroyauthor=D.+A.+Robinsonauthor=V.+C.+Smithauthor=I.+Hallyburtonauthor=J.+R.+Harrisonauthor=N.+R.+Norcrossauthor=D.+Spinksauthor=T.+Baylissauthor=S.+Norvalauthor=L.+Stojanovskiauthor=L.+S.+Torrieauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Discovery+of+a+Novel+Class+of+Orally+Active+Trypanocidal+N-Myristoyltransferase+Inhibitors&doi=10.1021%2Fjm201091t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Brand, Stephen; Cleghorn, Laura A. T.; McElroy, Stuart P.; Robinson, David A.; Smith, Victoria C.; Hallyburton, Irene; Harrison, Justin R.; Norcross, Neil R.; Spinks, Daniel; Bayliss, Tracy; Norval, Suzanne; Stojanovski, Laste; Torrie, Leah S.; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei.  We report the optimization of a high throughput screening hit (1) to give a lead mol. DDD85646 (63), which has potent activity against the enzyme (IC50 = 2 nM) and T. brucei (EC50 = 2 nM) in culture.  The compd. has good oral pharmacokinetics and cures rodent models of peripheral HAT infection.  This compd. provides an excellent tool for validation of T. brucei NMT as a drug target for HAT as well as a valuable lead for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCg4lhwv5cTrVg90H21EOLACvtfcHk0lgd6atZPcsKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK&md5=1479aed07e07e99f58de9012c7ec6631</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm201091t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201091t%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Orally%2520Active%2520Trypanocidal%2520N-Myristoyltransferase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D140%26epage%3D152%26doi%3D10.1021%2Fjm201091t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Broncel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciepla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Reagents for Quantitative Proteome-Wide Analysis of Protein Modification in Human Cells and Dynamic Profiling of Protein Lipidation during Vertebrate Development</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5948</span>– <span class="NLM_lpage">5951</span>, <span class="refDoi"> DOI: 10.1002/anie.201500342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1002%2Fanie.201500342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=25807930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlKht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=5948-5951&author=M.+Broncelauthor=R.+A.+Serwaauthor=P.+Cieplaauthor=E.+Krauseauthor=M.+J.+Dallmanauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Multifunctional+Reagents+for+Quantitative+Proteome-Wide+Analysis+of+Protein+Modification+in+Human+Cells+and+Dynamic+Profiling+of+Protein+Lipidation+during+Vertebrate+Development&doi=10.1002%2Fanie.201500342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Reagents for Quantitative Proteome-Wide Analysis of Protein Modification in Human Cells and Dynamic Profiling of Protein Lipidation During Vertebrate Development</span></div><div class="casAuthors">Broncel, Malgorzata; Serwa, Remigiusz A.; Ciepla, Paulina; Krause, Eberhard; Dallman, Margaret J.; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5948-5951</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Novel multifunctional reagents were applied in combination with a lipid probe for affinity enrichment of myristoylated proteins and direct detection of lipid-modified tryptic peptides by mass spectrometry.  This method enables high-confidence identification of the myristoylated proteome on an unprecedented scale in cell culture, and allowed the first quant. anal. of dynamic changes in protein lipidation during vertebrate embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrepU8XZGNxbLVg90H21EOLACvtfcHk0lgd6atZPcsKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlKht7c%253D&md5=d78c278b1535bdb86a5b31c57313e39b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.201500342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201500342%26sid%3Dliteratum%253Aachs%26aulast%3DBroncel%26aufirst%3DM.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DCiepla%26aufirst%3DP.%26aulast%3DKrause%26aufirst%3DE.%26aulast%3DDallman%26aufirst%3DM.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DMultifunctional%2520Reagents%2520for%2520Quantitative%2520Proteome-Wide%2520Analysis%2520of%2520Protein%2520Modification%2520in%2520Human%2520Cells%2520and%2520Dynamic%2520Profiling%2520of%2520Protein%2520Lipidation%2520during%2520Vertebrate%2520Development%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D5948%26epage%3D5951%26doi%3D10.1002%2Fanie.201500342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heal, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Protein Labeling via Enzymatic N-Terminal Tagging and Elaboration by Click Chemistry</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/nprot.2011.425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1038%2Fnprot.2011.425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=105-117&author=W.+P.+Healauthor=M.+H.+Wrightauthor=E.+Thinonauthor=E.+W.+Tate&title=Multifunctional+Protein+Labeling+via+Enzymatic+N-Terminal+Tagging+and+Elaboration+by+Click+Chemistry&doi=10.1038%2Fnprot.2011.425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional protein labeling via enzymatic N-terminal tagging and elaboration by click chemistry</span></div><div class="casAuthors">Heal, Wiliam P.; Wright, Megan H.; Thinon, Emmanuelle; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-117</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A protocol for selective and site-specific enzymic labeling of proteins is described.  The method exploits the protein co-/post-translational modification known as myristoylation, the transfer of myristic acid (a 14-carbon satd. fatty acid) to an N-terminal glycine catalyzed by the enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT).  Escherichia coli, having no endogenous NMT, is used for the coexpression of both the transferase and the target protein to be labeled, which participate in the in vivo N-terminal attachment of synthetically derived tagged analogs of myristic acid bearing a 'clickable' tag.  This tag is a functional group that can undergo bio-orthogonal ligation via 'click' chem., for example, an azide, and can be used as a handle for further site-specific labeling in vitro.  Here we provide protocols for in vivo N-terminal tagging of recombinant protein, and the synthesis and application of multifunctional reagents that enable protein labeling via click chem. for affinity purifn. and detection by fluorescence.  In addn. to general N-terminal protein labeling, the protocol would be of particular use in providing evidence for native myristoylation of proteins of interest, proof of activity/selectivity of NMTs and cross-species reactivity of NMTs without resorting to the use of radioactive isotopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoxNpNTi44lrVg90H21EOLACvtfcHk0lh1heybqNdF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kisbc%253D&md5=4fc52c6ad99164c10634be5f407a5679</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2011.425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2011.425%26sid%3Dliteratum%253Aachs%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DMultifunctional%2520Protein%2520Labeling%2520via%2520Enzymatic%2520N-Terminal%2520Tagging%2520and%2520Elaboration%2520by%2520Click%2520Chemistry%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D105%26epage%3D117%26doi%3D10.1038%2Fnprot.2011.425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title"><i>XDS</i></span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&issue=2&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lh1heybqNdF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P.</span></span> <span> </span><span class="NLM_article-title">Scaling and Assessment of Data Quality</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1107/S0907444905036693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444905036693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=16369096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=72-82&author=P.+Evans&title=Scaling+and+Assessment+of+Data+Quality&doi=10.1107%2FS0907444905036693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Scaling and assessment of data quality</span></div><div class="casAuthors">Evans, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-82</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The various phys. factors affecting measured diffraction intensities are discussed, as are the scaling models which may be used to put the data on a consistent scale.  After scaling, the intensities can be analyzed to set the real resoln. of the data set, to detect bad regions (e.g. bad images), to analyze radiation damage and to assess the overall quality of the data set.  The significance of any anomalous signal may be assessed by probability and correlation anal.  The algorithms used by the CCP4 scaling program SCALA are described.  A requirement for the scaling and merging of intensities is knowledge of the Laue group and point-group symmetries: the possible symmetry of the diffraction pattern may be detd. from scores such as correlation coeffs. between observations which might be symmetry-related.  These scoring functions are implemented in a new program POINTLESS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravLSLU62RhLVg90H21EOLACvtfcHk0lh1heybqNdF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant7jM&md5=293d3876e534c0c57813990515bb3c76</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444905036693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905036693%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%26atitle%3DScaling%2520and%2520Assessment%2520of%2520Data%2520Quality%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D72%26epage%3D82%26doi%3D10.1107%2FS0907444905036693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span> <span> </span><span class="NLM_article-title"><i>Xia2</i>: An Expert System for Macromolecular Crystallography Data Reduction</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1107/S0021889809045701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0021889809045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=186-190&author=G.+Winter&title=Xia2%3A+An+Expert+System+for+Macromolecular+Crystallography+Data+Reduction&doi=10.1107%2FS0021889809045701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">xia2: An expert system for macromolecular crystallography data reduction</span></div><div class="casAuthors">Winter, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-190, S186/1-S186/5</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An expert system for macromol. crystallog. data redn. is presented, which builds on existing software to automate the complete data redn. process from images to merged structure factor amplitudes.  This can automatically identify multi-wedge, multi-pass and multiwavelength data sets and includes explicit procedures to test for crystallog. special cases.  With the push towards high-throughput crystallog. at synchrotron beamlines and automation of structure soln., the ability to reduce data with no user input fills an important gap in the pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOi3u0ydXbSrVg90H21EOLACvtfcHk0lh1heybqNdF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFalsrk%253D&md5=27771caa813f3e828abdf2a331ae55e3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889809045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889809045701%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DXia2%253A%2520An%2520Expert%2520System%2520for%2520Macromolecular%2520Crystallography%2520Data%2520Reduction%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2010%26volume%3D43%26spage%3D186%26epage%3D190%26doi%3D10.1107%2FS0021889809045701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liDbaiK7Gx6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and Development of COOT</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+COOT&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liDbaiK7Gx6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520COOT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4cgo','PDB','4cgo'); return false;">PDB: 4cgo</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb','PDB','6qdb'); return false;">PDB: 6qdb</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc','PDB','6qdc'); return false;">PDB: 6qdc</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9','PDB','6qd9'); return false;">PDB: 6qd9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd','PDB','6qdd'); return false;">PDB: 6qdd</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde','PDB','6qde'); return false;">PDB: 6qde</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf','PDB','6qdf'); return false;">PDB: 6qdf</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg','PDB','6qdg'); return false;">PDB: 6qdg</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh','PDB','6qdh'); return false;">PDB: 6qdh</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qda" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qda','PDB','6qda'); return false;">PDB: 6qda</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i119"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00570">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81268"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00570?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00570</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Sequence alignment of L<i>m</i> and L<i>d</i>NMT; CPM data; Alamar blue-based assay data; X-ray diffraction data and refinement statistics; and HPLC traces of key compounds <b>1</b>, <b>43</b>, <b>50</b>, and <b>52</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular strings for final and intermediate compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_002.csv">CSV</a>)</p></li><li><p class="inline">NMR files for final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_001.pdf">jm0c00570_si_001.pdf (2.38 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_002.csv">jm0c00570_si_002.csv (6.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00570/suppl_file/jm0c00570_si_003.pdf">jm0c00570_si_003.pdf (3.28 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factor files have been deposited in the Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qd9">6qd9</a> (<i>Lm</i>NMT-MyrCoA-<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qda">6qda</a> (<i>Lm</i>NMT-MyrCoA-<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdb">6qdb</a> (<i>Lm</i>NMT-MyrCoA-<b>10</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdc">6qdc</a> (<i>Lm</i>NMT-MyrCoA-<b>12</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdd">6qdd</a> (<i>Lm</i>NMT-MyrCoA-<b>43</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qde">6qde</a> (<i>Lm</i>NMT-MyrCoA-<b>51</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdf">6qdf</a> (<i>Lm</i>NMT-MyrCoA-<b>52</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdg">6qdg</a> (<i>Lm</i>NMT-MyrCoA-<b>56</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6qdh">6qdh</a> (<i>Lm</i>NMT-MyrCoA-<b>64</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00570&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00570%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00570" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799caac1f561991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
